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1 Introduction 
1.1 Function  and  organisation of ABC transporters 
ATP binding cassette (ABC) transporters comprise a large family of membrane proteins 
that catalyze the active transfer of a variety of solutes across biological membranes (Higgins, 
1992). ABC transporters operate in all living cells from bacteria to human and fulfil a lot of 
cellular functions. Most of them act as ATP-driven transporters, which use the energy of ATP 
hydrolysis to pump substrates against a concentration gradient. However, ABC proteins can also 
function as ion channels, channel regulators, receptors, proteases and even as sensors of the 
environment (Higgins, 1995). A large variety of molecules is recognized as substrates ranging 
from ions, anticancer drugs, phospholipids, and peptides to antibiotics (Dean and Allikmets, 
1995; Kuchler and Thorner, 1992). ABC transporters can function as importers and exporters. In 
bacteria, ABC transporters often work as nutrient uptake systems like the maltose importer 
MalFGK2 from E. coli or the histidine permease HisQMP2 from S. typhimurium (Bavoil et al., 
1980; Ames and Lever, 1970). ABC pumps like LmrA or HlyB confer resistance to antibiotics and 
toxins by exporting them out of the bacterium (van Veen et al., 2001; Blight et al., 1995). 
The dysfunction of ABC transporters has been reported to be central to various human 
pathologies such as cystic fibrosis (CFTR), adrenoleukodystrophy (ALD), familial 
hyperinsulinemic hypoglycemia of infancy (SUR), and Stargardt`s disease (hABCR). A separate 
class of ABC transporters is implicated in multidrug resistance (MDR) as P-glycoprotein (P-gp) 
whose overexpression in tumour cells causes resistance to various cytotoxic agents used in 
chemotherapy (Gottesman et al., 1995). Another clinically relevant human ABC transporter is 
TAP (transporter associated with antigen processing), which translocates peptides from the 
cytosol to the ER and plays a key function in the presentation of antigenic peptides at the cell 
surface (Lankat-Buttgereit and Tampé, 2002). 
The ABC transport family shares a common modular architecture consisting of two 
polytopic transmembrane domains (TMD) and two nucleotide binding domains (NBD). The four 
domains can be arranged in any possible combination (Fig.1). The subunits may be encoded as 
separate polypeptides as in the case of several bacterial transporters. The histidine permease 
complex of S. typhimurium comprises the membrane channel subunits HisQ and HisM and two 
ATP-binding subunits HisP. The majority of eukaryotic ABC transporters are expressed as a 
single polypeptide (P-gp). In half-size transporters like TAP each TMD is fused to an NBD. 
Several different arrangements are also observed but they are less frequent. In addition to the 
four core components, prokaryotic ABC transporters involved in solute uptake employ a 
periplasmic binding protein to capture the substrate (Van Der Heide and Poolman, 2002).  Introduction    
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Fig.1: Organisation of ABC transporters.  
The typical ABC transporter has two membrane-associated domains (TMDs), two ATP-binding domains (NBD) and in 
some cases the periplasmic substrate binding protein. The domains can be fused in different combinations: i) they can 
be encoded as four separate polypeptides (as for the histidine permease), ii) fused NBDs (as for the ribose transporter 
RbsA) iii) fused TMDs (as for the iron-chelate transporter FhuCB) iv) half-size transporter with one NBD fused to one 
TMD (as for the peptide transporter TAP) v) all four domains fused into a single polypeptide (as for the drug 
transporter MDR1) vi) intercalating R domain (only known for the chloride channel CFTR). 
 
The TMDs span the membrane multiple times via putative α-helices forming the 
substrate translocation pore across the membrane (Fig.2). The majority of ABC transporters 
contain twelve predicted α-helices. However, examples of ABC-transporters with a different 
number of α-helices are known. Each TMD of the vitamin B12 transporter BtuCDE of E. coli 
consists of 10 α-helices and the TMDs of human TAP1 and TAP2 are predicted to possess 10 
and 9 α-helices, respectively (Locher et al., 2002; Lankat-Buttgereit and Tampé, 2002). Some of 
the predicted membrane-spanning α-helices may not be crucial to the core function of substrate 
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translocation but may serve auxiliary functions such as membrane insertion or regulation of the 
transporter (Higgins, 2001). The substrate specificity is determined by the TMD or the 
periplasmic binding protein. As the substrate spectrum of the ABC transporter family is very 
broad, the TMDs generally share little homology (Holland and Blight, 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2: Predicted membrane topology of a half-size ABC transporter.  
Typically, there are six predicted membrane spanning α-helices per domain (twelve per transporter). The TMDs form 
the pathway through which solutes cross the membrane and determine the specificity of the transporter through the 
substrate-binding sites. Two other domains, the NBDs, are hydrophilic and energize the transport by hydrolysis of 
ATP.  
 
The NBDs act as molecular motors which drive the transport process by hydrolysis of 
ATP (for details, see below). The amino acid identity of NBDs is over 25%, suggesting that even 
in transporters of unrelated function the structure and function of NBDs is highly conserved 
(Schneider and Hunke, 1998).  
 Introduction    
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1.2  ABC transporters in the yeast S. cerevisiae 
The yeast S. cerevisiae was the first eukaryotic organism whose complete genome was 
sequenced and revealed the presence of 30 ABC protein genes (Tab.1) (Decottignies and 
Goffeau, 1997; Taglicht and Michaelis, 1998). Fungal ABC proteins are implicated in a variety of 
cellular functions ranging from drug resistance, pheromone secretion, stress response to cellular 
detoxification (Fig.3). Here only a brief overview of the ABC subfamilies in S. cerevisiae will be 
provided (for review see Bauer et al., 1999). Based on phylogenetic analysis, yeast ABC 
proteins were classified into six subfamilies: MDR, PDR; MRP/CFTR, ALDp, YEF3, and RLI 
subfamily (Decottignies and Goffeau, 1997).  
 
Fig.3: Subcellular localisation of S. cerevisiae ABC transporters.  
ER, endoplasmic reticulum; G, Golgi apparatus; M, mitochondria; N, nucleus; P, peroxisome; V, vacuole. 
 
V
P
G
M 
Bat1p? 
Ycf1p 
Bpt1p  
Atm1p 
Mdl1p, Mdl2p 
Pxa1p
Pxa2p
Gcn20p
Yef3p 
Ste6p 
Yor1p 
Snq2p
Pdr11p
Pdr5p 
Pdr10p 
Pdr15p 
Pdr12p 
N 
ER    Introduction 
   13 
Tab.1: Functional classification of S. cerevisiae ABC transporters and their homologues. 
Abbreviations: conj., conjugates; Cyto, cytoplasm; Es, endosome; GS, glutathione; GV, Golgi vesicle; Hs, 
hypersensitivity; LC, long chain; M, mitochondria; PM, plasma membrane; Ps, polysomes; Px, peroxisome, R, 
regulatory domain; Ribo, ribosome; TMS, transmembrane segment; V, vacuole. 
ABC Protein  Substrate(s)  Length  Topology  Localisation  Phenotype 
MDR family           
Ste6p  a-factor  1290 (TMS6-ABC)2  PM, GV, Es  Sterile 
Atm1p Fe/S  proteins  694  TMS6-ABC M  slow-growth 
Ssh1p/Mdl2p ?  820  TMS6-ABC M  Viable 
Mdl1p peptide  696  TMS6-ABC M  Viable 
PDR family           
Pdr5/Sts1/Ydr1/Lem1p Drugs,  steroids, 
antifungals 
1511 (ABC-TMS6)2 PM  Drug
HS 
Pdr10p Weak  acids  1564  (ABC-TMS6)2 PM  Viable 
Pdr15p ?  1529  (ABC-TMS6)2 PM  Viable 
Snq2p Drugs,  steroids, 
mutagens 
1501 (ABC-TMS6)2 PM  Drug
Hs 
Pdr12p weak  acids  1511  (ABC-TMS6)2 PM  weak  acid
Hs 
Pdr11p ?  1411  (ABC-TMS6)2 PM(?)  Viable 
Adp1p ? 1049  TMS2-ABC-TMS7 ?  Viable 
YNR070w ?  1333  (ABC-TMS6)2 ?  ? 
YOR011w ?  1394  (ABC-TMS6)2 ?  ? 
YOL075c ?  1095  (ABC-TMS6)2 ?  ? 
MRP/CFTR family           
Yor1p Oligomycin, 
Reveromycin 
1477 (TMS6-ABC)2 PM  Drug
Hs 
Ycf1p GS-conj./Cd
2+ 1515  (TMS6-R-ABC)2 V  Cd
Hs 
YLL048 Bile  acids  1661  (TMS6-ABC)2 V  Viable 
YLL015w ?  1559  (TMS6-ABC)2 ?  ? 
YHL035c ?  1592  (TMS6-ABC)2 ?  ? 
YKR103w/YKR104w ?  1524 (TMS6-ABC)2 ?  ? 
ALDp family           
Ssh2/Pal1/Pxa1/Pat2p LC-fatty  acids  870  TMS6-ABC Px  Oleate- 
YKL741/Pxa2/Pat1p LC-fatty  acids  853  TMS6-ABC Px  Oleate- 
YEF3 family           
Yef3p Drugs  1044  ABC2 Ribo?,  Cyto?  Essential 
Gcn20p ?  752  ABC2 Ps  Viable 
YNL014w/Hef3p ?  1044  ABC2 Cyto?  Viable 
YPL226w ?  1196  ABC2 ?  ? 
YER036c ?  610  ABC2 ?  ? 
RLI family           
YDR091c ?  608  ABC2 ?  ? 
Others           
YDR061w ?  539  ABC  ?  ? 
YFL028c ?  289  ABC ?  ? Introduction    
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Ste6p, which belongs to the multidrug resistance (MDR) subfamily, was the first known yeast 
ABC transporter and is one of the best characterised (Kuchler et al., 1989; McGrath and 
Varshavsky, 1989). While steady state localisation of Ste6p appears to be the Golgi apparatus 
and endosome-like compartments, it functions at the plasma membrane and mediates ATP-
dependent secretion of the yeast a-factor pheromone (Kuchler et al., 1993; Kuchler et al., 1989). 
The other members of the MDR subfamily are mitochondrial half-size ABC transporters. Atm1p 
is localised in the inner mitochondrial membrane with its NBD facing the mitochondrial matrix 
(Leighton and Schatz, 1995) and functions as an exporter of Fe/S precursors (Kispal et al., 
1999). Two other members have been detected in the mitochondrial inner membrane, Mdl1p 
and Mdl2p. Mdl1p has been identified as an intracellular peptide exporter, while the function of 
Mdl2p has not been defined so far (Young et al., 2001). 
The pleiotropic drug resistance (PDR) subfamily is the largest subfamily of ABC-proteins 
in S. cerevisiae. Pdr5p and Snq2p mediate PDR through an ATP-dependent drug efflux pumping 
hundreds of structurally and functionally unrelated compounds. They are functional homologues 
of mammalian P-gp (Balzi and Goffeau, 1995).  
 The best-characterised members of the multidrug resistance related protein (MRP/CFTR) 
family are Yor1p and Ycf1p (Katzmann et al., 1999; Szczypka et al., 1994). Overexpression of 
Yor1p confers resistance to oligomycin, reveromycin A and organic anions (Cui et al., 1996). 
Ycf1p plays a role in the detoxification of the cytosol by translocation of metal ions (cadmium), 
glutathione-S-conjugates and metal-containing peptides into the vacuole (Li et al., 1996). The 
ORF YLL048 encodes a full-length transporter (Bat1p) that was reported to translocate bile acids 
into vacuoles (Ortiz et al., 1997), but also transports peptides as described in this thesis. 
The adrenoleukodystrophy family (ALD) consists of two members, namely the 
PXA1/PAR2/SSH2/PAL1 (Shani et al., 1995) and PXA2/PAT1/YKL741 (Shani et al., 1996) 
genes. Both of them are half size transporters and putative orthologues of human ALDP and 
PMP70. They import long-chain fatty acids into the peroxisomes for subsequent β-oxidation 
(Hettema et al., 1996). 
 
1.3 ABC  transporters  associated  with cellular peptide transport 
The transporter associated with antigen processing (TAP) has been for a long time the 
only known intracellular peptide transporter which mediates the import of peptides into the lumen 
of the endoplasmatic reticulum (Lankat-Buttgereit and Tampé, 2002). As potential homologous 
of TAP, two candidates, Mdl1p and Mdl2p, have been found in yeast (Dean et al., 1994). The 
function of the mitochondrial Mdl2p has not been assigned so far, but it was excluded that Mdl2p    Introduction 
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forms a heterodimer with Mdl1p. Mdl1p has been identified as a mitochondrial peptide exporter 
(Young et al., 2001). Mdl1p and TAP2 share 35% identity and 55% similarity. Both transporters 
translocate peptides of a similar size (6-21 amino acids for Mdl1p and 8-16 amino acids for TAP). 
So far, Mdl1p is the only characterised member of the Mitochondrial Peptide Exporter (MPE) 
family. Members of this family have also been found in other species as Asperigillus fumigatus 
(MDR2),  Candida albicans (MDL1), Homo sapiens (M-ABC2) (Zhang et al., 2000) and Mus 
musculus (ABC-me: mitochondrial erythroid) (Shirihai et al., 2000). 
By investigation of peptide transport in yeast microsomes, we discovered a new peptide 
uptake activity which was mediated by ORF YLL048. This ORF encodes a full-length ABC 
transporter belonging to the MRP family. Surprisingly, this protein was reported to work as 
vacuolar bile acid transporter (Bat1p) (Ortiz et al., 1997). 
To obtain insight into the mechanism of peptide transport, the yeast ABC transporter 
Mdl1p as well as the newly discovered peptide pump encoded by YLL048 has been studied in 
detail in this PhD thesis. 
 
1.4  Cooperation of the subunits during the transport process 
The ability to mediate vectorial transport of substrates requires intricate coupling between 
the TMDs and NBDs (and the periplasmic binding protein where applicable) (Higgins, 2001). The 
mechanism by which the conformational changes of NBDs in response to ATP hydrolysis are 
transmitted to conformational rearrangement at the TMDs to mediate substrate translocation is 
not well understood. One of the recent focuses on ABC transporter research is to gain insights 
into the inter-domain communication. Three types of inter-domain communications of the 
subunits have been described (Kerr, 2002): i) TMD-TMD interactions which may influence 
binding and release of substrate ii) NBD-TMD interactions which are proposed to mediate the 
coupling of nucleotide hydrolysis with substrate translocation iii) NBD-NBD interactions which 
are essential for coordination of ATP-hydrolysis of the complex.  
 
1.5 Structure  and  function of the NBDs 
Much of the mechanism how ABC motor domains work and communicate was learned 
from the characterisation of isolated NBDs.  Based on their primary structure the NBDs are 
characterised by five consensus motifs. The Walker A and Walker B motif are found in all 
nucleotide binding proteins (Walker et al., 1982). The Walker A motif has the sequence 
‘GxxGxGKS/T’, where x is any amino acid. The Walker B motif is less stringent with the 
sequence ‘Rx(6-8)ΦΦΦΦD’, where Φ represents any hydrophobic residue. A subset of ATP-Introduction    
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binding proteins contains an extended Walker B site with the consensus ‘Rx(6-
8)ΦΦΦΦDEATSALD’ (Michaelis and Berkower, 1995). The diagnostic hallmark of the ABC 
family is the ‘C-loop’ with the consensus sequence ‘LSGGQ’, which is unique to ABC 
transporters and also known as the ABC signature motif (Bianchet et al., 1997; Higgins, 1992; 
Michaelis and Berkower, 1995). The C-loop has been described as a hot spot for mutations 
which causes loss of function in ABC transporters (Hoof et al., 1994).  
An invariant histidine is placed downstream of the Walker B motif in the so-called switch 
II region, which is proposed to be involved in the ATPase hydrolysis (Nikaido and Ames, 1999). 
Between the Walker A motif and the C-loop a conserved Q-loop is located. The Q-loop might 
undergo conformational changes during the catalytic cycle and function as a signal transducer 
between TMDs and NBDs (Jones and George, 2002).  
Crystal structures of monomeric NBDs (e.g. HisP, MalK, TAP1) showed as a consensus 
fold an L-shaped molecule with two arms, one including the ATP-binding domain containing the 
Walker A and B motifs, and the other including the signature motif (Fig. 4a) (Hung et al., 1998; 
Diederichs  et al., 2000; Gaudet and Wiley, 2001). The hinge region between the two arms 
contains the H-loop (Switch) and Q-loop. Mutagenesis studies of HisP implicated arm II in the 
interaction with the membrane-spanning domain. The mutations in arm II were characterised by 
a loss of regulatory control by TMDs resulting in a constitutive ATPase activity (Hung et al., 
1998). 
 
 
 
 
 
 
 
 
Fig.4a: Structure of the momomer 
of TAP1-NBD 
The structure is displayed in ribbon 
format. The L-shaped monomer is 
divided into a RecA-like domain (red, 
arm I) and a helical domain (blue, 
arm  II). Conserved sequence motifs 
are depicted in yellow. The co-
crystallized ADP is green and the Mg
2+ 
ion is cyan (Gaudet and Wiley, 2001).    Introduction 
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Fig.4b: Dimeric structure of a DNA repair ABC transporter-like domain, Rad50cd.  
The structure is displayed in ribbon format. The L-shape of the monomer including the two arms is indicated. The two 
monomers are coloured in yellow and red. Two ATP molecules are sandwiched at the dimer interface and are 
coloured green and rendered in a space-filling style (Hopfner et al., 2000). 
 
Crystal structures of different NBD dimers have been solved, but they differ significantly 
in the manner how the monomers are associated (Kerr, 2002). The dimer of Rad50cd, a DNA 
repair enzyme that shares homology with the NBDs of ABC proteins, is assumed to be the 
‘functional’ dimer  (Fig.4b). This dimer contains two nucleotides, which are clamped at the 
interface between two monomers causing them to dimerize in a head-to-tail manner (Hopfner et 
al., 2000). The ATP molecules are sandwiched between the Walker A and B motifs from one 
monomer and the LSGGQ-motif from the other monomer. The crystal structure shows that the 
Walker A lysine and Walker B aspartate/ glutamate pair closely interact with the β- and γ-
phosphate of ATP, while the signature motif of the other monomer provides interactions with the 
adenine ring, ribose and triphosphate. Mutagenesis studies suggest that this dimer represents a 
true physiological association state since mutation of the serine of the signature motif to arginine 
prevented ATP-dependent dimerization (Hopfner et al., 2000). 
This proposed functional dimer configuration was very recently found in the crystal 
structure of the mutant NBD MJ0796 (E171Q) from Methanococcus jannaschii (Smith et al., 
2002) and of the NBDs of the vitamin B12 transporter BtuCDE from E. coli (Locher et al., 2002). 
Biochemical data on the maltose transporter (MalFGK2) and on P-gp further confirmed the 
involvement of the C-loop in ATP binding (Fetsch and Davidson, 2002; Loo et al., 2002). While 
the crystallographic dimer of HisP does not show the sandwiched ATP, an equivalent dimer 
formation for HisP as described for Rad50 was modelled based on comparative sequence 
Arm-I 
Arm-I
Arm-II
Arm-II 
ATP 
ATP Introduction    
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analysis (Jones and George, 1999). The association of the NBDs is regarded as a central step 
of the ATPase cycle, but it still remains controversial how both NBDs cooperate and coordinate 
ATP hydrolysis. Based on the high resolution structures of different NBDs it was proposed that 
two ATPs are bound to a dimer at the same time. Whether the motor domains work as 
equivalent modules hydrolysing both ATPs synchronically, sequentially or alternating is still 
under discussion. An alternating model based on P-gp, LmrA and HisMQP2 was proposed in 
which only one NBD hydrolyses ATP at a time (Senior et al., 1995; Urbatsch et al., 1995a; van 
Veen et al., 2000; Higgins, 2001; Jones and George, 2002).  
In addition to the alternative modus, non-equivalency of the NBDs has been proposed. 
Functional non-equivalency of NBDs was shown for HisP although both NBDs have complete 
sequence identity (Kreimer et al., 2000). P-gp is a full-length ABC transporter which consists of 
two different NBDs located at the N-half and C-half of this protein. Chimeras of P-gp containing 
two identical N-half NBDs showed full activity. The two N-half NBDs showed asymmetric 
behaviour which did not result from the difference in primary sequence but rather from their 
localisation inside P-gp (Hrycyna et al., 1999). It was suggested that hydrolysis of one ATP in 
the dimer provides energy for the translocation of the substrate whereas hydrolysis of the ATP in 
the second binding pocket might have regulatory functions, possibly returning the complex to the 
ground state of the ATPase cycle (Hrycyna et al., 1999; Jones and George, 1999). 
To obtain insight into the mechanism of NBD interaction and communication, the NBD of 
the yeast ABC transporter Mdl1p has been studied in detail in this work.  
 
1.6 Quality  control  in  mitochondria 
Mdl1p (multidrug resistance like) is localised in the inner mitochondrial membrane of S. 
cerevisiae. This transporter is required for the export of peptides derived from the degradation of 
non-assembled membrane proteins (Fig.5) (Young et al., 2001). These peptides are generated 
by ATP-dependent m-AAA proteases (YTA10-12) (matrix-oriented ATPases associated with a 
variety of cellular activities), which are responsible for the degradation and turnover of inner 
mitochondrial membrane proteins and short-lived regulatory proteins in an ubiquitin/proteasome-
independent manner (Arnold and Langer, 2002; Langer et al., 2001). Mdl1p translocates the 
breakdown products ranging from 6 to 21 amino acids into the intermembrane space from where 
they are released into the cytosol probably through porins or the TOM complex (translocase of 
the outer mitochondrial membrane). Alternatively, unfolded membrane proteins of the inner 
mitochondrial membrane are degraded by i-AAA proteases (YME1) which expose their catalytic 
site to the intermembrane space.     Introduction 
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This quality control consisting of two homologous proteolytic complexes and Mdl1p 
ensures the selective removal of non-assembled or short-lived polypeptides from mitochondria. 
But no accumulation of peptides has been observed in ∆mdl1 ∆yme1 double deletion mutant 
due to the fact that mitochondrial proteolysis system is capable of degrading proteins to amino 
acids. As the peptide export pump Mdl1p is not essential for cell viability, it is tempting to 
speculate that its physiological role might be in the communication between the mitochondrion 
and the cellular environment. Mitochondrially derived peptides could be major players in signal 
transduction between the mitochondrion and the nucleus coordinating mitochondrial and nuclear 
gene expression (Arnold and Langer, 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5: Quality control of mitochondria.  
The key components of the quality control are two membrane embedded ATP-dependent proteolytic systems, i- and 
m-AAA proteases, which expose their catalytic sites to the intermembrane space and matrix, respectively and 
degrade not correctly assembled or misfolded inner membrane proteins. The breakdown products are exported from 
the matrix into the intermembrane space by the ABC transporter, Mdl1p.  
OMM: outer mitochondrial membrane; IMM: inner mitochondrial membrane 
 
 Introduction    
20 
The presence of ABC transporters homologous to Mdl1p in mammalian mitochondria e.g. 
ABC-me, M-ABC2, and M-ABC1 suggests a similar pathway in mitochondria of higher eukaryotic 
cells (Shirihai et al., 2000; Zhang et al., 2000; Hogue et al., 1999). Peptides derived from 
mitochondrially encoded membrane proteins have been detected at the cell surface of 
mammalian cells where they are presented by class I major histocompatibility molecules (MHC) 
(Fischer Lindahl, 1997). It is possible that mitochondrially encoded minor histocompatiblity 
antigens are generated by AAA proteases and released into the cytosol, from where they enter 
the conventional class I antigen processing and presentation pathway. The fact that the TMDs, 
which typically defined substrate specificity, of M-ABC2 show strong similarity to TAP2 (24% 
identity) might be due to a coevolution of both proteins, indicating that they might work in concert 
in antigen presentation. 
2  Motivation and aims 
The principles of peptide transport have been studied in detail on TAP which translocates 
antigenic peptides from the cytosol into the lumen of the ER. TAP has been functionally 
expressed in the yeast S. cerevisiae. To receive a fast and efficient method to characterise a 
broad spectrum of TAP mutants, one aim of this PhD thesis was to establish a genetic in vivo 
screen. The strategy was to develop an autocrine stimulation assay based on the TAP-mediated 
secretion of peptide pheromones. 
By investigation of peptide trafficking in yeast, a new peptide uptake activity mediated by 
the ORF YLL048 has been discovered (in our group). Relatively little is known about the 
physiological relevance of peptide metabolism in yeast. Therefore, one task of this PhD thesis 
was the genetic and biochemical characterisation of this peptide pump YLL048p. 
Based on sequence alignments two potential homologs to TAP have been identified in 
yeast, Mdl1p and Mdl2p (Dean et al., 1994). As Mdl1p has been recently described as a peptide 
transporter (Young et al., 2001), we set out to characterise Mdl1p on molecular level. The main 
focus was put on the mechanism by which ATP hydrolysis drives the translocation of peptides. 
Inter-domain communication and signalling during transport process mediated by conformational 
changes of the individual domains are not well understood. The question how NBDs cooperate 
and coordinate the ATP hydrolysis in order to translocate substrate is of major interest. I tried to 
gain insights into the ATPase cycle of Mdl1p-NBD by characterisation of the interaction between 
the domains and by visualizing different catalytic transition states. A central target was to 
develop a model for the ATPase cycle of isolated Mdl1p-NBD.    Material 
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3 Material 
3.1 Chemicals 
Chemicals Company   
[α
32P]-ATP or [γ
32P]-ATP     ICN 
4-hydroxyazobenzen-2-carboxyl-acid (HABA)  Sigma-Aldrich GmbH   
8-azido-[α
32P]-ATP   ICN 
8-azido-biotin-ATP    Affinity labelling technology 
acrylamid 30% (w/v)  National Diagnostics   
adenosine-5'-diphosphate (ADP)  Fluka Chemie GmbH   
adenosine-5'-triphosphate (ATP)  Fluka Chemie GmbH   
apyrase   Sigma-Aldrich  GmbH 
ATP- agarose (C8 or N6 linked)  Sigma-Aldrich GmbH   
BCA-kit   Pierce 
benzonase   Merck 
Biobeads SM-2    New England Biolabs 
BL21(DE3)   Novagen 
BSA Sigma-Aldrich  GmbH   
calf intestine alkine phosphatase    Fermentas 
cardiolipin   Sigma-Aldrich  GmbH 
carrier salmon testis DNA    Sigma-Aldrich GmbH    
centrifugal filters (ultrafree)    Millipore S.A   
chloramine T   Riedel-de Haen    
concanavalin A-sepharose   Sigma-Aldrich GmbH 
D-(+)-desthiobiotin Sigma-Aldrich GmbH   
β-D-decylmaltoside   Calbiochem 
DeepVent     Biolabs 
digitonin   Calbiochem    
dimethylsulfoxide Fluka  Chemie  GmbH   
Dowex 1 x 8 anion exchange    Sigma-Aldrich GmbH    
Enhanced ChemiLuminescence system (ECL)   Amersham Pharmacia   
ethylendiamintetraacid (EDTA)  Carl Roth GmbH   
Ex-Taq polymerase    Takara 
hexokinase   Sigma-Aldrich  GmbH 
HiTrap desalting column    Amersham Pharmacia 
hyperfilm chemiluminescence film     Amersham Pharmacia 
isopropyl-ß-D-thiogalactopyranoside (IPTG)  BTS-BioTech Trade& Service GmbH   
Klenow fragment    New England biolabs 
megaprime DNA labelling system     Amersham Pharmacia 
N,N,N‘,N‘-tetramethylethylendiamin (TEMED)  Sigma-Aldrich GmbH   
Na
125I     Amersham Pharmacia     
Ni-NTA beads     Qiagen GmbH   Material    
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nucleospin plasmid kit    Machery-Nagel GmbH & Co. KG, Düren 
β-D-octylglycoside   Calbiochem 
Oregon Green    Molecular Probes 
pASK-IBAII   IBA 
pBAD-His   Invitrogen 
PEG 3350    Sigma-Aldrich GmbH 
pET28, 26    Novagen 
Pfu DNA polymerase    Promega 
phoshatidylcholine   Avanti  Lipids 
phosphatidylethanolamine   Avanti  Lipids 
plasmid midi kit    Qiagen GmbH 
polycarbonate filters (200 nm)    Avestin 
polyethylenimine cellulose plates    Merck 
Ponceau Red S     Sigma-Aldrich GmbH   
Proteinase K    Sigma-Aldrich GmbH 
pV1L392   Invitrogen 
Pwo DNA polymerase    Roche Diagnostics  
QIAquick gel extraction kit    Qiagen GmbH 
QIAquick spin PCR purification kit    Qiagen GmbH 
reactive RED 120     Sigma-Aldrich GmbH   
restriction enzymes    MBI fermentas 
sephadex G-50 columns     Amersham Pharmacia 
sepharose A    Sigma-Aldrich GmbH 
sequencing kit, big dye    Perkin Elmer 
streptactin     IBA GmBH   
streptavidin alkine phosphatase conjugate  IBA GmbH   
Superdex 75 30/10    Amersham Pharmacia 
Superose 200 HR 11/15    Amersham Pharmacia 
Superose 6    Amersham Pharmacia 
T4 DNA ligase    MBI fermentas   
TA-cloning kit     Invitrogen 
Texas Red     Molecular Probes 
Top 10 cells    Invitrogen    Material 
   23 
3.2 Oligomers 
Tab.2: Primer sequences used for cloning and sequencing of MDL1 
formdl1 fl  ATTGAATTCATGATTGTAAGAATGATACGTCTTTGTAAA  
           EcoRI  
formdl1-mt ATTGAATTCATGCAATCAGACATTGCGCAAGGAAAGAAG 
         EcoRI  
revmdl1 TACTCGAGAAGCTTTATACTTCCCGGGCAACACTA 
         XhoI   HindIII  
revmdl1-Strept ATACTCGAGAAGCTTTTATTTTTCAAACTGCGGATGAGACCAGCCGTT 
            XhoI  HindIII        
ACCACGTGGATAATACATTACTTCCCGGGCACCACTATTGTCCAAATC 
formdl1 fl NcoI 
new 
CATATCCATGGGTATGATTGTAAGAATGATACGTCTTTG 
               NcoI      
formdl1-mt Nco1 
new 
CATATCCATGGGTCAATCAGACATTGCGCAAGG 
               NcoI  
pASK2revmdl ATCCTAGGTCTCAGCGCTTACTTCCCGGGCAACACTATTGTC 
                   BsaI  
pASK2for-mt AGTCTAGGTCTCAGGCCCAATCAGACATTGCGCAAGGAAAG 
                   BsaI   
pET22/6bmdl-
mtfor 
ATTACGAATTCGCAATCAGACATTGCGCAAGGAAAG 
               EcoRI  
pET22/6bmdlrev ACGAAGCTTTACTTCCCGGGCAACACTATTGTC 
          HindIII  
revD598A GGCACTGGTTGCTTCAGCTAAAATAAGGACGGC   
forD598A GCCGTCCTTATTTTAGCTGAAGCAACCAGTGCC   
forH631R CTACTAATATCAAATGCACGTAGGCTTTCGACGATC   
revH631R GATCGTCGAAAGCCTACGCCTACGTGCAATTGATATAGTAG   
forE599Q GCCGTCCTTATTTTAGATCAAGCAACCAGTGCC   
revE599Q GGCACTGGTTGCTTCATGTAAAATAAGGACGGC  
revmdl1pXY ATAGTCGACTAAGCTTTACTTCCCGGGCAACACTAT 
              SalI    HindIII  
 
 
 Material    
24 
  primer for sequencing 
Seq1 mdl1 f   GAAGTCCACCAAGCCCACTT 
Seq2 mdl1 f  CGTGTCGGTGATTTGATCTC 
Seq3 mdl1 f  GGAAGTACTGGGCTAGTTGG 
Seq4 mdl1 f  CTTTGTTGCTCAGGTACTAC 
Seq5 mdl1 f  GAATTGCATTAGCTAGAGCG 
Seq  mdl1 r  TTAGATAAGACGAATAGCCG  
mdl1rev1 GGAAGGTACAGCCATACT   
mdl1rev2 TGTCTTTAAACCCCGACG   
T7 promotor  TTAATACCACTCACTATAGG  
T7 terminator  CGATCAATAAGCAGTCGG  
pBadfor ATGCCATAGCATTTTTATCC 
 
Tab.3: Primer sequences applied in the YLL048 gene construction 
Yll Nterm pRSc  TCCCCCCGGGGGACTAGTCTGAAGAAAAAGCCACTC 
                XmaI           SpeI 
Yll Cterm pRSc  CGGGGTACCCCGCTAATT(AAGATCCTCTCCGGAAATGAG 
           KpnI                                  (myc-tag) 
CTTTTGTTC)GTCCTTTTTAGACTTCAATTTTTCC 
NtermXhoSiYll GTCGTCCCCAGCTCTCGAGCCAAGGCAGGAACTAATA 
                                     XhoI 
CtermXhoSiYll GTTCTTGCCTTGGCTCGAGAGCTGGGACGACAACCTTAC 
                                     XhoI 
YLL forward1  CCGACGAAGACGAACAGA 
YLL forward2  AATCTATGGTCGGTATC 
YLL forward3  ATTTTGTGGACCATAAGG 
YLL forward4  ATTTCCACCAACAAGACT 
YLL forward5  GCTGCGATTGTGGGTGTC 
YLL forward6  CGTTCAAGGCGAGGTATT 
YLL forward7  TGGCATTATTAGGTGAAA 
YLL forward8  GGTGGTCAAAAGCAGAGA 
YLL forward9  TAACCTACCCGCTGTCAA 
YLL forward10  TTATTCCCAGAGCACAAC 
YLL forward11  TGATGCTACTTCACCAGG    Material 
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YLL forward12  ATGAAGGGAGGTTTATGC 
YLL forward13  GCCATACAACGAACACAA 
YLL forward14  ATTCACAGGGACCATTTA 
 
Tab.4: List of α-factor constructs as sense and antisense nucleotide sequence 
α-MOD1/H  GTCAATGGATCCATGAACGCTACTTTGGCTAAGAGAGAAGCTGAAGCT
TGGCATTGGCTGCAGCTGAAGCCTGGCCAACCAATGTACTAAATCGAT
AAGTCAA  
α-MOD1/R  TGACTTATCGATTTAGTACATTGGTTGGCCAGGCTTCAGCTGCAGCCA
ATGCCAAGCTTCTCTCTTAGCCAAAGTAGCGTTCATGGATCCATTGAC  
α-MOD2/H  GTCAATGGATCCATGAAGAGAGAAGCTGAAGCTGAAGCTTGGCAGTG
GCAGTGGCTGCAGCTGAAGCCTGGCCAACCAATGTACTAAATCGATAA
GTCAA  
α-MOD2/R  TGACTTATCGATTTAGTACATTGGTTGGCCAGGCTTCAGCTGCAGCCA
ATGCCAAGCTTCAGCTTCTCTCTTCATGGATCCATTGACA  
α-MOD3/H  GTCAATGGATCCATGTGGCATTGGCTGCAGCTGAAGCCTGGCCAACAA
ATGTACAAGAGAAACGCTACTTAAATCGATAAGTCAA  
α-MOD3/R  TGACTTATCGATTTAAGTAGCGTTTCTCTTGTACATTGGTTGGCCAGGC
TTCAGCTGCAGCCAATGCCACATGGATCCATTGACA  
α-MOD4/H  GTCATTGGATCCATGTGGCATTGGCTGCAGCTGAAGCCTGGCCAACCA
ATGTACTAAATCGATAAGTCAA  
α-MOD4/R  TGACTTATCGATTTAGTACATTGGTTGGCCAGGCTTCAGCTGCAGCCA
ATGCCACATGGATCCATTGACA  
TOPO-Hin AGCGCCCAATACGCAAAV 
TOPO-Rück CCAAGCGGCCGGAGAACC 
Insert-alpha TACATTGGTTGGCCAGGC   
 
3.3 Peptides 
Tab.5: Peptide sequence used for transport assays 
Peptide Sequence 
R9LQK RRYQKSTEL 
R10T RYWANATRST 
α-factor  WHWLQLKPGQPMY 
    Methods 
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4 Methods 
4.1  E. coli methods 
4.1.1  E. coli media, culture conditions and methods 
E. coli cells were grown in LB-medium (10 g trypton, 5 g yeast extract, 10 g NaCl per liter) 
at 37°C. If indicated, 100 µg/ml ampicillin or 50 µg/ml kanamycin were added after autoclaving. 
For selection with zeocin (50 µg/ml) LB-medium with reduced salt concentration was used (5 g 
NaCl per liter). 
 
4.1.2  Competent E. coli cells 
An o/n-culture of E. coli DH5α cells was diluted 1:50 in 100 ml LB-medium and grown at 
37°C to an OD600 of 0.5. The culture was incubated on ice for 10 min and the cells were 
harvested at 1,000 x g at 4°C for 10 min. The cell pellet was carefully resuspended in 10 ml 
sterile, ice-cold 0.1 M CaCl2 and incubated on ice for 90 min. After centrifugation the pellet was 
resuspended in 2 ml sterile ice-cold 0.1 M CaCl2 and 400 µl 87% glycerol. Cell aliquots of 100 µl 
were frozen in liquid nitrogen and stored at -80°C. 
 
4.1.3  Transformation of competent E. coli 
Competent E. coli cells were thawn on ice for 10 min. Plasmid DNA (10 ng to 1 µg) was 
dissolved in 10 µl water, mixed with 100 µl of competent cells and incubated on ice for 30 min. 
The suspension was transferred to 42°C for 90 sec (heat shock). The cells were regenerated in 
1 ml LB-medium for 1 h at 37°C with vigorous shaking. The cell suspension was centrifuged 
(1,000 x g, 10 min, 25°C) and plated on prewarmed (37°C) LB-agar plates supplemented with 
the appropriate antibiotic and incubated overnight at 37°C. 
 
4.1.4  Plasmid construction 
Plasmid purification was performed using Mini or Midi-kits. Restriction enzyme digestion 
was performed using the amount of enzyme and the incubation temperature suggested by the 
manufacturer. Before electrophoresis DNA samples were mixed with 1x loading buffer (10x: 40% 
sucrose (w/v), 0.25% bromphenol blue, xylenecyanol in TE-buffer). DNA fragments were 
analysed in 0.8%-2% agarose gels in TAE-buffer (40 mM Tris-acetate pH 8, 1 mM EDTA) and Methods    
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stained with ethidium bromide. If indicated, fragments were extracted from gel using QIAEX 
extraction kit.  
To create blunt end from sticky end DNA, the digested DNA was incubated with 1 unit 
Klenow fragment and 200 µM dNTPs in 1x manufacturer`s reaction buffer for 15 min at 25°C.  
To reduce religation of vector with blunt ends, dephosphorylation was performed. 
Routinely, 1-2 µg DNA in a total volume of 50 µl was incubated with 1 unit phosphatase (calf 
intestine) in 1x manufacturer`s reaction buffer for 1 h at 37°C. The enzyme was heat inactivated 
at 72°C for 10 min.  
Ligation was performed by incubating vector DNA with a 3-10x excess of insert DNA with 
T4-DNA ligase in 1x manufacturer`s reaction buffer overnight at 16°C.  
PCR (polymerase chain reaction) was used to amplify insert DNA using chromosomal 
yeast DNA or plasmid DNA as template. For PCR high fidelity Ex-Taq, Pwo-polymerase or 
DeepVent were used according to manufacturers´ instructions. Site-directed mutagenesis was 
performed by PCR and a polymerase system producing blunt ends at the PCR fragments (e.g. 
DeepVent, for details see mutagenesis, NBD(E599Q)). Alternatively, PCR products with a 5´-
end A-overhang produced by Ex-Taq were cloned using the TA-cloning kit.  
Clones were checked via restriction analysis or colony-PCR. Positive clones were 
verified by DNA sequencing. For cloning and amplification of DNA the E. coli strain DH5α was 
used. For gene expression different E. coli strains were applied in this thesis. Expression under 
the control of a T7 promotor was performed in BL21(DE3) cells or C41. For expression of genes 
under the control of the arabinose inducible promotor, the strain TOP10 was used which has a 
deletion in the ara-operon and is therefore unable to metabolize arabinose . 
 
4.1.5  Plasmids encoding for MDL1 and their expression conditions in E. coli 
The MDL1 gene (ORF YLR188W) was amplified by PCR from the genomic DNA of S. 
cerevisiae. Unless indicated otherwise, PCR was performed with the Ex-Taq using 1  µl 
concentrated genomic DNA (200 ng/µl) as template and 10 pmol primers, respectively following 
this protocol: 2 min denaturation at 92°C, 30 cycles of 1 min denaturation at 92°C, 1 min 
annealing at 55°C, 2.5 min extension at 72°C, 10 min final extension at 72°C. The PCR 
fragments were cloned into different expression vectors of E. coli.  
To clone MDL1 into the pBAD vector the PCR was performed according to standard 
procedure with the primers (formdl1 fl) and (revmdl1). The PCR fragment was ligated into the 
pBAD-HisB using the restriction sites EcoRI and HindIII resulting in the construct pBADHis-mdl1.    Methods 
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In this construct MDL1 was fused at the 5´end with a His6-tag derived from the vector. The 
affinity tag can be cleaved by enterokinase.  
  To delete the N-terminal predicted mitochondrial targeting sequence of MDL1, a PCR 
was carried out according to standard procedure using the primers (formdl1-mt) and (revmdl1). 
The PCR fragment trunctated in 180 bp at the 5´end was cloned into pBAD-HisB using EcoRI 
and  HindIII. The construct pBADHis-∆mt-mdl1 contains an N-terminal His6-tag which can be 
cleaved by enterokinase. 
  A C-terminal StrepII-tag was introduced to MDL1 by PCR using the primers (formdl1 fl 
NcoI new) and (revmdl1-Strep). The PCR insert was cloned into the pBAD vector using NcoI and 
HindIII and obtaining the construct pBAD-mdl1StrepII.  
MDL1 deleted in the mitochondrial targeting sequence was obtained by PCR with the 
primers (formdl1-mt Nco1 new) and (revmdl1-Strep). By this PCR a C-terminal StrepII-tag was 
introduced to MDL1. The PCR insert was cloned into the pBAD vector using NcoI and HindIII 
and resulting in the construct pBAD-∆mt-mdl1StrepII. 
The expression of all MDL1  constructs in the pBAD-vector was performed in E. coli 
strains TOP10 or C41. Transformed bacteria were grown at 30°C in LB-medium with 100 µg/µl 
ampicillin. At an OD600 of 0.5 bacteria cells were induced with 0.02 % arabinose, and after 
different time points of induction the cells were harvested by centrifugation. 
 
The  MDL1 gene was amplified by PCR using the primers (pASK2for-mt) and 
(pASK2revmdl) deleting the mitochondrial targeting sequence. The PCR fragment was cloned 
into the pASK-IBA2 vector using BsaI resulting in the recombinant plasmid pASK-IBA2-∆mt-
mdl1StrepII. BsaI is a restriction enzyme cutting outside its recognition site thus determining the 
final orientation of the insert in the vector. Mdl1p was fused N-terminally with the OmpA 
periplasmic leader sequence and C-terminally with a StrepII-tag (WSHPQFEK). Both features 
were encoded by the pASK-IBA2 vector.  
The expression of MDL1 in this construct is under the control of the tet-promotor. E. coli 
strain C41 was transformed with the plasmid and grown at 30°C in LB-medium with 50 µg/µl 
kanamycin. At an OD600 of 0.5 cells were induced with 200 ng/ml anhydrotetracycline (AHT) 
(1:10000 dilution from 2 mg/ml AHT stock solved in DMF, stored at -20°), and after 3 h the cells 
were harvested by centrifugation. 
 
MDL1 truncated in the mitochondrial targeting sequence (180 bp) was amplified by PCR 
using the primers (pET22/6bmdl-mtfor) and (pET22/6bmdlrev). The PCR fragment was cloned 
into the pET22 vector using EcoRI and HindIII resulting in the construct pET22-∆mt-mdl1His. Methods    
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Using this approach Mdl1p was fused N-terminally with a periplasmic leader sequence (PepB) 
and C-terminally with a His6-tag. Both features were derived from the pET22 vector.  
The expression of Mdl1p in pET22 was under the control of a T7-promotor. E. coli strain 
BL21(DE3) was transformed and grown at 30°C in LB-medium with 100 µg/µl ampicillin. At an 
OD600 of 0.5 cells were induced with 0.2 mM isopropyl-β-D-thio-galacto-pyranoside (IPTG), and 
after 3 h the cells were harvested by centrifugation. 
 
The transmembrane domain of Mdl1p without the mitochondrial targeting sequence was 
subcloned from the pBADHis-∆mt-mdl1 into the pET28b using the NcoI and the BamHI site 
derived from position 1266 inside the MDL1. The new construct pET28His-∆mt-TMDHis contains 
an N-terminal His6-tag derived from the pBAD vector and a C-terminal His6-tag encoded by 
pET28b. BL21(DE3) cells were transformed and were grown at 30°C in LB-medium with 50 µg/µl 
kanamycin. At an OD600 of 0.5 cells were induced with 0.2 mM IPTG, and after 3 h the cells were 
harvested by centrifugation. 
 
The C-terminal domain of Mdl1p (amino acids 427 to 695) corresponding to the NBD was 
subcloned from the pBADHis-∆mt-mdl1 into pET28b using BamHI and HindIII. The resulting 
construct pET28His-NBD includes a 30 residues N-terminal extension with His6-tag, thrombin 
cleavage site and a T7-tag encoded by the vector. A conserved glutamate 599 downstream of 
the Walker B motif was changed to glutamine via site directed mutagenesis resulting in the 
construct pET28His-NBD(E599Q) (Fig.6). To introduce the mutation into the gene, there different 
PCRs were performed. In PCR1 and PCR2 pET28-NBD was used as template and the primers, 
(T7 promotor) and (revE599Q) or (forE599Q) and (revmdl1), respectively. For amplification 
DeepVent polymerase creating blunt ends of the PCR fragments was used. Both PCR products 
were purified from agarose gel, mixed in an equimolar ratio and used as a template for a third 
PCR using the primers (T7 promotor) and (revmdl1). The resulting PCR fragment of 800 bp was 
sequenced to confirm the mutation and cloned BamHI and HindIII into pET28b. The conserved 
aspartate 598 in the Walker B motif was changed to alanine according to the procedure 
described above resulting in the construct pET28His-NBD(D598A). For PCR1 the primer set (T7 
promotor) and (revD598A), for PCR2 the set (forD598A) and (revmdl1) and PCR3 (T7 promotor) 
and (revmdl1) were used. The conserved histidine 631 in the switch region was changed to 
arginine resulting in pET28His-NBD(H631R). PCR1 was performed with the primer set (T7 
promotor) and (revH631R), PCR2 with (forH631R) and (revmdl1) and PCR3 with (T7 promotor) 
and (revmdl1).     Methods 
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BL21(DE3) cells were transformed by the plasmids encoding the NBDs and bacteria 
were grown at 30°C in LB-medium with 50 µg/µl kanamycin. At an OD600 of 0.5 cells were 
induced with 0.2 mM IPTG, and after 3 h the cells were harvested by centrifugation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.6: PCR based mutagenesis. Point mutations were introduced into the gene (NBD) by 3 step PCR. The 
gene of interest was subdivided into 2 fragments by PCR1 and 2 introducing the mutation. To avoid a frame-
shift a PCR polymerase was used which creates blunt ends of the PCR products. In the PCR3 the full-length 
gene was re-amplified. 
4.1.6  Plasmids encoding for MDL1 and their expression in yeast 
MDL1 was amplified by PCR with the primers (formdl1 fl) and (revmdl1-Strept) and 
cloned into the p426 vector using EcoRI and HindIII. In the resulting construct p426-mdl1StrepII 
the gene was fused at the 3´end with a StrepII-tag derived from the reverse primer. The same 
cloning procedure was performed with MDL1 deleted in the mitochondrial targeting sequence. 
The primers (formdl1-mt) and (revmdl1-Strept) were used to obtain the construct p426-∆mt-
mdl1StrepII. The yeast strain ∆mdl1 was transformed by the recombinant plasmids and the clones 
were selected on URA drop out agar plates. The expression of MDL1 is under the control of the 
strong, constitutive GDP promotor (680 bp). The transformed yeast cells were grown at 25°C in 
selective medium to OD600 of 1-1.5 and harvested. 
MDL1 was subcloned from the pBADHis-∆mt-mdl1 into the pXY113 vector using NcoI and 
HindIII. The resulting construct pXY113His-∆mt-mdl1 contains an N-terminal His6-tag derived 
from the pBAD. As Mdl1 kept its natural stop codon, the HA-tag at the C-terminus encoded by 
pXY113 was not expressed. The expression of the gene is under the control of the strong Methods    
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inducible GAL promotor. The induction of MDL1 was performed with 2% galactose for different 
times in selective media in the absence of Uracil.  
 
4.1.7  Plasmids encoding for YLL048 
As it was not successful to obtain a DNA fragment of the full length gene YLL048 
(including a 1000 bp promotor region) by PCR from the genomic DNA, the gene was subdivided 
into two fragments: a 5´-fragment of 3290 bp (nt -1001 to +2290) and the 3´-fragment of 2724 kb 
(nt 2291-4015) including a myc-tag. The 5´-part of the ORF YLL048 was cloned by TA-cloning 
into the pCR-XL-Topo vector resulting in the construct pCR-Topo-F1. In the PCR Ex-Taq 
polymerase, 1 µl concentrated genomic yeast DNA as template and 10 pmol primers (pRS-N) 
and (C-termXho) were used and the following protocol applied: 2 min initial denaturation at 94°C, 
30 cycles of 30 sec denaturation at 94°C, 1 min annealing at 60°C, 3.5 min extention at 72°C, a 
final extension for 10 min. The reverse primer contained a silent mutation creating a unique XhoI 
into the gene. This restriction site was later used to fuse the two gene fragments. As TA-cloning 
does not direct the orientation of the insert in the vector, the orientation of the insert was 
checked by XhoI digestion. Digestion of the plasmid, which contained the insert in sense 
orientation, resulted in a 6.8 kb fragment. When the insert was cloned in the opposite direction, a 
digestion resulted in a 3290 bp and a 3500 bp fragment. For further cloning, clones with the anti-
sense orientation were used. 
The 3´-part of the ORF YLL048 was amplified by PCR using the primers (N-termXho) 
and (pRS-C). The same protocol as above was applied. The forward primer introduced a silent 
XhoI site into the 5`-end of the PCR product. The PCR product with ligated with pCR-XL-Topo 
resulting in the construct pCR-Topo-F2. The constructs  were checked for orientation of the 
fragment inside the vector by XhoI. In sense orientation two fragments of the size of 2.7 kb and 
3.5 kb were obtained, while in the case of the anti-sense orientation a 6 kb fragment was 
obtained. For further cloning, fragments with anti-sense orientation were used. The 3´-fragment 
(2.7 kb) from pCR-Topo-F2 was cloned into Yep352 vector using PstI and SacI resulting in the 
construct Yep352-F2 (7.9 kb). This construct was fused with the 5`-part of the gene (3290 bp) 
from pCR-Topo-F1 using PstI and XhoI and resulting in Yep352-yll048  (12 kb). The vector 
Yep352 contains the URA marker for selection in yeast. The expression of the gene is under 
control of the YLL048 promotor. 
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4.1.8  Plasmids containing different constructs of the α-factor  
In order to express a minigene in yeast, the DNA of the peptide pheromone α-factor was 
ordered as single stranded DNA oligomers with sense and antisense sequence. After 
hybridization of the oligomers to double stranded DNA, the insert was ligated to pCR-XL-Topo 
by TA-cloning and transformed to E. coli. Different truncated forms of the α-factor were cloned 
following the same cloning strategy described in details for pCR-Topo-mod4 coding for the 
mature α-factor. Oligomers coding for the amino acid sequence: MWHWLQLKPGQPMY were 
ordered as sense and anti-sense primers with an additional A-overhang at the 3`-end. Oligomers 
were mixed (30 ng/µl), denatured for 1 min at 94°C, and annealt for 30 min at 50°C. The 
hybridized DNA (120 ng) was mixed with 10 ng pCR-XL-Topo-vector and incubated with 1 µl 
topoisomerase at RT, after 5 min 1 µl stop solution was added, and the sample was centrifuged. 
An aliquot of 2 µl was mixed with 50 µl electrocompetent DH5α provided with the TA-cloning kit. 
Electroporation was carried out at 1.8 kV and after regenerating the cells for 1 h at 37°C in LB 
medium, they were plated out on kanamycin containing agar plates (50 µg/ml). Clones were 
checked with EcoRI digestion. The orientation of the insert DNA was checked by PCR using the 
primers TopoHin (annealing upstream of the MCS) and insert-alpha primer, and alternatively, 
TopoRück (annealing downstream of the MCS) and insert-alpha primer. In case of sense 
orientation (same reading orientation of insert and vector) a PCR fragment of the size of 400 bp 
was obtained by using TopoHin and Insert-primer. In case of anti-sense orientation a PCR 
fragment of the size of 1400 bp was amplified by TopoRück and Insert-primer. For cloning into 
an expression plasmid, clones with the sense orientation were selected. The positive plasmids 
were sequenced with the M13 forward primer. 
The insert DNA was subcloned from the pCR-Topo-mod1 into the p424 yeast expression 
vector using SpeI and XhoI, BamHI and ClaI, and SpeI and ClaI respectively. The expression of 
the α-factor is under the control of the constitutive ADH-promotor. The selection marker for yeast 
is TRP. 
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Tab.6: List of α-factor constructs as amino acid sequence 
Plasmid  Insert (amino acids)  Restriction 
pCR-Topo-mod1  MNATLAKREAEAWHWLQLKPGQPMY   
p424-mod1  MNATLAKREAEAWHWLQLKPGQPMY  SpeI and XhoI 
    BamHI and ClaI 
    SpeI and ClaI 
pCR-Topo-mod2  MKREAEAWHWLQLKPGQPMY   
p424-mod2  MKREAEAWHWLQLKPGQPMY  SpeI and XhoI 
   BamHI and ClaI 
   SpeI and ClaI 
pCR-Topt-mod3  MWHWLQLKPGQPMYKRNAT   
p424-mod3  MWHWLQLKPGQPMYKRNAT  SpeI and XhoI 
   BamHI and ClaI 
   SpeI and ClaI 
pCR-Topo-mod4  MWHWLQLKPGQPMY   
p424-mod3  MWHWLQLKPGQPMY  SpeI and XhoI 
   BamHI and ClaI 
   SpeI and ClaI    Methods 
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4.2 Yeast  methods 
4.2.1  Yeast media and growth conditions 
Yeast peptone dextrose medium (YPD) was composed of 5 g yeast extract and 10 g 
peptone per 1 L and after autoclaving 100 ml of 20% glucose was added.  
Lactate medium contained 3 g yeast extract, 0.5 g glucose, 0.5 g CaCl2, 0.5 g NaCl, 0.6 
g MgCl2, 1 g KH2PO4, 1 g NH4Cl, 22 ml 90% lactic acid, 7.5 g NaOH per 1 L and the pH was 
adjusted to 5.5 with NaOH.  
Minimal medium was composed of 6.7 g yeast nitrogen base and 5 g (NH4)2SO4 per 1 L. 
After autoclaving 100 ml of 20% glucose and 50 ml amino acid mix (20x) were added. The 
medium was further supplemented by 10 ml auxotropic components as leucine, histidine, uracile, 
tryphtophane depending on the plasmid expressed in the yeast. The selection markers were 
prepared as stock solutions in water with 192 mg uracil, 192 mg tryptophane, 288 mg leucine, or 
192 mg histidine, respectively per 50 ml. The amino acid mix consisted of 112 mg adenine, 384 
mg arginine, 384 mg methione, 144 mg tyrosine, 576 mg isoleucine, 480 mg phenylalanine, 576 
mg valine, and 576 mg threonine per 500 ml.  
All yeast strains were grown routinely at 30°C, unless indicated otherwise. 
 
4.2.2  Competent yeast cells 
Competent yeast cells were prepared according to the protocol of Schiestl and Gietz 
(1989). Shortly, cells were inoculated from a fresh overnight culture in 50 ml YPD medium to an 
OD600 of 0.2. They were grown at 30°C with vigorous agitation until the OD600 of 0.8-1 was 
achieved. Cells were harvested by centrifugation (500 x g, 5 min, RT), washed once in 20 ml 
sterile water and resuspended in 1 ml sterile 100 mM LiAc, 10 mM Tris-HCl pH 8.0, 1 mM EDTA. 
For  P. pastori instead of LiAC LiCl was used. The samples were transferred into a sterile 
eppendorf tube and centrifuged 500 x g, 5 min. The pellet was resuspended in 100 µl LiAC-
buffer. 
 
4.2.3  Transformation of yeast cells 
Single stranded carrier salmon testis DNA was dissolved at a concentration of 2 µg/µl in 
TE-buffer on a stir plate overnight at 4°C and aliquots were stored at -20°C. Before use, the 
carrier DNA was denatured by incubation at 95°C for 5 min and chilled immediately on ice. 
The competent cells (50µl) were vortexed, centrifuged at 20,000 x g for 30 s and the 
supernatant was removed. The cell pellet was sequentially resuspended in 240 µl PEG (50% Methods    
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w/v), 36 µl 1 M LiAc, 25 µl carrier DNA (2 µg/µl) and 50 µl plasmid DNA (0.1-10 µg) by vigorous 
vortexing. The transformation suspension was incubated at 30°C for 30 min. For heat shock 
cells were placed at 42°C for 20 min and inverted every 5 min. The cells were sedimented at 
20,000 x g for 30 s and the supernatant was discarded. To transform plasmid DNA, the pellet 
was carefully resuspended in 100 µl sterile water and incubated at RT for 5 min. No more than 
20 µl of the transformation mix was plated onto selective agar plates and incubated at 30°C for 
2-3 days. Recombination into the chromosome was achieved by transformation of a PCR 
fragment and subsequent regeneration of the cells in 2-3 ml YPD medium for 90 min. The cells 
were centrifuged at 20,000 x g for 5 min, suspended in 50 µl medium and spread onto selective 
medium plates. To check for positive transformants, colony PCRs were performed with fresh 
colonies. A single colony was picked, transferred to an eppendorf tube, resuspended in 10 mM 
Tris-HCl pH 8, and incubated with 1% lyticase for 15 min at 30°C. This suspension (1µl) was 
used as template for PCR. 
 
4.2.4  Preparation of genomic DNA of yeast 
A culture (5 ml) of the wild type S. cerevisiae strain W303-1A was grown overnight at 
30°C on YPD medium to an OD600 of 1-2. The cells  were harvested at 500 x g, 5 min at 4°C and 
the pellet was resuspended in 500 µl 0.9 M sorbitol, 0.1 M Tris-HCl pH 8, 10 mM EDTA 
containing 10 mM fresh DTT. 20 units lyticase per OD600 of cells were added and the suspension 
was incubated for 1 h at 30°C with gentle shaking (200 rpm). After sedimentation of the 
spheroplasts at 500 x g for 5 min, the pellet was resuspended in 500 µl 50 mM Tris-HCl pH 8, 20 
mM EDTA. Cells were lysed by addion of 50 µl 10% SDS. After mixing the suspension by careful 
inverting, the sample was incubated for 20 min at 65°C. After the addition of 200 µl 5 M KAc pH 
5, the sample was placed on ice for 30 min. Subsequently, the cell debris was removed by 
centrifugation at 20,000 x g for 5 min. The DNA in the supernatant was precipitated with 1 ml 
100% ethanol. A short centrifugation of 10 sec at 20,000 x g sedimented the genomic DNA, 
which was resuspended in 300 µl 100 mM Tris-HCl pH 8 and incubated for 15 min at 65°C. 
Contamination with RNA was removed by incubating the samples with 5 µl RNAse (10 mg/ml) 
for 1 h at 37°C. Finally, the genomic DNA was precipitated with 500 µl isopropanol and 
centrifuged at 20,000 x g for 20  sec. The DNA pellet was washed with 70% ethanol and 
resuspended in 50 µl 100 mM Tris-HCl, pH 8, 10 mM EDTA.     Methods 
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Tab.7: List of yeast strains used 
Name  Background strain  Mutations 
W303-1A  MATa ura3-52 leu2-3, 122 his3-11 trp1-1 
ade2-1 can1-100 
 
∆yll048  W303-1A  ∆yll048::HIS 
Cadus6259  MATa ura3-52 leu2-3, 122 his3-11,15 
trp1-∆1 lys2-1 
far1-1 tbt1-1 bar1::hisG fus-
His3 ste14::trp1::lys3 
∆mdl1  W303-1A  ∆mdl1::HIS 
 
4.3 RNA  methods 
4.3.1  Random-primed labelling of DNA-fragments 
The messenger RNA (mRNA) level of the gene of interest was detected using a gene-
specific radiolabelled DNA probe. YLL048 mRNA was detected by a DNA probe corresponding 
to nt +145 through nt +868 of ORF YLL048. This sequence is not conserved in the ABC 
superfamily. To obtain the probe, the plasmid pCR-Topo-F1 was digested with NdeI and the 
resulting 723 bp fragment was purified from agarose gel. Radioactve labelling of DNA fragments 
was performed using the Megaprime DNA Labelling System. About 20-50 ng of agarose gel 
extracted DNA were mixed with 5 µl of randomized primer mix in a total volume of 28 µl and 
denatured for 10 min at 95°C. After cooling the sample on ice, the sample was briefly 
centrifuged and mixed with 10 µl labelling buffer, 10 µl [α-
32P] dCTP (6000 Ci/mmol) and 2 units 
Klenow enzyme in a total volume of 40 µl. The labelling reaction was performed for 3 h at 37°C. 
The labelled DNA fragment was separated from free nucleotides by gelfiltration using Sephadex 
G-50 columns equilibrated with TE-buffer pH 8. The amount of radioactivity was determined for 
the eluted fractions. For hybridization, normally a DNA probe with a specific activity of 10
6 cpm 
per ml was used. 
 
4.3.2  Isolation of total RNA 
All solutions used for RNA preparation and Northern blot were autoclaved (121°C, 20 min) 
twice to inactivate RNAses. Total RNA was isolated from logarithmically growing cells by the hot 
phenol method as described by (Schmitt et al., 1990). A fresh yeast culture (10 ml) of OD600 1 
was harvested and resuspended in 400 µl 50 mM Na-acetate, pH 5.3, 10 mM EDTA. The 
suspension was mixed with 40 µl 10% SDS and vortexed vigorously. An equal volume of phenol 
preequilibrated with Na-acetate and preheated at 65°C was added, vortexed and incubated at Methods    
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65°C for 4 min. The suspension was immediately chilled in a dry ice/ethanol bath until phenol 
crystals appeared. To separate the aqueous from the phenol phase, the suspension was 
centrifuged at 20,000 x g for 5 min. The aqueous upper phase was collected and extracted with 
an equal volume of phenol/chloroform for 5 min at RT. The RNA was precipitated with 1/10 
volume of 3 M Na-acetate pH 5.3 and 2.5 volumes ethanol. After incubation at -20°C for 30 min, 
the RNA was pelleted at 20,000 x g for 15 min. The pellet was washed once with 80% ethanol, 
dried and resuspended in 20 µl sterile water and stored at -80°C. 
 
4.3.3  Northern blot 
Total RNA (20 µg) was mixed with 11.8 µl DMSO, 2.4 µl 0.1 M phosphate-buffer 
(Na2HPO4/NaH2PO4, pH 6.8) and 40% deionized glyoxal and incubated for 1 h at 50°C. After 
cooling the mixture in ice water, 6.3 µl glyoxal loading buffer (50% glyoxal, 10 mM phosphate-
buffer pH 6.8, 0.4% bromphenolblue, 0.25% xylenecyanol FF) was added prior to loading on a 
1% agarose gel prepared with 10 mM phosphate-buffer pH 6.8. Electrophoresis was performed 
at 60 V for 4 h and the running buffer was recycled every 30 min to avoid changes in the pH 
during the run. RNA was transferred from the gel onto a Nylon membrane (Hybond N+) by 
capillary transfer overnight with 20x SSC buffer (175.3 g NaCl, 88.2 g Na-citrate in 1 L H2O, pH 
7.0) and UV-crosslinked in a Stratagene crosslinker. The membrane was washed with 1x SSC, 
1% SDS and rinsed with sterile water. To check the efficiency of the transfer, the RNA was 
stained with 0.02% methylene blue in 0.3 M Na-acetate pH 5.5 for 5-10 min. After removal of 
excess stain with 5-10% ethanol, the stained rRNA bands could be visualized on the membrane. 
The membrane was prehybridized in 10 ml 10x Denhardt´s buffer (50x Denhardt´s: 5 g 
Ficoll 400, 5 g polyvinylpyrrolidone, 5 g BSA fraction V in 500 ml water, 0.45 µm filter sterilized, 
stored at -20°C), 2x SSC, 1% SDS, 20 µg/ml salmon sperm DNA for 3-6 h at 65°C. The labelled 
probe was added to the prehybridization solution after heat-denaturation. After an o/n incubation 
at 65°C the membrane was washed 3 times for 15 min with 2x SSC, 1% SDS and 3 times for 15 
min with 1x SSC, 1% SDS, at 65°C, and exposed to an X-ray film at -80°C or to a 
phosphoimager screen at RT for the indicated time. 
 
4.4  Cell biology of yeast 
4.4.1  Preparation of crude cell extract 
The crude extract from yeast cells was prepared according to (Knop et al., 1999). Yeast 
cells were inoculated from a fresh o/n culture in 10 ml YPD medium to an OD600 of 0.2 and were    Methods 
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grown at 30°C with vigorous agitation to an OD600 of 0.8-1.0. 5-10 OD600 equivalents were 
harvested and resuspended in 1 ml cold water. The cell suspension was mixed with 150 µl 1.85 
M NaOH, 7.5% β-mercaptoethanol and placed on ice for 10 min. 150 µl 50% TCA (w/v) was 
added and the sample was incubated for 10 min on ice. The precipitated protein was collected 
by centrifugation (5 min at 20,000 x g, 4°C). The supernatant was removed, and all residual 
traces of TCA were aspirated off. The pellet was resuspended in 55 µl sample buffer and 
neutralized with 5 µl 1 M Tris not adjusted to pH. Proteins were denatured for 10 min at 65°C. 
After centrifugation aliquots corresponding to 0.5 OD600 of cells were analysed for protein 
content by SDS-PAGE. TCA-precipitated proteins required a longer blotting transfer time than 
non-treated proteins. 
 
4.4.2  Preparation of total membranes 
Yeast cells were inoculated from a fresh overnight culture in 50 ml YPD medium to OD600 
0.2. They were grown at 30°C until early logarithmic phase (OD600 of 1-1.5). The cells were 
harvested and resuspended in 1 ml cold water. The cell suspension was mixed with 200 µl TE-
buffer (100 mM Tris pH 8, 10 mM EDTA) and 1 mM PMSF. Cell disruption was performed 
mechanically by vigorous vortexing the cell suspension with glass beads. Every sample was 
alternatingly vortexed for 30 s and placed on ice for 8 times. After gravity sedimentation of the 
glass beads the supernatant was collected. Nuclei and cell debris were removed by 
centrifugation at 500 x g for 5 min. The supernatant was sedimented for 30 min at 20,000 x g in 
an eppendorf centrifuge. The pellet contained crude membranes of yeast cells. 
 
4.4.3  Cultivation of yeast cells for mitochondria preparation  
A preculture of the wild type S. cerevisiae strain W303-1A was grown o/n at 30°C on 
lactate medium. The main culture (500 ml) was inoculated to an OD600 of 0.2 in lactate medium 
and grown at 30°C with vigorous agitation until the early logarithmic phase (OD600 of 1-1.5) was 
achieved. Transformed yeast cells (e.g. ∆mdl1, p426-mdl1) were grown for 24 h as a preculture 
at 25°C in drop out medium. The main culture was cultivated at 25°C until an OD600 of 1 was 
reached. Cells were harvested by centrifugation (5 min at 3,000 x g). 
 
4.4.4  Preparation of spheroplasts 
The cell pellet was washed once with distilled water, and resuspended in 30 ml 0.1 M 
Tris-sulphate, pH 9.4, 10 mM DTT, and incubated for 10 min at 30°C to break the disulfide Methods    
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bonds in the cell wall. After centrifugation (5 min at 3,000 x g) the cell pellet was suspended in 8 
to 20 ml 1.2 M sorbitol, 20 mM phosphate buffer, pH 7.4. To determine the cell density, an 
aliquot was taken, diluted 1:100 in water and the OD600 was determined. The starting OD600 
should not exceed 50. The cell wall was digested by 20 units of lyticase per OD600 of cells at 
30°C with gentle shaking for 1 to 2 h. Conversion to spheroplasts was checked by measuring 
the OD600 of a 1:100 (in water) diluted suspension. Spheroplasts are osmotic labile, therefore 
1:100 dilution in water should result in drop of the OD600 to less than 10% of the initial value. 
Spheroplasts were harvested by centrifugation (1,000 x g, 5 min, 4°C) and washed carefully in 8 
ml 1.2 M sorbitol-buffer. After resuspending the pellet in 3-10 ml ice-cold 1.2 M sorbitol, 40 mM 
HEPES pH 7.4, 1 mM PMSF and equal volume water, the spheroplasts were lysed by 
homogenization with 40 strokes in a tight-fitting douncer at 4°C. The homogenate was 
centrifuged at 4,000 rpm for 10 min at 4°C to remove any non-lysed spheroplasts and cell debris. 
4.4.5  Preparation of mitochondria 
The mitochondria were isolated by differential centrifugation according to (Daum et al., 
1982). The spheroplasts were prepared as described above. After lysis of the spheroplasts the 
supernatant was centrifuged at 9,200 rpm for 12 min in a sorvall SS34 rotor (Beckmann). The 
pellet was carefully resuspended in 1-8 ml 0.6 M sorbitol, 20 mM HEPES pH 7.4 and centrifuged 
at 4,000 rpm for 5 min. The supernatant was pelleted at 9,200 rpm for 12 min. The crude 
mitochondria pellet was resuspended in 500 µl 0.6 M sorbitol, 20 mM HEPES pH 7.4, aliquoted, 
frozen in liquid nitrogen and stored at -80°C.  
To purify yeast mitochondria devoid of microsomal contaminations, a purification 
procedure using a sucrose density gradient was applied (Meisinger et al., 2000). The crude 
mitochondria purified as described above were loaded onto a step sucrose gradient composed 
of 1.5 ml of 60% (w/v), 4 ml of 32%, 1.5 ml of 23%, and 1.5 ml of 15% sucrose in 20 mM HEPES, 
pH 7.2. After centrifugation at 134,000 x g in a SW41 swing-out rotor for 1 h at 4°C, the purified 
mitochondria were recovered from the 32% / 60% sucrose interface. 
 
4.4.6  Generation of mitoplasts by osmotic swelling 
Mitoplasts are mitochondria from which the outer membrane has been removed by 
osmotic shock (Gasser et al., 1982; Fritz et al., 2001). Crude mitochondria were diluted with 5 
volumes of 20 mM HEPES, pH 7.4 to a final concentration of 0.1 M sorbitol. The suspension was 
stirred gently for 20 min at 4°C. The submitochondrial membranes were loaded on a sucrose 
step gradient [30%, 34%, 40%, 44%, 50% (w/v) sucrose in 20 mM HEPES, pH 7.2] and 
centrifuged at 134,000 x g in a SW 28 rotor for at least 12 h. The outer membrane was enriched    Methods 
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at the top of the gradient, whereas the inner membrane vesicles were collected from fractions 
corresponding to 35-45% sucrose. 500 µl fractions were collected and the refractive index was 
determined. The samples were TCA-precipitated (final concentration 5%) and analysed by SDS-
PAGE and immunostaining. Alternatively, the inner membrane fractions were 3 fold diluted in 20 
mM HEPES-buffer, pH 7.2 and sedimented for 20 min at 20,000 rpm in a SS34 rotor. The pellet 
was used for reconstitution. 
 
4.4.7  Digitonin fractionation of mitochondria and proteinase K digestion 
Mitochondria were fractionated with digitonin as described (Hartl et al., 1986; Klanner et 
al., 2001; Fritz et al., 2001) with slight modifications. Shortly, mitochondria (100 µg) in a 
concentration of 5 mg/ml were resuspended in SEMK buffer (250 mM sucrose, 10 mM MOPS-
KOH pH 7.2, 80 mM KCl, 1 mM EDTA) supplemented with varying concentrations of digitionin in 
the presence and absence of proteinase K (100 µg/ml) and incubated for 5 min at 4°C. For 
control, mitochondria were completely solubilized by adding 0.17% (v/v) Triton X-100. 
Solubilization of mitochondrial membranes was stopped by diluting the sample five-fold with ice-
cold SEMK. Protease digestion was continued for additional 30 min on ice before it was inhibited 
by addition of 1 mM PMSF. The samples were TCA-precipitated (5%) and analysed by SDS-
PAGE and immunostaining. 
 
4.4.8  Preparation of microsomes 
To obtain microsomes from yeast cells, spheroplasts were prepared and lysed as 
described above. The supernatant of lysed spheroplasts was mixed with a 72% sucrose solution 
to obtain a suspension of 50% final sucrose concentration. The suspension was overlayed with 
10 ml 42% sucrose and 10 ml 24% sucrose and centrifuged at 104,000 x g for at least 4 h in a 
SW-28 rotor. The microsomes were harvested from the 24% / 42% sucrose interphase and 
diluted with 2 volumes of 20 mM HEPES, 100 mM NaCl, pH 7.5. The suspension was 
centrifuged at 227,000 x g in Ti50 rotor for 45 min. The pellet was resuspened in 500 µl 20 mM 
HEPES, 100 mM NaCl, pH 7.5, aliquots were frozen in liquid nitrogen and stored at -80°C. 
 
4.4.9  Preparation of vacuoles 
The procedure for isolation of vacuoles was performed as described (Roberts et al., 1991; 
Zinser and Daum, 1995). The spheroplasts were prepared by lyticase treatment as described 
previously, but in order to avoid disruption of the fragile vacuolar membrane, a more careful lysis Methods    
42 
of spheroplasts was applied. The pellet of spheroplasts was resuspended in 6-10 volumes of 10 
mM 2-(N-morpholino)ethanesulfonic acid (MES)/Tris, pH 6.9, 0.1 mM MgCl2 and 12% Ficoll 400 
and homogenized 10 times with a loose-fitting douncer at 4°C. The lysate was centrifuged at 
2,200 x g for 10 min at 4°C. For the Ficoll flotation experiment, the lysed spheroplasts were 
overlayed with an equal volume of 10 mM MES/Tris, pH 6.9, 0.1 mM MgCl2 and 12% Ficoll 400 
and centrifuged at 60,000 x g for 30 min in a SW-28 rotor. A white turbid fraction containing the 
vacuoles was collected from the top of the Ficoll gradient and homogenized with a loose-fitting 
douncer in 10 mM MES/Tris, pH 6.9, 0.1 mM MgCl2 and 12% Ficoll 400. The suspension was 
overlayed with an equal volume of 10 mM MES/Tris pH 6.9, 0.5 mM MgCl2 and 8% Ficoll 400 
and centrifuged at 60,000 x g for 30 min in a SW-41 rotor. Again the white turbid suspension on 
top of the Ficoll gradient was harvested and diluted in 10 mM MES/Tris pH 6.9, 5 mM MgCl2, 25 
mM KCl. The suspension was homogenized with a loose-fitting douncer and centrifuged for 1 h 
at 37,000 x g in a Ti50 rotor. The pellet was resuspended in a small volume of 10 mM MES/Tris 
pH 6.9, 5 mM MgCl2, 25 mM KCl containing 5% glycerol. Aliquotes of the vacuole vesicles were 
frozen in liquid nitrogen and stored at - 80°C. 
 
4.4.10 Marker enzyme for vacuole 
The enrichment of vacuole fractions in sucrose gradients was checked using α-
mannosidase as vacuolar marker. Fractions were preincubated for 10 min at 37°C in 100 mM 
Tris-HCl, pH 6.8, 0.2% Triton X-100 and the reaction was started with 7.2 mM p-nitrophenyl-α-D-
mannoside. The reaction was allowed to proceed for 2 h at 37°C and was stopped by addition of 
250 mM Na2CO3. The α-mannosidase activity was followed by measuring the decrease in the 
absorption at 405 nm. 
 
4.4.11 Subcellular fractionation 
Spheroplasts were prepared as described above with slight modifications (Zinser and 
Daum, 1995). The cell pellet was resuspended in 0.1 M Tris-sulphate, pH 9.4, 10 mM DTT, and 
incubated for 10 min at 30°C. After centrifugation (5 min at 3,000 x g) the cell pellet was 
suspended in 1.4 M sorbitol, 50 mM phosphate buffer, pH 7.5 to 50 OD600/ml and incubated with 
20 units lyticase per OD600 of cells at 30°C with gentle shaking for 1 to 2 h. Spheroplasts were 
harvested by centrifugation (1,000 x g, 5 min, 4°C) and suspended in lysis buffer (0.8 M sorbitol, 
10 mM MOPS pH 7.5) with 1 mM PMSF to 100 OD600/ml. After douncing 40 times with a tight 
fitting douncer, the suspension was centrifuged for 10 min at 500 x g and the supernatant was    Methods 
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loaded on a sucrose step gradient (18, 24, 30, 36, 42, 48, 54, 60% (w/v)) (according to R. Egner, 
personal communication). After centrifugation for at least 3 h at 30,000 rpm in a SW-41 rotor, 1 
ml fractions were collected. The refractory index, the activity of marker enzymes, the protein 
concentration as well as peptide uptake activity were determined of each fraction. Aliquots of the 
fractions were analysed by Western blot analysis. According to the different sedimentation 
properties, it was possible to distinguish light microsomes containing smooth ER and heavy 
microsomes containing rough ER decorated with ribosomes. In order to remove ribosomes from 
the rER, microsomes were suspended in 0.8 M sorbitol, 10 mM MOPS, 10 mM EDTA pH 7.5. 
Since the adherence of ribosome to the ER is dependent on divalent cations, the EDTA 
treatment released ribosomes from the ER. The microsomes were applied to a sucrose step 
gradient (see above) and centrifuged at least 3 h at 30,000 rpm in a SW-41 rotor. Stripped 
microsomes underwent a density shift, and were recovered from 20-25% (w/v) sucrose gradient. 
 
4.4.12 Preparation of transport-competent cells 
Semi-permeabilized cells were prepared as described by (Baker et al., 1988) and used in 
peptide uptake assays. S. cerevisiae strain W303-1A was grown at 30°C in YPD medium to an 
OD600 of 1. The cells were harvested by centrifugation (1,000 x g, 5 min, 24°C) and resuspended 
at 50 OD600 units per ml in 0.1 M Tris-sulphate, pH 9.4 including 10 mM DTT. Spheroplasting 
was performed as described previously, but with slight modifications. Shortly, lyticase treated 
spheroplasts were harvested at 1,000 x g, 5 min, 24°C and resuspended at 5 OD600/ml in 
spheroplasting medium (0.75x YP, 0.7 M sorbitol, 1% glucose). To regenerate the spheroplasts 
and resume their metabolism, they were incubated with gentle shaking for 20 min at 30°C. The 
suspension was harvested at 1,000 x g, 5 min at 4°C and resuspended at 300 OD600 per ml in 
ice-cold lysis buffer (400 mM sorbitol, 20 mM HEPES, pH 6.8, 150 mM KOAc, 2 mM MgOAc and 
0.5 mM EGTA). Aliquots (200µl) were carefully frozen in the vapours above liquid nitrogen for 45 
min. The frozen tubes were transferred to a -80°C freezer. No loss in transport activity was 
detected after 2 months of storage. 
 
4.5 Biochemical  methods 
4.5.1  SDS-PAGE (polyacrylamide gel electrophoresis) 
The stacking gel buffer is composed of 0.5 M Tris-HCl, pH 6.8 and 0.4% SDS. The 
running gel buffer contains 1.5 M Tris-HCl, pH 8.8 and 0.4% SDS. The acrylamide solution Methods    
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consists of 30% acrylamide and 0.8% N,N´methylenbisacrylamide. Stock aliquots of 10% 
ammoniumperoxodisulphate (APS) are prepared in water and stored at -20°C. 
The 8 disk gel block was assembled. For the running gel the ingredients were mixed 
according to table 8. The polymerization reaction was started by addition of N,  N, N`, N`-
tetramethylethylenediamine (TEMED) and APS. Quickly, the mixture was poured into the disk 
gel block and overlayered with isobutanol. After polymerization of the running gel (1 h), the 
isopropanol was removed, washed with water, and the stacking gel solutions were prepared 
according to table 8. The polymerization reaction was started by addition of TEMED and APS. 
The mixture was poured into the gel block and the combs were immediately put inside the 
stacking gel.  
Before electrophoresis the proteins were denatured in 3x sample buffer (150 mM Tris pH 
6.8, 6% SDS, 30% glycerol, 0.3% bromphenolblue and freshly added 40 mM DTT). Soluble 
proteins were incubated 5 min at 95°C, membrane proteins were incubated 10 min at 65°C. The 
SDS electrophoresis was performed at 180 V for 2-3 h in running buffer (25 mM Tris, 192 mM 
glycine, 0.1% SDS, pH ~8.3). 
 
Tab.8: Composition of stacking and running gel according to Laemmli (1970) 
  stacking gel  running gel 
 5%  7.5%  10%  12% 
acrylamid  6.8 ml  18 ml  24 ml  29 ml 
stacking buffer  5 ml       
running buffer    18 ml  18 ml  18 ml 
H20  28 ml  36 ml  30 ml  25 ml 
APS  320 µl  470 µl  470 µl  470 µl 
TEMED  32 µl  40 µl  40 µl  40 µl 
 
4.5.2  Western blotting 
To transfer proteins from the gel onto nitrocellulose, the gel was placed on several 
Whatmann papers soaked in blotting buffer (25 mM Tris, 192 mM glycine, 20 % methanol, pH 
8.2) and covered with a nitrocellulose membrane followed by several Whatmann papers soaked 
in blotting buffer. The sandwich was transferred to a semidry blotting apparatus (BioRAD) with 
the nitrocellulose membrane facing the anode. The electroblotting was performed at constant 
current (100 mA) per gel. Alternatively, the sandwich was placed into a tank blot apparatus 
(BioRAD) filled with blotting buffer. Proteins were transferred o/n at a constant voltage of 18 V.    Methods 
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To determine the efficiency of the transfer, the membrane was stained with Ponceau Red (0.1% 
Ponceau Red S, 5 % acetic acid) for 5 min, and washed with water until defined bands were 
visible. For immunodetection the membrane was blocked with blocking buffer (TBS-T: 10 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 0.1% (v/v) Triton X-100, including 7% (w/v) skim milk powder 
and 0.1% (w/v) NaN3) for at least 30 min at RT or o/n at 4°C. When either the α-strep-tag or α-
biotin was used, the membrane was blocked in 3% BSA in TBS-T. The membrane was 
incubated at RT for 1 h with the primary antibody diluted in blocking buffer, respectively. After 
washing 5 times for 5 min with TBS-T the protein bands were visualized using horseradish 
peroxidase conjugated second antibodies (1:10,000). The protein was detected via the 
Enhanced ChemiLuminescence (ECL) system according to the manufactures instructions. The 
luminescence signal was recorded on Hyperfilm chemiluminescence film. 
 
Tab.9: List of antibodies and recommended dilutions  
antibody  source  dilution (Western)  Reference 
α-Mdl1  rabbit  1:500  Research Genetic Inc, 
Huntsville 
α-Sec61  rabbit 1:10,000  Schekman 
α-Kar2  rabbit   1:10,000  Schekman 
α-porin  rabbit 1:1,000  Lill 
α-pre-pro alpha factor  rabbit 1:500  Schekman 
α-biotin  goat 1:10,000   
α-strep-tag  mouse 1:2,000  IBA 
α-myc  mouse 1:500  HIS-Diagnostic 
α-goat, mouse, rabbit   1:10,000  Amersham  Pharmacia 
 
4.5.3  Stripping of immunoblots 
To re-use Western blots, membranes were stripped with a stripping buffer (60 mM Tris-
HCl, pH 6.7, 2% SDS (w/v), 100 mM β-mercaptoethanol) for 20 min at 50°C in a water bath and 
washed afterwards with TBS, 0.1% Triton X-100 before extensive blocking (at least 1 h) and 
incubation with the next antibody. 
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4.5.4  Generation of Mdl1p-specific antiserum 
For generation of Mdl1-specific antisera, the synthetic 15mer peptide 
KGGVIDLDNSVAVER (corresponding to the last C-terminal amino acids) was sent to Research 
Genetic Inc, Huntsville and used for generation of antibodies in rabbits. 
 
4.5.5  Solubilization of membrane proteins from mitochondria  
Detergents are amphiphilic molecules which disrupt the bilayer of the membrane. An 
important property of a detergent is its critical micelle concentration (CMC). Below its CMC, a 
detergent is soluble in water in monomeric form, but, at concentrations above the CMC, 
organized structures are formed, termed micelles. Proteins are solubilized in detergent micelles, 
with the hydrophobic membrane-penetrant part of the protein coated by the hydrophobic part of 
the detergent. Tab.10 summarizes the detergents used in the thesis. As Triton X-100 is a 
heterogeneous mixture of long-chain polyexyethlene polymers, information about properties 
differ in literature. 
 
Tab.10: Detergent and some of their properties  
detergent   Monomer MG  CMC [mM]  Aggregation number 
Decyl-β-D-maltoside 483  1.6  --- 
Octyl-β-D-glycopyranoside 292  25  84 
Triton X-100   1625  0.3  140 
Digitonin 1229  0.7  60 
 
Mitochondria (1 mg) were thawn on ice and centrifuged at 20,000 x g, 5 min, 4°C. The 
membrane pellet was resuspended in 100 µl solubilization buffer (20 mM HEPES, pH 7.4, 150 
mM NaCl, 2 mM KCl, 20% glycerol, 2 mM MgCl2, 0.5 mM MnCl2) containing the appropriate 
concentration of detergent e.g. decylmaltoside (1.4%) or digitonin (2%) and was solubilized for 
30 min on ice. Non-solubilized material was removed by centrifugation at 100,000 x g, 30 min 
and 4°C. The supernatant was used for chromatography, reconstitution or azido-ATP 
crosslinking.  
4.5.6  Enrichment of Mdl1p from solubilized mitochondria by gelfitration 
All chromatographic procedures with membrane proteins were performed in detergent 
buffer (0.114% DM or 0.5% digitonin, 20 mM HEPES, pH 7.4, 150 mM NaCl, 2 mM KCl, 20% 
glycerol, 2 mM MgCl2, 0.5 mM MnCl2). Proteins derived from solubilized mitochondria were 
separated by gelfiltration using a Superose 6 PC3.2/30 column (Amersham Pharmacia)    Methods 
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equilibrated with detergent buffer. All fractions were analysed via SDS-PAGE and 
immunostaining with α-Mdl1. Mdl1p containing fractions were pooled and used for reconstitution. 
 
4.5.7  Affinity-isolation of Mdl1p from solubilized mitochondria 
4.5.7.1 ATP-agarose 
ATP-agarose (C-8, N-6 or ribose coupled) or reactive RED 120 was washed 3 times with 
destilled water and once with detergent buffer (0.114% DM or 0.5% digitonin, 20 mM HEPES, 
pH 7.4, 150 mM NaCl). ATP-agarose was then incubated in batch with detergent solubilized 
mitochondrial proteins supplemented with 2 mM MgCl2 with constant agitation for 1 h at 4°C. 
The ATP-agarose was washed with detergent buffer, and the protein was eluted with 5 mM ATP 
in detergent buffer in case of ATP-agarose or by a salt gradient from 150 to 900 mM NaCl in the 
presence of 5 mM ATP in case of Red-agarose.  
 
4.5.7.2 Metal affinity chromatography 
For immobilized metal affinity chromatography (IMAC), solubilized His6-tagged constructs 
of the Mdl1p were applied to Ni-NTA-beads. Before use, the Ni-NTA-beads were stripped with 
10 mM EDTA, washed 10 times in destilled water (180 x g, 30 sec), incubated with 10 mM NiCl2 
for 5 min, washed 10 times in destilled water and preequilibrated with detergent buffer (0.114% 
DM or 1% Triton X-100, 20 mM HEPES, pH 7.4, 150 mM NaCl). Binding of the protein was 
performed in batch with constant agitation for 1 h at 4°C. Washing was performed with 20 mM 
imidazole steps from 20 mM to 80 mM in detergent buffer and protein was eluted using a 
imidazole gradient of 80 to 250 mM. 
 
4.5.7.3 Streptactin chromatrography 
To purify the strepII-tagged constructs of Mdl1p, a streptactin resin was used. Before use, 
beads were regenerated with 5 mM hydroxyazophenyl benzoic acid (HABA) and extensively 
washed with 10 mM HEPES, pH 7.2, 150 mM NaCl, 1 mM EDTA. Afterwards, the resin was 
equilibrated with detergent buffer (0.114% DM, 10 mM HEPES, pH 7.2, 150 mM NaCl). Binding 
to the resin was performed in batch with constant agitation for 1 h at 4°C. Washing steps were 
performed with detergent buffer and protein was eluted with detergent buffer supplemented with 
2.5 mM desthiobiotin.  
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4.5.8  Reconstitution into preformed liposomes 
For liposome preparation, a lipid mixture of 75% phosphatidylcholine, 20% 
phosphatidylethanolamine and 5% cardiolipin was dissolved in chloroform. If indicated, a 
different composition of lipids was used. The chloroform was removed under a stream of 
nitrogen, and lipids were dried in vacuum. The lipid film was rehydrated in phosphate buffer pH 8 
to a final lipid concentration of 8 mg/ml. Liposomes were extruded 11 times through a 200 nm 
pore-size polycarbonate filter using a LipoFast-Extruder followed by four freeze and thawn 
cycles. Preformed liposomes were stored at -80°C. If indicated, liposomes were destabilized by 
preincubation with 1.6% octylglycoside for 3 h before use.  
For reconstitution, preformed, unilamellar liposomes were thawn for 10-30 min on ice and 
collected by centrifugation (100,000 x g, 30 min, 4°C). The liposome pellet was mixed with 
solubilized membrane protein fraction derived directly from solubilization of mitochondria or from 
partially purified Mdl1p by gelfiltration or affinity chromatography. Solubilized membrane proteins 
were incubated with liposomes for 1 h on ice and detergent was removed by successive addition 
of biobeads SM-2. Before use, the biobeads were washed once with methanol and 10 times with 
destilled water and preequilibrated with solubilization buffer without detergent. After incubation of 
the reconstitution mixture with 100  mg biobeads for 20 min at 4°C, the suspension was 
centrifuged (200 x g, 2 min, 4°C) and the supernatant was incubated with a new batch of 
biobeads. The exchange of biobeads was repeated four times. Proteoliposomes were collected 
by centrifugation at 100,000 x g for 1 h at 4°C. 
 
4.5.9  Azido-ATP photolabelling of Mdl1p 
Crosslinking experiments with 8-azido-ATP were performed with solubilized as well as 
reconstituted Mdl1p. The samples were preincubated in the presence and absence of nucleotide 
triphosphates (1.5 mM) for 5 min on ice in solubilization buffer (20 mM HEPES pH 7.4, 150 mM 
NaCl, 5 mM MgCl2, 1 mM MnCl2, 15% glycerol, 1% digitonin). For control, proteoliposomes were 
completely solubilized by addition of 1% Triton X-100. Azido-[α-
32P]-ATP was added to a final 
concentration of 2 µM and incubated on ice for 5 min. Samples were irradiated by UV (254 nm) 
for 5 min (Xenotest GmbH, 50/60 Hz), and diluted 5 times in solubilization buffer. The 
photocrosslinked protein was incubated with α-Mdl1 (1:100) for 2 h at 4°C and the immuno-
complexes were recovered overnight with 60 µl preequilibrated protein A-sepharose. The beads 
were washed 3 times with solubilization buffer containing 0.1% digitonin. Finally, the beads were 
resuspended in loading buffer (1 mM DTT), incubated for 10 min at 65°C and separated by 12% 
SDS-PAGE. The gel was dried and exposed to a Kodak Biomax film for 2 weeks.    Methods 
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4.5.10 Peptide labelling with NaI
125 
Peptides were iodinated using the chloramine T-method (Hunter and Greenwood, 1964). 
Chloramine T solution (1 mg/ml) and sodiumdisulfite (1 mg/ml) were freshly prepared in 10 mM 
Na2HPO4/NaH2PO4, pH 7.4, 150 mM NaCl, 5 mM KCl. The reaction was routinely performed 
with 1.5 nmol peptide in a total volume of 50 µl and 1 µl (100 µCi) Na
125I. The reaction was 
started by addition of 10 µl chloramine T. After 5 min incubation at RT the reaction was stopped 
by addition of 20 µl Na2S2O5 (sodiumdisulfite) and further diluted with 100 µl phosphate buffer. 
Free iodine was removed by ion exchange chromatography using Dowex 1 x 8 material. Anion 
exchange material (10 mg) was equilibrated in phosphate buffer containing 0.2% dialyzed BSA 
and was washed 2 times with phosphate buffer without BSA. The Dowex suspension (220 µl) 
was added to the radiolabelled reaction mix, vortexed and incubated for 5 min at RT. The 
suspension was applied to an empty spin column and centrifuged for 2 min at 200 x g. The flow-
through contained the radiolabelled peptide in a concentration of 5 µM. 
4.5.11 Peptide transport assay 
The peptide transport reaction was started by addition of 50 pmol (10µl) radiolabelled 
peptide to 150 µl vesicles in transport buffer (20 mM HEPES, pH 7.2, 150 mM NaCl, 5 mM 
MgCl2). If indicated, 3 mM ATP or ADP, non-hydrolysable ATP analogue (AMP-PNP) or 100 fold 
excess of competitor peptide was added. The reaction was performed for 3 min at 30°C and 
stopped by addition of excess of unlabelled peptide in 500 µl ice-cold transport buffer. The 
reaction was incubated 5 min on ice, centrifuged at 20,000 x g for 8 min and the pellet was 
washed twice with transport buffer. The radioactivity of the pellet was directly quantified by γ-
counting.  
For transport studies with microsomes peptides with a glycosylation site (NXS, NXT) 
were used. After the transport assay, microsomes were lysed by resuspending the pellet in 1 ml 
lysis buffer (1% (w/v) NP-40, 20 mM HEPES, pH 7.2, 150 mM NaCl, 5 mM KCl). After 
centrifugation the supernatant was loaded on 100 µl preequililbrated concanavalin A-sepharose. 
After 2 h at 4°C, the sepharose suspension was centrifuged (200 x g, 5 min, 4°C) and washed 
two times with lysis buffer. Glycosylated peptide was eluted by 1 ml 200 mM α-methylmannoside 
prepared in lysis buffer for 1 h at RT. After centrifugation the eluted fractions were quantified by 
γ-counting. 
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4.5.12 Purification of His6-tagged NBDs 
The cell pellet was resuspended in PBS (10 mM Na2HPO4/NaH2PO4, pH 7.6, 150 mM 
NaCl, 5 mM KCl) with 20 mM imidazole, 1 mM PMSF, 1% lysozyme, and 5-10 units benzonase 
and disrupted by French press treatment at 1000 p.s.i. After centrifugation for 1 h at 100,000 x g 
the supernatant was applied to a Ni-IDA column. Before use, the column was loaded with 100 
mM NiCl2 and extensively preequilibrated in PBS pH 7.6 with 20 mM imidazole. The column was 
washed with step gradients of 80 mM and 100 mM imidazole in PBS pH 7.4 and the protein was 
eluted with 250 mM imidazole. The fractions containing the NBD were pooled, concentrated 
using a centricon 10, and applied to a superdex 200 HR 11/15 gelfiltration column (Amersham 
Pharmacia) equilibrated in 20 mM Tris pH 8, 100 mM NaCl. The NBD eluted with an apparent 
molecular weight of 33 kDa corresponding to the size of the monomer. Fractions were 
concentrated to 30 mg/ml in a centricon 10 and stored in the presence of 5 mM ATP at 4°C. 
 
4.5.13 Azido-ATP photolabelling of the Mdl1p-NBD 
After preincubation of the purified NBD (0.3 µM) with different concentrations of 
nucleotide triphosphates for 5 min on ice in binding buffer (20 mM Tris pH 8, 100 mM NaCl, 5 
mM MgCl2, 1 mM MnCl2), 8-azido-[α-
32P]-ATP was added to a final concentration of 0.5 µM and 
incubated on ice for 5 min. Samples were irradiated by UV (254 nm) for 5 min (Xenotest GmbH, 
50/60 Hz), directly resuspended in SDS loading buffer (10 mM DTT) and separated by 15% 
SDS-PAGE. The gel was dried and exposed to Kodak Biomax film overnight. Alternatively, 
photocrosslinking with biotin-8-azido-ATP was performed by incubating the NBD (0.3 µM) with 
30 µM biotin-8-azido-ATP for 5 min on ice in the presence and absence of unlabelled 
nucleotides (10 mM) in the binding buffer. The samples were irradiated by UV (254nm) for 5 min. 
After SDS-PAGE the protein was transferred to a nitrocellulose membrane according to standard 
procedures. The blot was blocked with 3% BSA for 1 h, followed by incubation with anti-biotin 
antibody (1:10,000) for 1 h. After washing biotinylated protein bands were detected by 
peroxidase coupled anti-goat antibody (1:10,000) using the ECL system. 
 
4.5.14 ATPase assay 
ATPase activities were measured by the Malachite green assay as described previously 
(Morbach et al., 1993). The ATPase assay was performed in 20 mM Tris-HCl pH 8, 100 mM 
NaCl at 30°C with 30 µM NBD, unless specified differently. The reaction was started by addition 
of ATP and MgCl2 to final concentrations of 2 and 10 mM, respectively. 
    Methods 
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4.5.15 Dimerization Assays  
Ortho-vanadate stock solution (100 mM stock) was prepared from Na3VO4 in destilled 
water and was adjusted to pH 8 with HCl. After boiling for 2 min, the pH was again adjusted to 8. 
These steps were repeated until the pH did not change anymore. This stock solution was stored 
at -20°C. Before use, vanadate was again boiled to break polymeric species. At concentrations 
below 200 µM, monomeric vanadate is the predominant species in solution (Urbatsch et al., 
1995b).  
BeCl2 was prepared as a 10 mM stock solution in destilled water, NaF was prepared as a 
500 mM stock solution. Before use, beryllium fluoride solution was mixed in a ratio of 1:100 of 
BeCl2 and NaF. Purified wild type NBD (30 µM) was incubated with different concentrations of 
BeFx or ortho-vanadate in the presence or absence of ATP for 5 min at 30°C in binding buffer. 
The sample was applied to a Superdex 75 HR 30/10 gelfiltration column in 20 mM Tris-HCl pH 8, 
100 mM NaCl, 5 mM MgCl2 at 4°C and a flow rate of 45 µl/min. The same procedure was applied 
for purified mutant NBDs (E599Q; D598A; H631R) (30 µM) at different concentrations of ATP.  
 
4.5.16 Determination of the ATP/ADP composition of the dimer 
The wild type NBD was incubated with 625 µM ATP supplemented with 0.125 µM of 
either [α
32P]-ATP or [γ
32P]-ATP (4500 Ci/mmol) under trapping conditions and analysed by 
gelfiltration. The fractions were quantified for ATP concentration by β-counting and for protein 
concentration by the BCA kit. The mutant NBD (E599Q) (30 µM) was incubated for 5 min on ice 
with ATP supplemented with tracer amounts of [α
32P]-ATP or [γ
32P]-ATP and analysed by 
gelfiltration. The nucleotide composition of the dimer was analysed by thin layer chromatography 
(TLC). The fraction containing the dimer was incubated with 15 mM EDTA for 30 min and 
precipitated with trichloric acid (10 %) for 30 min at 4°C. After centrifugation at 20,000 x g for 5 
min, the samples were neutralized with 0.5 M KHCO3 pH 8.3 and applied onto polyethylenimin 
cellulose plates in 2 M formiat, 250 mM LiCl. To determine the positions of the radioactive 
species, [α
32P]-ATP and [γ
32P]-ATP were incubated with hexokinase, apyrase and NBD.  
 
4.5.17 Thiol-specific labelling of NBDs for FRET 
Thiol-reactive reagents like maleimides are used to modify a protein at its cysteines. 
Maleimide coupled Texas Red (Ex 582 nm, Em 600 nm) was dissolved in methanol and Oregon 
Green (Ex 490 nm, Em 515 nm) in DMF and used in a 5 to 10x molar excess to label the NBDs 
(30 µM). The labelling reaction was performed in 50 mM Tris-HCl pH 7.5, 100 mM NaCl for 1- 4 Methods    
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h on ice in the dark. The reaction was stopped with a 10x excess of glutathione (GSH) and 
incubated for 1 h on ice. GSH quenched the reaction of thiol-reactive probes, forming highly 
soluble adducts that are easily removed by dialysis or gelfiltration. After centrifugation (5 min, 
20,000 x g) the reaction mix was applied to a 5 ml desalting HiTrap column (Amersham 
Pharmacia) in 50 mM Tris-HCl pH 7.5, 100 mM NaCl to separate the labelled protein from the 
dye. The labelled NBDs were checked for dimerization in gelfiltration (Superdex 75 HR 30/10).    Results 
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5 Results 
5.1 Characterisation  of  the ABC transporter Mdl1p 
Although it is widely agreed that ABC transporters undergo a series of conformational 
changes in response to ATP binding and hydrolysis at the NBDs and to substrate binding, 
transport and release at the TMDs, only little information is available about the structure of the 
intermediate states during transport process. We addressed the question by which mechanism 
ATP hydrolysis powers the translocation of substate mediated by Mdl1p. Recently, Mdl1p has 
been identified as a peptide ABC transporter of the inner mitochondrial membrane of S. 
cerevisiae (Young et al., 2001). It is proposed that this half-size transporter acts as a homodimer 
in its minimal composition. Much of the mechanism how the motor domains of ABC transporters 
work and cooperate can be learned from the characterisation of isolated NBDs. Therefore, the 
Mdl1p-NBD was purified and investigated in vitro. Different intermediate states of the NBD were 
studied during ATPase cycle in detail.  
 
5.1.1  Heterologous expression and purification of wild type and mutant Mdl1p-
NBDs  
The C-terminal domain of the ABC transporter Mdl1p corresponding to the NBD (amino 
acids 427 to 695) was cloned into the pET28b vector under the control of a T7 promotor and 
expressed in E. coli BL21(DE3). The recombinant plasmid pET-NBD includes the expression 
cassette with an N-terminal His6-tag, a thrombin cleavage site and a T7-tag encoded by the 
vector (Fig.7).  
 
 
 
Fig.7: Expression cassette of NBD. 
The NBD gene was cloned into the pET28b vector under the control of IPTG-inducible promotor. The construct was 
fused with an N-terminal His6-tag, a thrombin cleavage site and a T7-tag encoded by the vector. 
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Fig.8: Purification of wild type and mutant Mdl1p-NBDs. 
A: Coomassie-stained 15% SDS-PAGE of crude extract of non-induced BL21(DE3) cells transformed with pET-NBD 
(n.i.), cells after 3 h induction with 0.2 mM IPTG (i), affinity-purified NBD after elution with 250 mM imidazole (IMAC) 
and gelfiltration using superdex 200 (g.f.).  
B: MALDI-TOF of purified wild type NBD. 
 
To gain insight into the ATP hydrolysis cycle, several mutants of Mdl1p-NBD were 
created according to mutations in different ABC transporters which affect ATPase activity. The 
mutations (E552Q; E1197Q) in the NBDs of P-glycoprotein were reported to be highly impaired 
in ATPase activity (Urbatsch et al., 2000a). An equivalent mutation of the conserved glutamate 
(E599Q) of Mdl1p-NBD was introduced by site-directed PCR mutagenesis. This glutamate 
functions as a catalytic base downstream of the Walker B motif. Another mutation concerns the 
conserved aspartate (D598) of the Walker B motif. The exchange of aspartate to alanine in 
Mdl1p was reported to abolish peptide export of the ABC transporter (Young et al., 2001). The 
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conserved histidine (H631R) in the switch region was changed to arginine according to the 
mutation of HisP (H211R). This mutant was reported neither to hydrolyse ATP nor to energize 
the transport of substrate by the whole HisQMP2 complex (Nikaido et al., 1997). All mutant NBD 
genes were cloned into the pET28b vector producing recombinant NBDs with an N-terminal 
His6-tag.  
All constructs were overexpressed in E. coli BL21(DE3) and purified by immobilized 
metal affinity chromatography (IMAC) followed by gelfiltration. The wild type protein as well as 
the E599Q mutant were purified to homogeneity as shown by SDS-PAGE and MALDI-TOF-MS 
(Fig.8). The purified proteins of the two other mutants contained minor contaminations. The yield 
of the purification was approximately 50 mg protein per 1 L culture and the proteins could be 
concentrated up to 30 mg/ml. 
 
5.1.2  Activity of wild type Mdl1p-NBD  
The activity of the isolated wild type NBD was investigated with respect to ATP and ADP 
binding using 8-azido-[α
32P]-ATP photocrosslinking. 8-Azido-[α
32P]-ATP was crosslinked to the 
NBDs and could be specifically competed by increasing the concentration of unlabelled 
nucleoside tri/diphosphates. The IC50 of the wild type NBD was 2 µM for MgATP and 64 µM for 
MgADP (Fig. 9). The absence of Mg
2+ strongly reduced the affinity for nucleotides of NBDs (data 
not shown). The affinity of MgCTP, MgGTP, and MgUTP was approximately 30 fold lower as 
compared to MgATP (Fig.10).  
The wild type NBD showed at a concentration of 30 µM an ATPase activity with a 
turnover number of 0.5 ATP per minute at 30°C and a Km value of 0.2 mM ATP (Fig.11). The 
isolated NBD did not show cooperativity in ATPase activity as determined by a Hill-coefficient of 
1.2. ATPase activity was observed to be non-linearly dependent on protein concentration, 
suggesting that the active form is not monomer (data not shown). ATPase activity of the NBD 
was inhibited to 50% by 2.4 mM BeFx (data not shown).  
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Fig.9: 8-Azido-[α
32P]-ATP photocrosslinking of purified wild type NBD. 
A: The NBD (300 nM) was incubated with different concentrations of unlabelled adenosine di/triphosphates (0 to 
10 mM) on ice for 5 min, crosslinked with 0.5 µM 8-azido-[α
32P]-ATP and separated by 15% SDS-PAGE.  
B: The signals of the autoradiography were quantified by a phosphoimager obtaining an IC50 for MgATP of 2 µM and 
for MgADP of 64 µM. 
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Fig.10: 8-Azido-[α
32P]-ATP photocrosslinking of purified wild type NBD in the presence of NTPs. 
A: NBD (300 nM) was incubated with various concentrations (0 to 1 mM) of different nucleotides on ice for 5 min, 
crosslinked with 0.5 µM 8-azido-[α
32P]-ATP and separated by 15% SDS-PAGE.  
B: The signals of the autoradiography were quantified (Phosphoimager). All nucleotides were bound by the NBDs 
obtaining on IC50 of about 35 µM. AMP could not compete binding of 8-azido-ATP. Results    
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Fig.11: ATPase activity of wild type and E599Q NBDs. 
A: ATPase activity of the NBDs (30 µM) was assayed at 30°C in presence of various concentrations of ATP (0 to 
2.5 mM). The wt NBD showed an activity with a turnover of 0.5 ATP per min and a Km value of 0.2 mM. The E599Q 
mutant exhibited no measurable activity at ATP levels higher than 2.5 mM. 
B: The wt NBD showed no cooperativity in ATPase activity with a Hill-coefficient of 1.2 (Hill-plot). 
 
5.1.3  The active form of NBD is a dimer 
It is postulated that the interaction of both NBDs plays a central role in the catalytic cycle 
of ABC transporters (Nikaido, 2002). So far, gelfiltration experiments with isolated NBDs (e.g. 
HisP and P-gp) did not demonstrate ATP-dependent dimerization, independent of the presence 
of nucleotides or non-hydrolysable analogues like AMP-PNP (Nikaido et al., 1997; Kerr, 2002). 
The wild type Mdl1p-NBD appeared as a monomer in gelfiltration studies independent of the 
presence of different nucleotides. In order to trap nucleotide binding proteins in a conformation 
during ATP hydrolysis, ATPase inhibitors like ortho-vanadate (Vi) or beryllium fluoride (BeFx) can 
be used. ATPase inhibitors are valuable tools for investigations of the catalytic mechanism of 
ATPase enzymes. Ortho-vanadate and BeFx act as analogues of inorganic phosphate. The 
inhibitory complex mimics the transition state during ATP hydrolysis in which ADP is still bound 
and phosphate is already released (Goodno, 1982; Urbatsch et al., 1995b; Shibuya et al., 2002).  
The Mdl1p-NBD was investigated by trapping with ortho-vanadate or BeFx under two 
different conditions. Non-hydrolysis condition means in the absence of Mg
2+ and at 4°C and 
hydrolysis condition means in the presence of MgATP and at 30°C. Interestingly, after 
preincubation of the NBD with the ATPase inhibitor ortho-vanadate under hydrolysis conditions, 
a stable dimer corresponding to a molecular weight of 66 kDa was observed (Fig.12). The dimer 
was stable during gelfiltration, which took 40 min, even in the absence of ATP and inhibitor in the 
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mobile phase. The appearance of the ATP induced-dimer, which was stabilized by BeFx, was 
dependent on the concentration of the inhibitor (Fig.13). Importantly, preincubation of NBD in the 
presence of ATPase inhibitors with either MgADP or MgAMP-PNP at 30°C or MgATP at 4°C did 
not induce dimerization of the NBD. Omitting Mg
2+ from the reaction strongly reduced the 
formation of dimers. These experiments demonstrated that ATP binding and subsequent ATP 
hydrolysis are essential for the formation of dimers.  
In order to test the stability of the formed dimer, the dimer fraction was immediately 
reinjected to a subsequent gelfiltration. It was observed that a peak at the position of the 
monomer appeared while the signal of the dimer peak decreased, demonstrating that trapping of 
the dimer state by BeFx is not irreversible (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.12: ATP-induced dimerization of the NBD stabilized by ortho-vanadate. 
Wild type NBD (30 µM) elutes as monomer from the gelfiltration column independent of the presence of nucleotides 
(blue line). After preincubation of the NBD with 5 mM ortho-vanadate in the presence of 1 mM MgATP for 5 min at 
30°C, a stable dimer was observed by gelfiltration Superdex 75 (red line). The column was calibrated with 
carboanhydrase (33 kDa) and BSA (66 kDa) with an elution volume of 1.2 ml. The void volumen (Vo) was determined 
by dextrane blue. 
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Fig.13: ATP-induced dimerization of the NBD depends on the concentration of BeFx.  
After preincubation of wt NBD (30 µM) with various concentrations of BeFx (0 to 1 mM) in the presence of 1 mM 
MgATP for 5 min at 30°C, a BeFx-dependent dimer was observed by gelfiltration (Superdex 75).  
 
5.1.4  Analysis of mutant NBDs  
The ability of the mutants D598A, E599Q and H631R of Mdl1p to bind ATP was analysed 
by 8-azido-biotin-ATP photocrosslinking experiments. As shown in Fig. 14 mutant NBDs bound 
ATP to the same extent as the wild type. As expected, all mutants were inactive in ATP 
hydrolysis as shown in standard ATPase assays measuring Pi release (Fig.11). It was reported 
that removal of the charge in catalytic base downstream of the Walker B motif (E552Q/E1197Q) 
of P-gp produced an ABC transporter with severely impaired transport activity and no substrate 
stimulated ATPase activity (Urbatsch et al., 2000a). It was also reported that an equivalent 
mutation of the archaeal NBDs from MJ0796 and MJ1296 (E171Q/E179Q) resulted in an 
ATPase deficient NBD. Interestingly, ATP binding was sufficient to induce a stable dimer of 
these mutant archaeal NBDs (Moody et al., 2002). 
    Results 
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Fig.14: 8-Azido-biotin-ATP photocrosslinking of purified NBD mutants. 
The NBDs (300 nM) were incubated with 30 µM 8-N3-biotin-ATP in the absence or presence of 10 mM MgATP or 
MgAMP-PNP, separated by 15% SDS-PAGE and immunostained with α-biotin.  
For control, incubation with the antibody was performed without proceeding crosslinking by UV (-UV). 
 
To assay the ability of the NBD mutants to form nucleotide-dependent dimers, 
experiments were performed in which the mutants were incubated with MgATP or MgADP 
(Fig.14). Gelfiltration experiments showed that only the E599Q mutant formed an ATP-induced 
dimer after preincubation with MgATP on ice. Dimerization of the E599Q mutant was dependent 
on the ATP concentration (Fig.15). The E599Q dimer was stable during gelfiltration even in the 
absence of nucleotides in the mobile phase. This indicates that the dimer dissociated very slowly. 
The concentration of 500 µM ATP was sufficient to shift the monomer NBD completely to the 
dimer. In contrast to ATP, ADP did not induce dimerization. Moreover, the addition of ADP 
inhibited ATP-dependent dimer formation. These results are in line with the data obtained for the 
mutant E171Q NBD from MJ0796 and E179Q NBD from MJ1296 (Moody et al., 2002). In 
contrast to data obtained from the archaeal NBDs the presence of Mg
2+ did not impair dimer 
formation of the Mdl1p-NBD. Different Mg
2+ concentrations did not influence the dimerization of 
the E599Q Mdl1p-NBD. Interestingly, MgAMP-PNP or ATPγS did neither induce dimerization 
with the wild type Mdl1p-NBD nor with the E599Q NBD. Similar results were obtained from the 
archaeal mutants. Binding of AMP-PNP to the mutant and wild type Mdl1p-NBD was, however, 
not impaired as demonstrated by 8-azido-ATP-biotin-photocrosslinking experiments (Fig.14).  
The H631R mutant showed in the absence of nucleotides predominantly a dimer, which 
was independent of ATP (data not shown). Because of the tendency of the D598A mutant to 
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precipitate, 50% of the protein was detected in the void volume. The remaining non-aggregated 
protein showed an ATP-independent dimer. It was reported that purification of HisP with a 
corresponding mutation in the Walker B motif was not successful as well due to precipitation of 
the protein during purification (Nikaido and Ames, 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.15: Dimerization of E599Q mutant NBD is dependent on ATP concentration. 
After preincubation of the E599Q mutant (30 µM) with increasing concentrations of ATP (0 to 500 µM) for 10 min on 
ice, an ATP-dependent dimerization was observed by gelfiltration (Superdex 75).  
 
5.1.5  Nucleotide composition of the dimer 
To analyse the ATP/ADP composition of the nucleotide-induced dimer, wild type NBD 
was incubated with tracer concentration of [α
32P]-ATP under hydrolysis conditions in the 
presence of BeFx and applied to gelfiltration. Radioactive nucleotides exclusively co-eluted with 
the NBD dimer, whereas no radioactivity was observed in fractions corresponding to the 
monomer (Fig.16,A). The concentration of [α
32P]-ATP bound per NBD dimer was determined 
and a stoichiometry of two nucleotides per dimer was obtained (Fig.16,C). The same experiment 
was repeated in the presence of [γ
32P]-ATP. Strinkingly, only a minor amount of radioactivity was 
co-eluted with the dimer compared to the radioactivity obtained from [α
32P]-ATP trapping 
experiment. This result clearly demonstrates that both ATP molecules have been hydrolysed by 
the dimer and inorganic phosphate has been released from the complex. TLC analysis of 
nucleotides extracted from the dimer confirmed these data (Fig.16,D).    Results 
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After incubation of the E599Q mutant either with [α
32P]-ATP or [γ
32P]-ATP, radioactivity 
was exclusively associated with the dimer. Again, no radioactivity was observed in fractions 
corresponding to the monomer. The mutant dimer always contained two nucleotide molecules. 
When the experiment was performed under non-hydrolysis condition (absence of Mg
2+ and on 
ice) the amount of [α
32P]-ATP and [γ
32P]-ATP bound per dimer was equal, and a stoichiometry of 
two ATP molecules bound per dimer was obtained (Fig.16,B). This suggested that either ATP 
was not hydrolysed or that ATP was hydrolysed to ADP but the [γ
32P]i was still associated with 
the complex. To distinguish between the two possibilities, TLC analysis was performed. TLC 
analysis demonstrated that ATP hydrolysis did not occur under this condition and obviously two 
ATP molecules were incorporated in the dimer (Fig.16,D).  
Incubation of the E599Q mutant under conditions which promote hydrolysis showed slow 
formation of ADP (Fig.16,D). After preincubation with MgATP for several hours at 30°C the 
analysis of E599Q dimer by gelfiltration and TLC showed that one ATP was hydrolysed, and a 
stable ATP/ADP ratio of 1 was achieved (data not shown, personal communication M. Hofacker). 
Prolongation of the incubation time did not result in two ADP molecules bound in the dimer. This 
suggests that the mutant dimer is not stable after hydrolysis of the second nucleotide. Prolonged 
incubation time resulted in an increased formation of monomer which did not contain any 
nucleotide. 
   After formation of the ATP-containing dimer no nucleotides could be incorporated into the 
dimer from the medium (Fig.16,E). 
As already mentioned, incubation of the E599Q mutant with non-hydrolysable ATP 
analogues did not induce a dimer formation. But incubation of the mutant at 30°C with equimolar 
ratio of unlabelled MgATP and MgATPγ
35S resulted in incorporation of radioactivity into the 
dimer. It was determined that one ATPγ
35S molecule was incorporated into a dimer. Suprisingly, 
incubation of the wild type NBD with equimolar ratio of unlabelled MgATP and MgATPγ
35S under 
hydrolysis conditions in the presence of BeFx did not result in incorporation of radioactivity, 
suggesting that for stabilization of the wild type dimer by the ATPase inhibitor both nucleotides 
have to be hydrolysed. 
 Results    
64 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
10 
15 
20 
25 
30 
0.8  0.9  1.0  1.1  1.2 1.3 1.4
[α
32P]-ATP
[γ
32P]-ATP
volume [ml] 
N
B
D
m
o
n
o
m
e
r
 
[
µ
M
]
 
A
T
P
 
[
µ
M
]
 
0.8 0.9 1.0 1.1  1.2  1.3 1.4
5
10 
15
20
25
30
35
volume [ml] 
WT E599Q 
[α
32P]-ATP
[γ
32P]-ATP
B
0.0 
0.5 
1.0 
1.5 
2.0 
2.5 
WT  
γ-ATP  
WT  
α-ATP 
E599Q  
γ-ATP 
E599Q 
α-ATP
n
u
c
l
e
o
t
i
d
e
/
d
i
m
e
r
 
C 
2.48 +/- 0.3 1.76 +/- 0.06  α-ATP
1.69 +/- 0.5 0.074  γ-ATP
E599Q  wt  [mol/mol] 
A    Results 
   65 
0
20
40
60
80
100
120
0.9  1.0 1.1
α-ATP
pre-loading by 
unlabelled ATP  
[
c
p
m
*
1
0
4
]
 
 
α-ATP γ-ATP
Mg
2+  +  -  -  + 
HK
ATP 
ADP 
WT  E599Q 
α-ATP γ-ATP 
Pi 
+   +  
S 
volume [ml]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.16: Determination of the nucleotide composition of trapped NBD dimers.  
A: Wt NBD (30 µM) was incubated with MgATP (625 µM) supplemented with either [α
32P]-ATP or [γ
32P]-ATP (0.125 
µM) under hydrolysis conditions in the presence of 500 µM BeFx and analysed by gelfiltration. The fractions were 
analysed by β-counting.  
B: Mutant E599Q NBD (30 µM) was incubated with ATP (625 µM) supplemented with [α
32P]-ATP or [γ
32P]-ATP (0.125 
µM) under non-hydrolysis conditions and was analysed by gelfiltration and β-counting. 
C: Evaluation of the gelfiltration data of panel. A and B. The stoichiometry of bound radioactive nucleotide (mol) per 
dimer (mol) of BeFx trapped wt dimer and of ATP-induced E599Q dimer under non-hydrolysis conditions was 
summarized. In the wt NBD 2 ADP molecules were obtained in the dimer. In the E599Q mutant 2 ATP molecules were 
preserved in the dimer under non-hydrolysis condition. 
D: Wt NBD was incubated with [α
32P]-ATP or [γ
32P]-ATP under trapping conditions in the presence of 500 µM BeFx 
and analysed by gelfitlration. After precipitation of protein nucleotides were analysed by TLC. Exclusively ADP was 
found in the wt dimer. Mutant E599Q NBD was incubated with radiolabelled [α
32P]-ATP or [γ
32P]-ATP under non-
D 
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hydrolysis and hydrolysis conditions and was analysed as described above. In the absence of Mg
2+ exclusively ATP 
molecules were incorporated into the mutant dimer. After preincubation of the mutant at 30°C for 15 min in the 
presence of Mg
2+, ADP together with ATP was observed in the dimer.   
S: standard, non treated ATP; HK: ATP preincubated with hexokinase  
E: The stability of the E599Q dimer was investigated by preloading the dimer with unlabelled ATP (625 µM) for 10 min 
on ice and subsequent incubation with [α
32P]-ATP (0.125 µM) for additional 10 min. The analysis by gelfiltration and 
β-counting showed that no incorporation of radioactivity into the dimer was observed. 
 
5.1.6  ATP hydrolysis cycle of Mdl1p-NBD 
Based on the results obtained from the characterisation of different NBD dimers the 
following reaction cycle of ATPase hydrolysis for the Mdl1p-NBD can be proposed (Fig.17). ATP 
binding to both NBDs induces formation of the dimer. After hydrolysis of both ATP molecules to 
ADP, the dimeric complex dissociates and ADP is released. Our data from both the BeFx 
trapped wild type NBD and the E599Q mutant suggest that during ATP hydrolysis at least three 
different states can be trapped. In one state, both nucleotides are bound as triphosphates as 
shown for the mutant dimer under non-hydrolysis condition. In the subsequent state, one ATP 
together with one ADP molecule is trapped in the mutant dimer at the same time after prolonged 
incubation at hydrolysis conditions. After slow hydrolysis of the second ATP the mutant dimer 
dissociates. For the wild type dimer a BeFx trapped dimer state is obtained in which two ADP 
molecules are incorporated at the same time.  
As an asymmetrically loaded state of ATP/ADP dimer for the E599Q mutant was obtained, 
this experiment strongly indicates that hydrolysis of the ATP molecules is sequential and that 
hydrolysis of the second ATP results in dissociation of the dimer.    Results 
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Fig.17: ATPase cycle proposed for Mdl1p-NBD (for details see text).  
ATP-induced 
dimer 
formation  + 2 ATP 
ATP
dissociation 
of dimer 
ADP 
ATP
Pi
ADP 
ATP 
E599Q 
ADP
ADP
 Pi
+ BeFx
ATP
ATP 
ADP 
ADP
 Pi
 Pi  1 Pi
1 Pi 
-Mg
+Mg
ADP
ADP ADP 
ADP 
ADP 
ADP Results    
68 
wt wt ∆mdl1 ∆mdl1
50 µg 
62 
33 
48
25 
85 
117 
Mdl1p
1.5 µg 
5.1.7  Expression and purification of full-length Mdl1p 
As we obtained very detailed information about the interaction of isolated NBDs during 
the ATPase cycle, we set out to characterise the inter-domain communication of the full-length 
ABC transporter Mdl1p. So far, Mdl1p has been identified as a peptide export pump of the inner 
mitochondrial membrane of S. cerevisiae, but no detailed information is provided for the 
transport mechanism and substrate spectrum of this peptide transporter. To address these 
questions, the approach was undertaken to overexpress this membrane protein in S. cerevisiae 
or E. coli. Purification of Mdl1p would enable us to investigate the transport function in vitro after 
reconstitution of Mdl1p into lipid vesicles. 
For purification Mdl1p was isolated from W303-1A mitochondria. The strain was grown 
on lactate medium at 30°C to mid-logarithmic phase (OD600 about 1). As a control, mitochondria 
were also isolated from the ∆mdl1 strain. Fig.18 shows a Western blot analysis of wild type 
mitochondria. A specific band of 62 kDa, which is not expressed in the ∆mdl1 strain, was 
detected by the polyclonal α-Mdl1, which is directed against the C-terminal 15 amino acids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.18: Mitochondria isolated from W303-1A strain and ∆mdl1 strain. 
50 µg or 1.5 µg protein of mitochondria was loaded onto a 12% SDS-PAGE and immunostained with α-Mdl1. 
 
As ABC transporters bind nucleotides, it is very convenient to purify Mdl1p by this kind of 
affinity chromatography. Mitochondria from wild type cells were solubilized with 1.4% 
decylmaltoside (30 mM) and applied to an ATP-agarose resin (Fig.19). The solubilization 
efficiency of Mdl1p by DM was only 50%. As a result, Mdl1p could not be purified by this 
approach since solubilized Mdl1p was unable to bind to different types of ATP-agarose such as 
C8-, N6- and ribose-coupled ATP.    Results 
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Alternatively, reactive Red-agarose was used for affinity purification. Most of the 
detergent solubilized Mdl1p could be bound to the resin, but not specifically eluted either by 5 
mM ATP or by NaCl gradient of 300 to 900 mM. It was shown that Mdl1p was absorbed 
unspecifically to the resin (Fig.20). It is possible that the decrease of the detergent concentration 
to 0.114% DM (2.4 mM), which is close by the CMC (1.6 mM), in the washing buffer caused 
precipitation of Mdl1p at the resin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.19: Purification of Mdl1p by ATP-agarose. 
Mitochondria were solubilized by 30 mM DM for 30 min on ice, after ultracentrifugation applied to ATP-agarose, 
washed with detergent buffer (2.4 mM DM) and eluted with 5 mM MgATP. Beads were incubated with loading buffer 
for 10 min at 65°C. The fractions were analysed by SDS-PAGE and immunoblotting using α-Mdl1. 
P: pellet after solubilization, S: solubilized mitochondria, FT: flow through, Wn: wash steps, En: elution with 5 mM 
MgATP, B: ATP-agarose beads 
 
 
 
 
 
      
     
  
 
 
 
 
 
 
 
Fig.20: Purification of Mdl1p by reactive Red-agarose. 
The samples were treated as described by Fig.19. 
S: solubilized mitochondria, FT: flow through, Wn: wash steps, En: elution with 5 mM MgATP and NaCl gradient (300-
900 mM), B: Red-agarose beads Results    
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5.1.8  Reconstitution of Mdl1p 
Based on the reconstitution protocol established for the TAP complex (Gorbulev et al., 
2001), Mdl1p solubilized from mitochondria was partially enriched by gelfiltration column 
Superose 6 PC 3.2/30 (Fig.21,A). The obtained fractions were analysed by immunoblotting 
(Fig.21,B). Solubilized Mdl1p did not aggregate since no Md1p was found in the void volumen of 
the column. Fractions containing Mdl1p were incubated with liposomes (23% cholesterol, 10 % 
phosphatidic acid, 67% phosphatidylcholine) and reconstitution was performed by rapid removal 
of detergent by biobeads. By this approach, the proteoliposomes did not incorporate Mdl1p and 
did not show radioactive peptide uptake.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.21: Reconstitution of Mdl1p enriched by gelfiltration. 
A: 100 µg mitochondria (10 µg/µl) were solubilized with 30 mM DM for 30 min on ice, centrifuged 20.000 x g for 
15 min and applied to a gelfiltration column (Superose 6 PC 3.2/30) containing 2.4 mM DM in the mobile phase. 
Fractionation was started at 460 µl with a fractionation size of 60 µl. 
B: Elution fractions were analysed by SDS-PAGE and immunostaining with α-Mdl1. Fractions containing Mdl1p (9-16) 
were incubated with preformed liposomes (23% cholesterol, 10% phosphatidic acid, 67% phosphatidylcholine) and 
reconstituted by rapid removal of detergent with biobeads.  
M: mitochondria P: pellet after solubilization S: solubilized mitochondria (load on the column) PL: proteoliposomes    Results 
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In order to apply higher concentrations of Mdl1p during the reconstitution procedure, DM -
solubilized mitochondria were directly incubated with rhodamine-labelled (0.4%) liposomes of 
the composition described above and reconstituted by rapid removal of detergent using 
biobeads. The proteoliposomes were floated in a sucrose gradient from 20 to 50% (w/v). 
According to their density, sealed proteoliposomes migrated in the sucrose gradient from the 
bottom to 20-25% sucrose monitored by the absorbance of rhodamine-labelled lipids (Fig.22). 
Liposomes without incorporated proteins floated to the top of the sucrose gradient. A strong 
absorbance derived from rhodamine-labelled lipids was observed at the top of the gradient. As 
shown by Western blot analysis the proteoliposomes enriched at 25-30% sucrose contained 
incorporated Mdl1p.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.22: Reconstitution of Mdl1p from solubilized mitochondria. 
DM-solubilzed mitochondria were incubated with rhodamine-labelled liposomes and reconstituted by rapid removal of 
detergent with biobeads. Proteoliposomes were floated in a sucrose gradient (134.000 x g, 12 h) from 20 to 50% and 
fractions were checked by absorbance 584 nm (for rhodomine), refractory index, SDS-PAGE and immunostaining with 
Mdl1p antisera. 
 
The proteoliposomes were tested for radioactive peptide uptake using the peptides 
R9LQK or R10T. However, no transport activity could be detected. One explanation could be 
that other proteins like porins, which could release imported peptides, were incorporated in the 
liposomes as well (Mannella, 1992).  Results    
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Furthermore, it is also conceivable that the lipid composition of 23% cholesterol, 10% 
phosphatidic acid, and 67% phosphatidylcholine was not suitable for the activity of a yeast 
mitochondrial protein like Mdl1p. Cholesterol has been reported to be inhibitory on the transport 
of reconstituted ATP/ADP carrier from mitochondria (Heimpel et al., 2001). In further 
experiments cardiolipin (CL), a characteristic phospholipid of the inner mitochondrial membrane 
in eukaryotic cells, was used. The lipid composition was changed to 75% phosphatidylcholine, 
20% phosphatidylethanolamine and 5% cardiolipin. 
 
To obtain proteoliposomes without porins, mitoplasts were generated from mitochondria 
by osmotic swelling (Fig.23). Mitoplasts are mitochondria from which the outer membrane has 
been removed. The generated mitoplasts were applied to a sucrose gradient of 30 to 50% (w/v). 
Fractions with highly enriched Mdl1p corresponding to the inner membrane were harvested from 
the 36.5% to 37.5% sucrose interphase. A high concentration of Mdl1p in these fractions could 
be observed by the Western blot analysis. The enriched inner membranes were used for 
reconstitution into liposomes which were destabilized by preincubation with 1.6% (55 mM) 
octylglucoside for 3 h before use. Detergent-mediated destabilization of liposomes was reported 
to enhance incorporation of membrane proteins. After reconstitution and removal of detergents 
by biobeads the proteoliposomes were floated in a sucrose gradient from 10% to 40%. After 
sucrose gradient centrifugation a high amount of Mdl1p was detected in the proteoliposomes by 
SDS-PAGE and immunostaining. However, the proteoliposomes were not active in transport 
activity using the peptides R9LQK and R10T. Western blot analysis showed the presence of 
porins, demonstrating that inner membrane preparation was still contaminated by proteins of the 
outer mitochondrial membrane. The existence of contact sites between outer and inner 
membrane makes it very difficult to separate both membranes. The presence of porins, through 
which solutes of the size of 6 kDa can diffuse, might be the reason for release of imported 
peptides back to the medium. It is also conceivable that the peptides used are not a suitable 
substrate for Mdl1p.    Results 
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Fig.23: Mitoplasts preparation and reconstitution of Mdl1p from mitoplasts. 
A: Mitoplasts were generated from mitochondria (1 mg) by osmoting swelling diluting the mitochondria in 5-fold 
volume for 30 min on ice. The suspension was applied to a sucrose gradient of 30 to 50% (134.000 x g, 12 h). 500 µl 
fractions were checked by refractory index, and subsequently TCA-precipitated, analysed by SDS-PAGE and 
immunoblotting with α-Mdl1. 
B: Inner membranes were prepared as described above and isolated from the sucrose fractions corresponding to 35 
to 42%. Fractions were checked by refractory index, SDS-PAGE and immunostaining with Mdl1p and porin antisera. 
MP: mitoplasts 
C: Inner membranes were 10-times diluted to decrease the sucrose concentration and centrifuged (227.000 x g, 
45  min). The pellet was solubilzed (30 mM DM) for 30 min on ice, centrifuged (15 min, 22.000 x g) and the 
supernatant was incubated with preformed and octylglycoside-destabilized (55 mM) liposomes (75% phosphatidyl-
choline, 20% phosphatidylethanolamine, 5% cardiolipin) and reconstituted by rapid removal of detergent with 
biobeads. Proteoliposomes were floated in a sucrose gradient from 40 to 10% (134.000 x g, 12 h). Fractions were 
checked by refractory index, SDS-PAGE and immunostaining with Mdl1 and porin antisera. 
PL: proteoliposomes 
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5.1.9  Specific ATP binding of Mdl1p 
In order to exclude that solubilization and subsequent reconstitution inactivate Mdl1p, 
ATP binding of wild type Mdl1p was investigated by 8-azido-[α
32P]-ATP photocrosslinking and 
subsequent immunoprecipitation (Fig.24). 8-Azido-[α
32P]-ATP was crosslinked to both DM-
solubilized and reconstituted Mdl1p. The binding was competed by an excess of unlabelled 
nucleotides. To obtain signals of ATP binding based on Mdl1p, specificity was achieved by 
immunoprecipitation of ATP-crosslinked protein with α-Mdl1. Solubilized mitochondria derived 
from ∆mdl1 strain did not show an ATP-crosslinking signal.  
In order to investigate the orientation of reconstituted Mdl1p, proteoliposomes were 
crosslinked either directly or after solubilization by Triton X-100. Both signals showed the same 
intensity, suggesting that Mdl1p is predominantly reconstituted with its NBDs facing the outside 
of the liposomes. But it cannot be excluded that ATP molecules could diffuse through porins into 
the liposomes causing crosslinking. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.24: Photocrosslinking of Mdl1p. 
DM-solubilized or reconstituted Mdl1p was incubated with 8-azido-[α
32P]-ATP (2 µM) in the presence or absence of 
1.5 mM MgATP for 5 min on ice and photocrosslinked with UV (254 nm) for 5 min. Proteoliposomes solubilized by 
Triton X-100 (1%) were used as control. The samples were 5-times diluted in solubilization buffer and 
immunoprecipitated with α-Mdl1 (1:100) and protein A sepharose. After SDS-PAGE the gel was dried and analysed 
by autoradiography (2 weeks exposure at -80°C). 
 
In summary, Mdl1p from wild type mitochondria was successfully reconstituted into 
proteoliposomes. The lipid composition of liposomes was adapted to a reconstitution of a 
mitochondrial membrane protein. The reconstitution procedure did not impair the ATP binding 
activity of Mdl1p. However, positive peptide transport activity could not be obtained. One 
possible explanation could be a contamination of the proteoliposomes by porins of the outer 
membrane. Therefore, the next approach was to introduce an affinity tag to Mdl1p in order to 
facilitate purification and subsequent reconstitution.     Results 
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5.1.10 Expression, purification and activity of recombinant Mdl1p 
In order to express higher amounts of Mdl1p in yeast, the MDL1 gene was cloned into 
the high copy plasmid p426 under the control of the strong and constitutive GPD promotor. The 
MDL1 gene deleted in its N-terminal mitochondrial targeting sequence was cloned into the same 
expression vector. To facilitate purification, plasmid-encoded Mdl1p was fused with a StrepII-tag 
at its C-terminus. The ∆mdl1 strain was transformed with the recombinant plasmid and positive 
transformants were selected on drop out media for uracil and checked by colony-PCR (Fig.25). 
Yeast cells were grown at 30°C in minimal media and mitochondria were isolated. Western blot 
analysis showed considerable degradation of overexpressed Mdl1p and no protein band of the 
proper size was detected (Fig.25,A). In order to avoid degradation, the growth temperature was 
decreased to 25°C. As shown in Fig.25,B a 10-50 fold overexpression of Mdl1p was achieved 
from plasmid-encoded gene compared to the chromosomal gene.  
 
 
 
 
 
 
 
 
 
 
Fig.25: Transformation and homologous expression of Mdl1p. 
A: Colony-PCR was performed with ∆mdl1 strain transformed with p426-mdl1-StrepII. Fresh colonies selected on 
drop out agar plates (without uracil) were lysed by lyticase and used as template for MDL1 specific PCR with the 
primers formdl1fl and revmld1 (see 4.1.5 for PCR conditions). 
B: Yeast cells were grown in minimal media at 30°C and at 25°C, respectively. 10 µg mitochondria of wt cells (+), 
p426-mdl1-StrepII (1) and p426-∆mt-mdl1-StrepII (2) were analysed by 12% SDS-PAGE and immunostained with α-
Mdl1. 
 
After overexpression of the recombinant Mdl1p in yeast, mitochondria were detergent 
solubilized by 30 mM DM (1.4%). Again, the solubilization efficiency was only 50%. The 
supernatant was applied to Streptactin-beads and washed with detergent buffer (1.6 mM DM). A 
part of detergent solubilized Mdl1p was obtained in the flow through and first wash step. Mdl1p 
which bound to Streptactin-beads could not be specifically eluted by 2.5  mM desthiobiotin, 
suggesting that Mdl1p was adsorbed unspecifically to the resin (Fig.26). One explanation for this 
observation could be that the decrease of the detergent concentration to 1.6 mM DM in the 
washing buffer caused precipitation of Mdl1p. To ensure the integrity of the tag, the blot was Results    
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incubated with a polyclonal α-Strep-tag. The Western blot analysis showed that a polyclonal 
antibody is not suitable to detect Strep-tagged proteins from yeast extracts because of its high 
cross-reactivity.  
Next, the functionality of Strep-tagged Mdl1p was investigated with respect to ATP 
binding using 8-azido-[α
32P]-ATP photocrosslinking experiments as shown before. 8-Azido-
[α
32P]-ATP was crosslinked to solubilized Mdl1p and could be specifically competed by an 
excess of unlabelled nucleotide. The ATP-crosslinking of the overexpressed Mdl1p was much 
more efficient than of the wild-type due to the higher expression levels (data not shown). 
In conclusion, the homologous overexpression of Mdl1p was achieved, the protein was 
active with respect to ATP binding, but purification based on the introduced Strep-tag at the C-
terminus could not be established. 
 
  
 
 
 
 
 
 
 
 
Fig.26: Purification of Mdl1p encoded by p426-mdl1-StrepII. 
Yeast cells transformed by p426-mdl1-StrepII were grown at 25°C. Isolated mitochondria were detergent solubilized 
(30 mM DM) and after ultracentrifugation applied to Streptactin-beads. After washing with detergent buffer (1.6 mM 
DM), protein was eluted with 2.5 mM desthiobiotin. Beads were incubated with loading buffer for 10 min at 65°C. The 
fractions were analysed by 12% SDS-PAGE and immunostaining by α-Mdl1. 
P: pellet after solubilization, S: solubilized mitochondria, FT: flow through, Wn: wash steps, En: elution steps, B: beads 
5.1.11 Deletion of mitochondrial targeting sequence (MTS) 
Mdl1p has been identified as an export pump translocating peptides from the matrix to 
the intermembrane space of mitochondria (Young et al., 2001). It is very difficult to investigate 
efflux pumps like Mdl1p because substrates have to be transferred into the mitochondria before 
starting the experiment. The strategy followed here was to convert the exporter into an importer 
by changing the subcellular localisation of Mdl1p to another compartment like ER or plasma 
membrane. 
Most mitochondrial proteins like Mdl1p are encoded in the nucleus and posttranslationally 
imported into the mitochondria. Mitochondrial targeting is often mediated by an N-terminal leader    Results 
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sequence (Neupert, 1997). The import signal peptide usually consists of 20 to 35 residues at the 
N-terminus and is highly degenerated in primary sequence, but rich in basic, hydrophobic and 
hydroxylated residues and generally lacks acidic ones (Fig.27) (Schatz and Dobberstein, 1996). 
It was suggested that due to the distribution of charged and apolar residues the leader peptide 
can fold into a defined secondary structure which is essential for import. The N-terminal part of 
the targeting sequence forms a positively charged amphiphilic α-helix or β-sheet, whereas the C-
terminal part probably serves as a recognition site for matrix proteases (von Heijne, 1986). In 
particular, arginine is enriched in positions -2, -3, -10, -11. Especially, the arginine at -2 seems to 
be part of a recognition signal for the major matrix protease (MPP) (Gavel and von Heijne, 1990). 
One of the proposed motifs seems to be conserved in Mdl1p (R-2 group: RXXS), in which the 
cleavage occurs between the two undefined residues. Therefore, a 59 amino acids truncated 
version of Mdl1p was created disrupting the RXXS site. For correct translation initiation an 
additional methionine was introduced at the new defined start position +60. 
 
 
Fig.27: The N-terminal sequence of Mdl1p contains a classical mitochondrial targeting sequence (MTS). 
The classical MTS is rich in Arg (red) as positive charged amino acid, Ser (blue) as hydroxylated amino acid, Leu, Phe, 
Tyr (green) as hydrophobic amino acids. Underlined sequence represents one of the potential recognition sites (Rx/xS) 
for mitochondrial proteases which cleave the MTS after import of the protein into the matrix. 
x: not defined amino acid, /: cleavage site of protease 
 
To investigate whether the truncation of the N-terminal 59 amino acids indeed influences 
the targeting of Mdl1p, the MDL1 gene and the truncated version were cloned into the plasmid 
p426. The ∆mdl1 strain was transformed with the recombinant plasmids, respectively. 
Mitochondria were prepared from the different yeast strains grown at 25°C. Using the standard 
isolation method of mitochondria by differential centrifugation (Daum et al., 1982), contamination 
of mitochondria with ER cannot be excluded. Therefore, mitochondria devoid of microsomal 
contaminations should be purified by sucrose gradient method (Meisinger et al., 2000). 
Comparison of the mitochondria prepared by the two different methods showed that the 
mitochondria isolated by differential centrifugation are only slightly more contaminated with ER Results    
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compared to mitochondria purified by sucrose gradient. Contamination with ER membranes was 
assayed by detection of the ER resident Sec61 protein using Western blot analysis. Surprisingly, 
the truncated Mdl1p was still targeted exclusively to the mitochondria (Fig.28,A). No difference 
between the distribution of full-length Mdl1p and truncated Mdl1p was observed. Loading crude 
mitochondria onto a sucrose gradient and analysis of the fractions by Western blot showed the 
same protein pattern for full-length as well as truncated Mdl1p (Fig.28,B).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.28: Influence of the deletion of the MTS for Mdl1p targeting. 
A: Transformed yeast cells were grown on minimal medium at 25°C. Mitochondria derived from p426-mdl1 
transformed cells were isolated either by differential (1) or by sucrose gradient (2) centrifugation. Mitochondria derived 
from p426-∆mt-mdl1 were isolated by the two different methods, respectively (3) (4). For control, mitochondria of wt 
cells were prepared by differential centrifugation (5). The fractions were analysed by 12% SDS-PAGE and 
immunostaining with α-Mdl1 or α-Sec61.  
B: Mitochondria derived from yeast transformed by p426-mdl1 (1) or p426-∆mt-mdl1 (2, 3) were separated in a 
sucrose gradient. TCA-precipitated fractions were analysed by 12% SDS-PAGE and immunostaining with α-Mdl1 or 
α-Sec61.  
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The subcellular localisation of Mdl1p was further investigated by partial digitonin-
mediated solubilization of mitochondria followed by proteinase K digestion (Klanner et al., 2001; 
Segui-Real et al., 1993). Mitochondria are organelles which are protected by an outer and inner 
membrane. In the presence of low digitonin concentration, only the outer membrane is 
solubilized. Therefore, matrix-resident proteins and regions of polytopic membrane proteins (e.g. 
the epitope for α-Mdl1) are protected from proteinase K digestion. After total detergent 
solubilization of both membranes the matrix-located proteins are degraded by proteinase K as 
well. 
The proteinase K protection assay showed the same degradation pattern for full-length 
as well as truncated Mdl1p (Fig.29). This is a strong indication that both proteins are localised in 
the same organelle and shared the same topology. The epitope of the α-Sec61 is exposed to 
the cytosol. As a control, the ER resident protein Sec61 was readily degraded in the absence of 
detergent. If Mdl1p deleted in its classical mitochondrial leader sequence would have been 
directed to the ER, the epitope would be exposed to the cytosol and would become degraded by 
proteinase K already in the absence of a detergent. 
In summary, the truncation of the N-terminal 59 amino acids did not impair the targeting 
of Mdl1p to the mitochondria. This suggests that an additional internal targeting sequence is 
present as shown previously for other inner mitochondrial membrane proteins e.g. ATP/ADP 
carrier and oxoglutarate carrier (Luciano et al., 2001; Wiedemann et al., 2001; Endres et al., 
1999; Kurz et al., 1999; Kubrich et al., 1998; Palmisano et al., 1998). The sequence of the 
internal signal peptide has not been defined so far. The simultaneous presence of a classical N-
terminal sequence and an internal targeting sequence in one protein has not been described, so 
far. 
 Results    
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Fig.29: Digitonin-mediated fractionation of mitochondria and proteinase K digestion. 
Mitochondria from yeast transformed with p426-mdl1 (A) or p426-∆mt-mdl1 (B) were incubated in the presence of 
increasing concentrations of digitonin or Triton X-100 (0.17%) as indicated and the accessibility of Mdl1p to 
proteinase K (0.1 µg/µl) was examined. TCA-precipitated fractions were analysed by SDS-PAGE and immunostaining 
with α-Mdl1p and α-Sec61. 
 
5.1.12 Expression and purification of His-tagged Mdl1p 
Mdl1p truncated in its N-terminal 59 amino acids was subcloned from pBAD-mdl1-mt into 
the low copy plasmid pXY113 under the control of the strong inducible GAL promotor. The 
Mdl1p construct contained an N-terminal hexa-histidine tag. ∆mdl1 strain was transformed with 
the plasmid and positive transformants were selected on drop out media for uracil and by 
colony-PCR. The yeast cells were grown at 30°C in minimal medium with glucose (2%) to OD 
0.8, washed and resuspended in minimal medium containing galactose (2%). Cells were 
harvested after 24 h induction.  
Mitochondria were detergent-solubilized (1% Triton X-100) and applied to Ni-NTA-beads 
(Fig.30). The beads were washed with detergent buffer (1% Triton X-100) containing 0, 10, 20, 
40 mM imidazole and protein was eluted with 250 mM imidazole. As shown by Western analysis 
the solubilization by Triton X-100 worked very efficiently. A part of detergent-solubilized Mdl1p 
was detected in the flow through and first wash step (0 mM imidazole) and a truncated version of 
Mdl1p was already eluted by 20 and 40 mM imidazole. Mdl1p could be specifically eluted by 
250 mM imidazole, but two different populations of Mdl1p were purified: a truncated as well as a 
full-length Mdl1p. It is conceivable that the truncated version of Mdl1p is generated by N-terminal 
cleavage by signal peptidases in the mitochondria. The full-length Mdl1p was not processed and 
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could bind via its N-terminal His-tag to the Ni-NTA resin, whereas the truncated version was 
processed at its N-terminus losing its His-tag. Therefore, the truncated form eluted already with 
low concentrations of imidazole. The fact that a part of the truncated version is eluted at 250 mM 
imidazole might be because the formation of dimers between trunctated Mdl1p and His-tagged 
full-length Mdl1p. This construct might present a promising canditate for purification of Mdl1p 
from yeast mitochondria. 
 
 
 
 
 
 
 
 
 
 
Fig.30: Purification of Mdl1p from mitochondria of pXY113-GAL-mdl1-His6 transformed yeast.  
Transformed yeast cells were cultivated with glucose (2%) in minimal medium (-URA) to OD 0.8 at 30°C, washed and 
induced with galactose (2%) for 24 h. Mitochondria were detergent solubilized (1% Triton X-100) for 1 h on ice, 
centrifuged (22.000 x g, 15 min), applied to NTA-beads, washed with detergent buffer containing 0, 10, 20, 40 mM 
imidazole and eluted with 250 mM imidazole. The fractions were analysed by SDS-PAGE and immunostaining with α-
Mdl1. 
S: solubilized mitochondria, FT: flow through, Wn: wash steps, W1-3: 0 mM imidazole, W4: 10 mM imidazole, W5: 
20 mM imidazole, W6: 40 mM imidazole, E: elution step with 250 mM imidazole 
 
5.1.13 Heterologous expression of Mdl1p in E. coli 
Several strategies were applied to facilitate overexpression and integration of a 
membrane protein into the inner membrane of E. coli: i) the use of inducible promotors, ii) 
decrease in growth temperature, iii) use of strains specialized for expression of membrane 
proteins (Shanklin, 2000) and iv) fusion of the gene to periplasmic signal sequences. 
MDL1 which has been deleted in its classical N-terminal targeting sequence was cloned 
into the pBAD-HisB in frame with an N-terminal His6-tag encoded by the vector. To regulate the 
expression of the membrane protein, transcription of MDL1 was tightly controlled by the 
arabinose-inducible promotor, whose activity is highly dependent on the concentration of the 
inducer. To facilitate proper incorporation of membrane protein into the inner membrane the 
expression was performed in the E. coli strain C41. This strain contains increased membrane 
surface through invagination of the inner membrane and is therefore optimized for expression of 
membrane proteins (Shanklin, 2000). Inner membrane vesicles were isolated from these cells, Results    
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after solubilization with 30 mM DM the supernatant was applied to SDS-PAGE and Western 
blotting. A strong induction of the Mdl1p was detected (Fig.31). The polytopic membrane protein 
was correctly targeted to the inner membrane. The affinity purification using the His-tag, 
however, could not be established. The protein could neither be bound to Ni-NTA-beads nor be 
detected by α-His-tag (data not shown). It is likely that the N-terminal His-tag was cleaved off by 
proteases of E. coli. As the N-terminus of Mdl1p might be processed in E. coli, affinity tags were 
introduced at the C-terminus in further constructs.  
   Alternatively, the gene truncated in its N-terminal 59 amino acids was cloned into pASK-
IBA2 under the control of the tet promotor. The construct was fused N-terminally with the OmpA 
periplasmatic leader sequence and C-terminally with a StrepII-tag. The construct was 
overexpressed in E. coli strain C41 induced by anhydrotetracycline (AHT). After preparation and 
solubilization of membrane vesicles by 30 mM DM, the non-solubilized material was removed by 
ultracentrifugation and the supernatant was applied to SDS-PAGE. The Western blot analysis 
showed for both, induced and uninduced cells, a 62 kDa band corresponding to the size of 
Mdl1p. Suprisingly, a band appeared at the appropriate size of Mdl1p in uninduced cells. The 
constitutive expression of the tet repressor, which is also encoded on the expression plasmid, 
should guarantee the repression of the promotor in the absence of the inducer (AHT). 
Purification approaches by streptactin resin were not successful; the protein could not be eluted 
by 2.5 mM desthiobiotin. 
  
 
 
 
 
 
 
Fig.31: Heterologous expression of different Mdl1p constructs in E.coli. 
E. coli transformed with pBAD-∆mt-mdl1 was induced at OD 0.5 with 0.02 % arabinose for 3 h at 30°C.  
E. coli transformed with pASK-∆mt-mdl1 was induced with AHT (200 ng/ml) for 3 h at 30°C. After cell lysis, debris 
were pelleted by 20.000 x g for 20 min and the supernatant was centrifuged at 100.000 x g for 1 h. The membrane 
pellet was solubilized with 30 mM DM for 1 h on ice, centrifuged at 20.000 x g for 15 min and the supernatant was 
analysed by SDS-PAGE and immunostaining with α-Mdl1. 
M: yeast mitochondria (pos. control), +: induced, -: non-induced 
 
Alternatively, MDL1 was cloned into pET22 under the control of T7 promotor resulting in 
a Mdl1p construct fused N-terminally with the PepB periplasmatic leader sequence and C-
terminally with His6-tag. BL21(DE3) cells transformed with pET-∆mt-mdl1 were induced by IPTG.    Results 
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Isolated membranes were solubilized with 30 mM DM, ultracentrifuged, and the supernatant was 
applied to Ni-NTA beads (Fig.32). After washing with step gradients of imidazole (10 - 80 mM) 
the protein was finally eluted with 250 mM imidazole. This construct might be a promising 
candidate to be purified from bacterial source.  
 
 
 
 
 
 
Fig.32: Heterologous expression of Mdl1p in E. coli and purification via His-tag. 
E. coli cells transformed with pET-∆mt-mdl1 were induced at OD 0.5 with 0.2 mM IPTG for 3 h at 30°C. After cell lysis 
debris were removed by 20.000 x g for 20 min and the supernatant was centrifuged by 100.000 x g for 1 h. The 
membrane pellet was solubilized with 30 mM DM for 1 h on ice, centrifuged at 20.000 x g for 15 min and the 
supernatant was applied to NTA-beads. The beads were washed with a step gradient of imidazole and finally eluted 
with 250 mM imidazole. The fractions were analysed by SDS-PAGE and immunostaining with α-Mdl1.  
S: solubilized membranes 
 
In conclusion, a screen of different gene constructs was performed in order to establish 
an overexpression of Mdl1p in E. coli. For several gene products a strong induction as well as 
the correct incorporation of Mdl1p into the inner membrane . Due to N-terminal processing of the 
gene product in E. coli, it was decided to introduce affinity tags exclusively at the C-terminus. 
Further experiments will focus on the establishment of the purification procedure 
 
 
 
5.2  Identification and characterisation of an intracellular peptide transporter 
of S. cerevisiae 
In experiments designed either to analyse the intracellular peptide trafficking in the yeast 
S.  cerevisiae or to express TAP heterologously (Urlinger et al., 1997), an intrinsic peptide 
transport system was observed which translocated peptides into microsomes. Based on studies 
of energy requirement and specific inhibition (e.g. by ortho-vanadate) of the transport, the newly 
discovered transport activity was suspected to be mediated by an ABC transporter. The genomic 
yeast data bank was screened for potential ABC transporter gene candidates whose function 
has not been defined, so far. To identify the open reading frame (ORF) which is responsible for 
the peptide transport activity, several mutants deleted in putative ABC transporter genes were Results    
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created (Urlinger`s PhD thesis). The deletion of the ORF YLL048::HIS3 resulted in a loss of 
peptide transport function. We set out to characterise this ABC transporter encoded by YLL048 
and to evaluate its physiological role for S. cerevisiae. 
5.2.1  Characterisation of the ABC transporter encoded by YLL048 
Microsomes derived from wild type cells (W303-1A) showed a significant uptake of the 
radiolabelled R9LQK peptide in the presence of ATP at 27°C (Fig.33). The transport activity was 
competed by a 300-fold excess of unlabelled peptide. The deletion mutant YLL048::HIS was 
completely impaired in peptide transport. Transformation of the deletion mutant (∆yll048) with 
the plasmid harbouring the YLL048 gene fully restored the transport activity. The observation 
that the transport activity of the transformed deletion mutant was even higher than of the wild 
type microsomes, was most likely due to the higher expression of gene encoded by the 2µ 
plasmid compared to the chromosome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.33: Restoration of ATP-dependent peptide transport of the ∆yll048 strain transformed with plasmid-
encoded YLL048 (pAA48). 
Peptide transport of radiolabelled R9LQK (100 nM) was measured in the presence of ATP (2 mM) at 27°C for 3 min 
into microsomes prepared from wild type, ∆yll048 deletion strain and ∆yll048 deletion strain transformed with pAA43. 
As a control, the peptide transport rate was measured with ADP or ATP in the presence of a 300-fold excess of 
unlabelled peptide. 
    Results 
   85 
40 20 0 
60  0  0 
40  0  0 
20  0  0 
0 
A  T  P  , 2  7  °  C 
A  D  P  , 2  7  °  C 
A  T  P  , 4  °  C 
a  p  y  r  a  s  e 
p  r  e  i  n  c  u  b  a  t  i  o  n 
time [min]
p
e
p
t
i
d
e
 
t
r
a
n
s
p
o
r
t
 
 
[
c
p
m
/
µ
g
]
 
Fig.34 shows the time-dependent peptide transport of radiolabelled R9LQK peptide into 
microsomes. The transporter was inactive at 4°C in the presence of ATP or at 27°C in the 
presence of ADP. The ATP-dependent peptide transport was inhibited by a 300-fold molar 
excess of unlabelled peptide. Presence of apyrase completely abolished the transport activity. 
To exclude that the transporter was denatured during the assay, transport activity was also 
determined after 40 min preincubation at 27°C resulting in the same transport rate as without 
preincubation.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.34: ATP-dependent peptide transport mediated by YLL048 encoded protein. 
Time-dependent peptide transport of radiolabelled R9LQK into wt microsomes was measured in the presence of ATP 
at 27°C. Transporter was inactive at 4°C in the presence of ATP or at 27°C in the presence of ADP. To exclude that 
the transporter was denatured during the assay, transport activity was determined after preincubation of 40 min at 
27°C (star). 
 
To investigate the energy requirement of the transporter, different nucleotide 
triphosphates (NTPs) were tested. GTP, UTP, and CTP also energized the transporter albeit to a 
lower extent compared to ATP (Fig.35). 
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Fig.35: Nucleotide-dependence of the transport activity of YLL048p. 
Peptide transport of radiolabelled R9LQK (100 nM) in wt microsomes was measured in the presence of different 
nucleotides (2 mM) at 27°C for 3 min as well as in the presence of apyrase (1 unit) and AMP-PNP. 
 
5.2.2  Substrate specificity 
The substrate specificity of YLL048p was analysed using randomized peptide libraries 
ranging from 5 to 56 amino acids (Fig.36). A competition of the translocation of reporter peptide 
R9LQK was observed with a 100-fold molar excess of different peptide libraries. This indicated 
that YLL048p has a broad substrate specificity. The transporter preferred peptides longer than 7 
amino acids. So far, no upper limit for substrate recognition was determined. Randomized 
nonamer libraries (x9) containing D-amino acids at different positions (x) competed for peptide 
translocation as well. Therefore, it can be concluded that D-amino acids were accepted in the 
substrate binding pocket. D-amino acids at the C-terminal position were slightly disfavoured.  
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Fig.36: Substrate specificity of the YLL048p. 
A: Peptide transport of reporter peptide R9LQK (100 nM) was measured into microsomes at 27°C for 3 min with ATP 
in the presence of 100-fold molar excess of randomized peptide libraries ranging from 5 to 56 amino acids. 
B: Competition of translocation of the reporter peptide R9LQK (100 nM) was measured in the presence of 100-fold 
molar excess of nonamer peptide libraries which contained a D-amino acid at defined positions.  
Red x: position of D-amino acid 
 
  Surprisingly, the YLL048p has been described as a bile acid transporter (BAT1p) (Ortiz et 
al., 1997). Using microsomes, an ATP-dependent [
3H]-taurocholate uptake activity was 
measured which was inhibited by competition with a 375-fold molar excess of unlabelled 
taurocholate (1.5 mM) (Fig.37). The ∆yll048 strain did not exhibit any bile acid transport activity. 
Furthermore, it was shown that a 7.5-fold molar excess of peptides already competed for the 
transport of [
3H]-taurocholate and vice versa, the peptides transport activity was reduced by a 
375-fold molar excess of taurocholate. Comparing the concentration of both substrates, the 
transporter YLL048p has a much higher affinity for peptides than for bile acids.  
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Fig.37: ATP-dependent [
3H]-taurocholate transport into microsomes.  
A: Transport of [
3H]-taurocholate (TC) (4 µM) was measured in the presence of ATP (2 mM) at 27°C for 3 min into 
microsomes prepared from wild type, ∆yll048 deletion strain and ∆yll048 deletion strain transformed with pAA43. For 
control, the transport rate was measured with ADP or ATP in the presence of a 375-fold excess of unlabelled TC (1.5 
mM). 
B: Transport of [
3H]-TC (4 µM) was measured in the presence of ATP (2 mM) at 27°C for 3 min into microsomes 
prepared from wild type strain. For control, the transport rate was measured with ADP or ATP in the presence of 1.5 
mM unlabelled TC (375-fold molar excess) or in the presence of 30 µM unlabelled peptide (7.5-fold molar excess).  
 
5.2.3  Subcellular localisation of the ABC transporter encoded by YLL048 
To determine the subcellular localisation of the transporter, peptide transport activity of 
different organelles separated by sucrose gradient centrifugation was measured (Fig.38). 
Fractions harvested from 37% to 42% sucrose exhibited a significantly increased ATP-
dependent peptide transport activity. These fractions were identified as endoplasmic reticulum 
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A    Results 
   89 
20 
40 
60 
80 
 ATP
ADP
1 2 3 4 5 6 7 8 9 10 11  12 
0 
100 
0 
10 
20 
30 
40 
50 
60 
p
e
p
t
i
d
e
 
t
r
a
n
s
p
o
r
t
 
[
*
1
0
3
 
c
p
m
]
 
 
m
a
n
n
o
s
i
d
a
s
e
 
a
c
t
i
v
i
t
y
 
s
u
c
r
o
s
e
 
c
o
n
c
 
Kar2 
   Sec61  45 
62 
(ER) by immunodetection with antibodies against Kar2p and Sec61p, two marker enzymes of 
the ER. To exclude that the YLL048 mediated transport activity is localised in the vacuoles, 
vacuoles containing fractions were identified by α-mannosidase assay. The vacuoles were 
detected at the top of the gradient (20% sucrose). This observation is in line with literature where 
vacuoles are described to float on sucrose gradients because of their association with lipid 
particles (storage granula) which decrease their density (Zinser and Daum, 1995). Here, we can 
provide evidence that YLL048p is not predominantly localised in the vacuole membranes or 
secretory vesicles as proposed by Ortiz et al. (Ortiz et al., 1997). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.38. Peptide transport activity is colocalised with microsomal fractions. 
ATP-dependent peptide transport activity of the reporter peptide R9LQK (100 nM) was measured into different 
fractions separated by a sucrose gradient. The localisation of the microsomal fractions in the gradient was determined 
by SDS-PAGE and immunostaining with two ER marker proteins (Sec61 and Kar2). The localisation of vacuoles was 
determined by α-mannosidase assay.  
 
 
In order to confirm the ER localisation of this transporter, the peptide R10T containing the 
recognition site (NXT/NXS) for glycosylation was used (Fig.39). The ER is the only compartment 
where N-glycosylation of proteins occurs. Microsomes containing YLL048p were incubated at Results    
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27°C for 3 min in the presence of ATP. Only a very little amount of glycosylated peptide could be 
detected by binding to concavalin A sepharose. One explanation for this observation might be 
that the yeast glycosylation machinery does not accept peptides, which are not delivered via the 
Sec61 complex into the ER. It is also possible that the N-glycan attached to the peptide is not 
recognized by the lectin concavalin A. In order to test the glycosylation in yeast microsomes, an 
acetylated and amidated tripeptide (Ac-NYT-NH2) was used, which enters the microsomes by 
passive diffusion (Wieland et al., 1987) (Fig.40,A). This Ac-NYT-NH2 consists of the N-linked 
glycosylation site including a tyrosine which could be efficiently iodinated. As diffusion is a slow 
process, microsomes were incubated with the radiolabelled Ac-NYT-NH2 for 30 min at 27°C. 
Radioactive Ac-NYT-NH2 could be eluted from concavalin A, demonstrating that an efficient 
glycosylation of the tripeptide was obtained. Surprisingly, although no efficient glycosylation of 
the peptide R10T could be observed, the R10T peptide decreased the glycosylation efficiency of 
the reporter tripeptide (Fig.40,B).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.39: Peptide transport into wild type microsomes. 
A: Microsomes were prepared from wild type yeast cells. Transport of radiolabelled R10T peptide (100 nM) containing 
an internal glycosylation site was measured in the presence of ATP (2 mM) at 27°C for 3 min. The microsome pellets 
were directly γ-counted. 
B: Alternatively, after transport assay microsomes were lysed by NP40 (1%) and incubated with concavalin A 
sepharose for 1 h. After washing, glycosylated peptide R10T was eluted by β-methyl-mannoside before γ-counting.    Results 
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Fig.40: Passive translocation of Ac-NYT-NH2 into microsomes.  
A: Passive translocation of radiolabelled Ac-NYT-NH2 (100 nM) into microsomes was performed at 27°C for different 
time points. The microsome pellets were directly γ-counted (open bars). Alternatively, NP40-lysed microsomes were 
incubated with concavalin A sepharose for 1 h and glycosylated tripeptide was eluted by β-methyl-mannoside and 
quantified (filled bars).  
B: Radiolabelled Ac-NYT-NH2 (100 nM) was incubated for 30 min at 27°C with microsomes in the  presence of 100-
fold molar excess of unlabelled Ac-NYT-NH2 or unlabelled R10T in the presence of 2 mM ATP. The microsome pellets 
were directly γ-counted (open bars) or glycosylated tripeptide was quantified after microsome lysis and elution form 
concavalin A sepharose (filled bars).  
 
In summary, we concluded that the ABC transporter YLL048p mediates ATP-dependent 
peptide transport. The radioactive transport activity is peptide specific because peptide 
translocation was competed by an excess of unlabelled peptides. In addition, we demonstrated 
that the same transporter mediates bile acid transport albeit with a decreased affinity compared 
to peptides. Subcellular fractionation experiments clearly correlated the peptide transport activity 
with ER membranes. But for unknown reasons, no efficient glycosylation of peptides with an 
internal glycosylation site could be observed after import. Efficiency of the glycosylation 
machinery was studied by Ac-NYT-NH2  which enters the ER lumen by passive diffusion. 
Surprisingly, the transport of peptides with a glycosylation site reduced the efficiency of the 
glycosylation of Ac-NYT-NH2.  
The physiological role for a peptide uptake system of the yeast cell is not well understood. 
Therefore, we set out to investigate different factors which might influence the expression of 
YLL048.  
5.2.4  Physiological function of YLL048p in yeast  
The physiological function of the bile acid transporter (Bat1p) proposed by Ortiz et al. 
was the detoxification of the cytosol by translocating bile acids and derivatives into vacuoles 
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(Ortiz et al., 1997). Kolaczkowska and colleagues reported a highly increased toxicity of bile 
acids toward the PDR1, PDR3 double disruptant mutants together with decreased level of BAT1 
promotor dependent β-galactosidase activity (Kolaczkowska et al.,1998). Therefore, Bat1p was 
described as a new member of the pleiotropic drug resistance (PDR) network. Although classical 
response elements for the transcription factors Pdr1p and Pdr3p are missing in the BAT1 
promotor, we tested this possibility. By Northern blot analysis mRNA levels of YLL048 were 
investigated in strains with PDR1 and PDR3 double deletion as well as in gain-of-function PDR1 
and PDR3 strains (Fig.41). In all strains tested no change of YLL048 mRNA level could be 
observed. Neither in the PDR1, PDR3 double deletion strains nor in strains overexpressing the 
transcription factors a change in YLL048 mRNA level was obtained. Therefore, a regulation of 
YLL048 in the PDR can be excluded.  
 
 
 
 
 
 
 
 
Fig.41: Northern blot analysis of YLL048 mRNA level.  
Total RNA was isolated from logarithmically growing cells by the hot phenol method as described previously (Schmitt 
et al., 1990) and applied to agarose electrophoresis. RNAs were transferred onto a Nylon membrane (Hybond N+) by 
capillary transfer. YLL048 mRNA was detected by hybridization with a 723 bp radioactive probe corresponding to nt 
+145 to nt +868 of this ORF. mRNA level of YLL048 was tested of W303-1A, deletion strain of PDR1 and/or PDR3 as 
well as of strains upregulating PDR1 or PDR3.  
 
In order to explain the physiological relevance of peptide transport into microsomes, we 
speculate that the YLL048 encoded protein might be part of a novel route of peptide trafficking in 
yeast involved in the unfolded protein response (UPR) (Higashio and Kohno, 2002). To test the 
hypothesis, upregulation of YLL048 expression induced by heat shock was studied (Fig.42,A). 
Cells grown at room temperature were shifted to 37°C for different time periods. However, the 
synthesis of YLL048 mRNA did not change during the chase of 60 min. For positive control, the 
mRNA level of PDR15 showed a shift on RNA level in dependence of increased growth 
temperature (H. Wolfger, PhD thesis).  
To test the involvement of YLL048 in stress response, cells were exposed up to 60 min to 
stress factors as increased concentration of NaCl, sorbate and sorbitol (Fig.42). Again no shift in 
the synthesis of YLL048 mRNA level could be observed under the tested conditions. As negative 
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control, H2O2 was used which induced the lysis of the cells and therefore a decrease in the 
mRNA level. In summary, an upregulation of YLL048 in response to stress conditions and heat 
shock could not be observed on mRNA level.  
 
 
 
Fig.42: Northern blot analysis of mRNA of PDR15, PDR5, and YLL048 after stress. 
A: Total RNA was isolated from cells grown at RT which have been exposed to heat shock (37°C) for different time 
periods.  
B: Total RNA was isolated from cells grown for different time periods in the presence of H202, 0.3 M NaCl, 5 mM 
sorbate, and 0.4 mM sorbitol Results    
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5.3  In vivo screen of TAP mutants based on an autocrine stimulation assay 
in yeast 
The mechanism of peptide transport by the TAP complex has been studied in detail 
(Lankat-Buttgereit, 2002). The transporter is responsible for translocation of peptides from the 
cytosol into the lumen of the ER. The functional expression of human TAP in the yeast S. 
cerevisiae has been established (Urlinger et al., 1997). The heterologously expressed TAP1 and 
TAP2 subunits have been reported to be located in the ER membrane as well as the plasma 
membrane. In order to establish a fast and efficient method to characterise a broad spectrum of 
TAP mutants and associated factors, which might alter the transport activity, a genetic in vivo 
screen was designed. This assay should be based on TAP-mediated peptide transport 
monitored by a fast read out system. 
However, peptide trafficking in yeast is not well characterised. Several peptide 
transporters are involved in nutrient uptake. Beside the use of peptides as energy source, 
peptides play an important role in mating of yeast cells. The process of mating is mediated by 
peptide pheromones, the α- and a-factor. We set out to build up a screening assay based on 
TAP-mediated secretion of peptide pheromones. To establish such an in vivo screen was very 
convenient because in vitro transport assays already demonstrated that the TAP complex 
recognized the pheromone α-factor as substrate. 
 
5.3.1  Pheromones mediate mating in the yeast 
The assay takes advantage of processes involved in mating of two haploid cells, MATα 
and MATa (Cross, 1988). Mating requires the action of extracellular peptide hormones (α- and 
a-factor) that are released from haploid partners of opposite mating type. The α-factor is 
secreted by MATα cells and binds to a G-protein-coupled receptor on the surface of a-mating-
type cell and vice versa. The pheromone receptors Ste2 and Ste3 induce a MAP-kinase-
dependent signal transduction, which switches the expression of specific genes causing a cell 
cycle arrest in G1, combined with a change of the cell morphology (Sprague, Jr. et al., 1983; 
Kuchler et al., 1993; Blumer et al., 1988).  
In contrast to the a-factor, which is exported by the ABC transporter Ste6, the α-factor is 
expressed as a larger pre-pro-protein (120 amino acids) including an ER leader sequence and is 
secreted by the classical secretory pathway (Julius et al., 1983). During the maturation of the α-
factor (WHWLQLKPGQPMY) its pre-pro sequence is processed in the ER and Golgi.    Results 
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5.3.2  TAP-mediated α-factor secretion 
To bypass the Sec61-dependent secretory pathway of the α-factor, the mature 
pheromone was planned to be expressed from a minigene lacking the pre-pro-sequence. 
Therefore, mature α-factor is predicted to remain in the cytosol. Yeast cells expressing a 
functional TAP should export the α-factor into the extracellular space, whereas TAP deficient 
cells are not able to secrete the pheromone. Four different constructs of the α-factor were 
cloned into the yeast expression vector p426 under the control of the strong, constitutive ADH 
promotor. The first construct (MWHWLQLKPGQPMY) contained the mature α-factor sequence 
including an N-terminal methionine. The second construct (MWHWLQLKPGQPMYKRNAT) 
consisted of a recognition site for the Kex2 protease (KR) and a glycosylation recognition site 
(underlined) at its C-terminus. In the third construct (MKREAEAWHWLQLKPGQPMY) the 
mature α-factor was N-terminally fused with its natural recognition site of Kex2 protease (KR) 
and Ste13 (EA) based on the original sequence of the pro-α-sequence. The fourth construct 
(MNATLAKREAEA-WHWLQLKPGQPM) contained a glycosylation site as well as the Kex2 
protease recognition sites. The Kex2 protease is responsible for cleavage of the pro-sequence in 
the Golgi apparatus. The reason to introduce glycosylation sites into the peptide was to protect 
the pheromone from retrograde transport from the ER to the cytosol as described for peptides 
(Koopmann et al., 2000). The α-factor constructs were designed to be transported to the ER by 
TAP from where they can follow the classical secretory pathway.  
 
To obtain autocrine stimulation, expression of the α-factor was performed in a-mating 
cells Cadus 6259. After secretion, the α-factor should interact with its Ste2 receptor at the same 
cell surface resulting in an autocrine stimulus which triggers a MAPK-cascade. Normally, the 
pheromone stimulation causes a cell cycle arrest. To avoid this arrest, the strain used was 
deleted in the FAR1-gene (McKinney et al., 1993; Peter et al., 1993). In addition, this strain 
contains a BAR1 (protease) mutation in order to reduce degradation of the α-factor and a STE14 
mutation to reduce background cascade stimulation in the absence of extracellular pheromone 
(Manfredi et al., 1996). For screening of stimulated cells, the HIS3 gene cassette was set under 
the control of α-factor inducible FUS1-promotor, integrated into the genome (Trueheart et al., 
1987; Manfredi et al., 1996). Thus, the selection of functional TAP complex was based on a shift 
from histidine auxotrophy to prototrophy of stimulated cells (Fig.43). 
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Fig.43: Scheme of the function of the autocrine stimulation assay. 
Mature α-factor is expressed in an a mating-type cell and becomes exported into the medium by TAP. At the cell 
surface, the pheromone binds to the Ste2 receptor inducing a signal cascade which results in the activation of the 
FUS-promotor dependent expression of HIS-cassette. Thus, the selection of functional TAP complex is based on a 
shift form histidine auxotrophy to prototrophy of stimulated cells.  
 
5.3.3  Functionality of the autocrine stimulation assay 
In order to investigate the functionality of the autocrine stimulation of the strain Cadus 
6259, synthetic mature α-factor was added to freshly inoculated yeast cells in the absence of 
histidine. The α-factor triggered the growth of the cells as measured by the increase of the OD600 
(0.5-1) after 24 h incubation. The external concentration of the α-factor sufficient to induce the 
shift from HIS auxotrophy to prototrophy was determined to be 112 nM. Cells did not grow in the 
absence of external pheromone. The sensitivity of cells towards α-factor could be controlled by 
addition of aminotriazole (AT) (Klopotowski and Wiater, 1965). AT is a competitive inhibitor of 
HIS3 gene product (imidazole glycerol phosphate dehydratase). The addition of 1.7 mM AT in 
combination with 560 nM α-factor inhibits the growth of the cells. The addition of AT to the 
medium reduces the sensitivity of the cells to the pheromone 10 times. 
The Cadus 6259 strain transformed with plasmid-encoded TAP1 (Ura) and TAP2 (Leu) 
genes in combination with different constructs of α-factor (Trp) did not grow in the absence of    Results 
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histidine. The presence of the TAP genes and α-factor gene in the yeast cells was confirmed by 
colony-PCR. However, the expression of the TAP1 and TAP2 subunits could not be detected in 
the Cadus strain by Western blot analysis (Fig.44,A). The expression of the mature α-factor in 
yeast cells was investigated using an antibody against the pre-pro-α-factor (Fig.44,B) (kind gift 
from R. Schekman). The antibody was generated against the precursor form of the α-factor, but 
was able to recognize the mature α-factor as well.  
 
 
 
 
 
 
 
 
 
 
 
Fig.44: Western blot analysis of TAP expression and western dot blot analysis of α-factor expression in yeast. 
A: Microsomes derived from W303-1A strain and Cadus 6259 strain transformed with TAP1 and 2 genes were applied 
to 12% SDS-PAGE and immunostained with α-TAP1 and TAP2.  
B: Cytosolic extract of Cadus strain 6259 transformed with p426-α-factor (mod 4) was TCA-precipitated (5% final 
conc.). The supernatant was applied to nitrocellulose and immunostained with α-pre-pro-alpha-factor. Different 
concentrations of the extract were applied to the membrane.  
 
In summary, a selection assay for TAP mutants based TAP-mediated secretion of the α-
factor could not be established. The functionality of the signalling pathway of the Cadus strain 
was demonstrated by addition of synthetic α-factor to the medium. Furthermore, in vitro assays 
clearly demonstrated that the pheromone is recognized by the TAP complex. But for unknown 
reasons, the expression of the TAP subunits was not detected in the Cadus strain. As previously 
described we have characterised an intracellular peptide transporter encoded by YLL048. In 
vitro transport assays on isolated yeast microsomes showed that the YLL048p transported the 
α-factor as well (data not shown). But no stimulation to HIS prototrophy was obtained in Cadus 
strain. One reason might be that the expression of α-factor in the cytosol was not efficient. It is 
possible that the peptide was rapidly degraded in the cytosol before it could be transported to 
the ER lumen. It is also possible that the truncated α-factor although imported into the ER did 
not follow the secretory pathway to the cell surface but became either degraded in the ER or 
exported into the cytosol for degradation.     Discussion 
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6 Discussion 
6.1  Characterisation of the ATPase cycle of isolated Mdl1p-NBD 
ABC transporters undergo a series of conformational changes in response to ATP 
binding and hydrolysis at the NBDs. These conformational changes are coupled to 
rearrangements in the TMDs which finally results in the translocation of solutes across the 
membrane. Observations of strong cooperativity between the two NBDs in ATP hydrolysis of the 
complete transporter suggested a dimerization of the NBDs during the catalytic cycle (Nikaido et 
al., 1997; Sharma and Davidson, 2000; Jones and George, 1999). The fact that inactivation of 
one of the NBDs entirely abolishes the transport activity confirmed the necessity of two 
functional ATPase subunits in each transport cycle (Urbatsch et al., 1998; Urbatsch et al., 2000a; 
Urbatsch  et al., 2000b). But only recently the reason for the interdependency of the ABC 
subunits was clarified on molecular level. The catalytic pocket for ATP hydrolysis is produced 
only by cooperation of two monomers (Nikaido, 2002). Structural (Hopfner et al., 2000; Smith et 
al., 2002; Locher et al., 2002) and biochemical data (Fetsch and Davidson, 2002; Loo et al., 
2002) clarified which residues are involved in ATP binding and subsequent dimerization of the 
NBDs. Although dimerization has been recognized as an essential intermediate in the ATPase 
cycle, the mechanism of ATP hydrolysis in both NBDs is still under debate and the nature of 
structural changes occurring at each step of the ATPase cycle has not been defined. 
 
Recently, an intracellular half-size ABC transporter Mdl1p  (multidrug resistance like), 
localised in the inner mitochondrial membrane of Saccharomyces cerevisiae, has been identified 
(Young et al., 2001). Mdl1p was proposed to act as a homodimer in its minimal composition. We 
are interested in the mechanism how ATP hydrolysis drives the export of peptides. Therefore, 
the C-terminal domain (amino acids 427 to 695) corresponding to the NBD of the mitochondrial 
ABC transporter Mdl1p was overexpressed in E. coli and purified to homogeneity. Purified NBD 
was active with respect to ATP binding and hydrolysis. The Mdl1p-NBD appeared as a monomer 
in gelfiltration studies independent of the presence of nucleotides as was previously observed for 
isolated HisP (Nikaido et al., 1997).  
Importantly, in the presence of ATPase inhibitors such as ortho-vanadate or BeFx the 
isolated Mdl1p-NBD was trapped as a dimer which was stable during gelfiltration. Ortho-
vanadate and BeFx act as analogues of inorganic phosphate and mimick an intermediate state 
during ATP hydrolysis after phosphate dissociation but before release of ADP (Goodno, 1982; 
Phan and Reisler, 1992; Urbatsch et al., 1995b). Ortho-vanadate acts as a transition state 
analogue presumably occupying the γ-phosphate position adjacent to the ADP (Smith and Discussion    
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Rayment, 1995), whereas BeFx is a ground state analogue mimicking the bound MgATP (Maruta 
et al., 1993; Henry et al., 1993). Each of these stable inhibitory complexes mimics specific states 
in the ATPase kinetic pathway (Shibuya et al., 2002). As demonstrated on myosin X-ray 
structures, the inhibited complex trapped by ortho-vanadate reassembles a posthydrolysis state 
while the complex trapped by BeFx represents a prehydrolysis state (Fisher et al., 1995).  
ADP could not replace ATP in the trapping reaction. Incubation of the NBD with MgATP 
at 4°C in the presence of BeFx did not induce dimerization either. These experiments 
demonstrate that ATP binding and hydrolysis are essential for dimerization. Using [α
32P]-ATP or 
[γ
32P]-ATP the nucleotide composition of BeFx-trapped states was analysed by β-counting and 
thin layer chromatography after gelfiltration. Radioactive nucleotides coeluted exclusively with 
the dimer in the gelfiltration, whereas no radioactivity was observed in fractions corresponding to 
the monomer. Analysis of the dimer showed exclusively two ADP molecules without Pi bound in 
the dimer. These data indicate that ATP could not be preserved in the NBD. After hydrolysis of 
two ATP molecules the dimer is stabilized by exchange of Pi with BeFx. The half-life of the 
inhibitory complex was significantly longer than 1 h as no dissociation of the dimer was observed 
during the gelfiltration (1 h). During this time only inorganic phosphate was released from the 
dimer.  
 
6.1.1  Analysis of mutants in the ATPase cycle 
An ATPase deficient mutant of the Mdl1p-NBD was created by removal of the charge in 
the catalytic centre downstream of the Walker B motif (E599Q). This exchange was equivalent to 
the mutation of P-gp (E552Q/E1197Q), which was described to be severely impaired in transport 
activity and in substrate-stimulated ATPase activity (Urbatsch et al., 2000a). Although the 
E522Q mutant of P-gp was catalytically inactive in standard ATPase assays (as measured by Pi 
or ADP release), the ability to form an ortho-vanadate-stimulated transition state (P-gp-ADP-Vi) 
was retained. Binding of Mg
2+ to this mutant was not impaired. As ortho-vanadate could be 
bound to E522Q mutant, it was suggested that the mutant is not inhibited in ATP hydrolysis, but 
rather in the release of ADP. Therefore, this mutant was described to be incapable to complete a 
single catalytic turnover (Urbatsch et al., 2000a). The observation that an equivalent mutant of 
isolated archaeal NBDs from MJ0796 (E171Q) or MJ1267 (E179Q) induced an ATP-dependent 
dimerization of the NBDs was a key step in visualizing the dimer as a catalytic intermediate 
(Moody et al., 2002). The mutant (E599Q) of Mdl1p-NBD also formed a stable dimer upon ATP 
binding. Gelfiltration analysis and thin layer chromatography demonstrated that two nucleotides 
were incorporated per dimer. The nucleotide composition was determined under non-hydrolysing    Discussion 
   101 
conditions, which means in the absence of Mg
2+ at 4°C, and under hydrolysing conditions, in 
which the NBD was incubated in the presence of Mg
2+ at 30°C. Under non-hydrolysing 
conditions exclusively two ATP molecules were observed in the dimer. Under hydrolysis 
conditions the dimer contained ATP and ADP along with a very small amount of phosphate. This 
result indicates that the E599Q mutant is able to hydrolyse at least one ATP although with 
decreased efficiency compared to the wild type NBD. Two ADP molecules sandwiched in the 
mutant dimer were not observed simultaneously although the incubation was prolonged to 8 h. 
This indicated that a dimer with two ADP molecules seems to be unstable, suggesting that at 
least one ATP molecule is required to hold the dimer together. Probably, incubation of the 
E599Q mutant in the presence of BeFx under hydrolysis conditions would result in a transition 
state with two ADP molecules. 
 
The dimer formation of the archaeal NBDs from MJ0796 (E171Q) and MJ1267 (E179Q) 
was impaired by Mg
2+. In comparison, Mg
2+ did not effect the formation of Mdl1p-NBD dimers 
significantly. However, Mg
2+ influenced the species of nucleotides trapped in the NBDs. As 
described previously, the presence of Mg
2+ triggered the hydrolysis of ATP within the dimer. 
Based on these results, we can conclude that ATP binding is essential and sufficient for 
dimerization of the mutant NBD. It was shown that ABC transporters are unable to hydrolyse the 
ATP-analogues AMP-PNP or ATPγS or at least the hydrolysis efficiency is highly decreased. 
Surprisingly, incubation of the E599Q mutant of Mdl1p in the presence of AMP-PNP or ATPγS 
did not induce dimerization. The same observation was made with E171Q mutant from MJ0796 
or E179Q from MJ1267 (Moody et al., 2002). The inability of AMP-PNP to promote dimerization 
might be explained by its poor imitation of ATP. However, binding of AMP-PNP to NBD as tested 
for E599Q mutant was not impaired. But we could demonstrate that incubation of the E599Q 
mutant with equimolar ratio of unlabelled ATP and ATPγ
35S resulted in the incorporation of one 
ATPγ
35S molecule bound per dimer, suggesting that the presence of one hydrolysable ATP 
molecule is essential for dimer formation. 
 
Mutagenesis of aspartate into alanine in the Walker B motif (D598A) of Mdl1p resulted in 
a mutant which was indeed deficient in hydrolysis of the γ-phosphate anhydride bond although 
binding of ATP was not impaired. This mutant did not show ATP-induced dimerization. Another 
invariant residue of NBDs is the histidine 631 of Mdl1p in the switch II region. It was proposed 
that this histidine is intimately involved in hydrolysis since it forms an H-bond with γ-Pi of ATP via 
a water molecule (Nikaido and Ames, 1999). A homodimer of HisP (H211R) was inactive in Discussion    
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ATPase activity but retained full activity in complex with wild type HisP. An equivalent mutation 
in the Mdl1p-NBD (H631R) resulted in an inactive NBD. Gelfiltration analysis of the H631R 
mutant in the absence of nucleotides showed predominantly a dimer, which was not dependent 
on ATP.  
 
6.1.2  Model of the ATPase cycle 
Based on our data we propose a model, where ATP binding to both NBDs induces 
formation of the dimer. After hydrolysis of two ATP molecules, the dimeric complex dissociates 
and ADP molecules are released. The association of the NBDs is a central step of the ATPase 
cycle, but it remains still controversial how both NBDs cooperate and coordinate ATP hydrolysis. 
Based on dimeric crystal structures it is proposed that two ATP molecules are bound to a dimer 
at the same time (Hopfner et al., 2000; Smith et al., 2002). As the two ATP molecules are buried 
into the interior made up by the dimer interface, no nucleotides are exchangeable as long as the 
dimer does not dissociate. Preloading of the Mdl1p-NBD with non-radiolabelled ATP followed by 
incubation with [α
32P]-ATP resulted in no incorporation of radioactive nucleotides into the dimer. 
The same observation was made with P-gp (Urbatsch et al., 1995b). 
 
Both NBDs are required for the functionality of an ABC transporter and both must 
hydrolyse ATP (Higgins, 2001; Urbatsch et al., 1995a; Urbatsch et al., 1998). But the question 
remains whether the motor domains work as equivalent modules hydrolysing both ATPs 
synchronically, sequentially or alternatingly. A model based on P-gp, LmrA and HisMQP2 was 
proposed in which only one NBD hydrolyses one ATP molecule at a time (Senior et al., 1995; 
van Veen et al., 2000; Higgins, 2001; Jones and George, 2002). In this alternating model two 
ATP molecules are bound simultaneously. Hydrolysis of ATP occurs at one NBD followed by 
release of ADP and Pi. Before the ATP at the second NBD can be hydrolysed, the first NBD has 
to be reloaded by new ATP.  
For sterical reasons loading of a new nucleotide into the dimer without dissociation of the 
subunits is difficult to imagine. Therefore, following the alternating catalytic cycle model, the 
dissociation of the dimer occurs after every hydrolysis of ATP at each NBD. It is also 
conceivable that the association of the NBDs, which are fixed to the TMDs, in a full-length 
transporter is not as tight as in isolated NBDs.  
The ATPase model based on isolated NBDs clearly contradicts an alternating modus. 
Once a dimer is formed, both ATPs are hydrolysed before the dimer dissociates. After loading of 
the monomers with new ATP molecules a new cycle of hydrolysis can be performed. In a BeFx-   Discussion 
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trapped dimer two ADP molecules were observed for Mdl1p. In contrast, for P-gp ortho-
vanadate-induced trapping of nucleotides resulted in 1 mol [α
32P]-ADP bound per mol P-gp 
(Urbatsch  et al., 1995b). The same stoichiometry was observed concerning the inhibitory 
complex stabilized by BeFx (Sank Aran et al., 1997). For MalFGK2 trapping of nucleotides by 
ortho-vanadate demonstrated 0.9 mol nucleotides bound per mol protein (Sharma and Davidson, 
2000). In contrast to our data, isolated MalK was insensitive to ortho-vanadate and it was 
proposed that the TMDs of MalFGK2 are crucial for conferring sensitivity to the ATPase inhibitor 
(Hunke et al., 1995). 
 
It is difficult to understand why the stoichiometries concerning Mdl1p-NBD and P-gp or 
MalFGK2 differ. P-gp and MalFGK2 resemble full-length transporters, whereas the investigations 
with Mdl1p were performed on isolated NBDs in the absence of TMDs and substrate. It is known 
that isolated NBDs (e.g. HisP, H211R) can show a different behaviour compared to the complex 
since TMDs might superimpose a regulatory effect on the NBDs (Nikaido and Ames, 1999). 
Finally, we cannot exclude the possibility that different ABC transporters function in a different 
modus to hydrolyse ATP. The fact that ABC transporters behave different can be shown by the 
fact that trapping of P-gp with ortho-vanadate or BeFx even worked in the presence of ADP 
(Sankaran et al., 1997). For Mdl1p-NBD, trapping the dimer by ortho-vanadate or BeFx was 
strictly dependent on proceeding ATP hydrolysis.  
 
6.2 Characterisation  of  yeast ABC transporter Mdl1p 
The inner membrane of mitochondria and chloroplasts is the only cellular membrane that 
is not exposed to the cytosol and therefore not accessible to the ubiquitin/proteasome pathway. 
Therefore, the mitochondria rely on an additional quality control system mediated by ATP-
dependent AAA proteases working in concert with Mdl1p, a member of the ABC superfamily. 
These AAA proteases degrade improperly folded mitochondrial membrane proteins and short-
lived regulatory proteins to peptides and amino acids (Arnold and Langer, 2002; Langer et al., 
2001). Breakdown products of a molecular mass of 600-2100 dalton are transported to the 
intermembrane space by Mdl1p. 
In general, it is difficult to study exporters like Mdl1p since the substrate binding site and 
the ATP binding pocket are not directly accessible. To investigate efflux transport, the substrates 
as well as competitive inhibitors have to be delivered into mitochondrial matrix. Subsequently, 
the release of labelled substrates into the medium has to be measured. The transport activity of 
Mdl1p was characterised by quantification of peptides in the intermembrane space. These Discussion    
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peptides are derived from degraded proteins after in-organello-synthesis and labelling (Young et 
al., 2001). Based on this method it is impossible to influence the generated pool of peptides 
inside the mitochondria. It is also impossible to manipulate the ATP concentration inside the 
organelle. Using isolated mitochondria it cannot be excluded that after export of the peptides into 
the intermembrane space, these peptides become further processed by other proteases. So far, 
the information about the substrate spectrum of Mdl1p is very limited and the transport 
mechanism how ATP energizes the export of peptides is not understood. To address these 
questions, we followed the strategy to overexpress this transporter in S. cerevisiae or E. coli. 
Purification of Mdl1p and reconstitution into liposomes would facilitate the investigation of 
transport function in vitro. Alternatively, an approach to study the transport activity in vivo was 
performed. For this reason, we tried to convert the export function of Mdl1p into an import 
activity by disrupting the mitochondrial targeting of Mdl1p. Mdl1p delocalised to the ER 
membrane might function as a peptide importer comparable to TAP. 
 
6.2.1  Expression and reconstitution of Mdl1p 
Homologous overexpression of Mdl1p in yeast has been established. The first step in 
purification of a membrane protein is the detergent-mediated solubilization. Decylmaltoside (DM) 
has been used for solubilization as it is a very mild detergent and it was successfully used in the 
functional reconstitution of TAP (Gorbulev et al., 2001). DM solubilization did not impair ATP 
binding of Mdl1p, but the solubilization efficiency was only 50%. Much better solubilization 
(about 90%) was achieved by 1% Triton X-100.  
Although first approaches to purify Mdl1p based on affinity chromatography were not 
successful, reconstitution approaches with Mdl1p partially enriched by gelfiltration were 
performed. After gelfiltration and subsequent reconstitution into liposomes, no incorporation of 
Mdl1p could be detected. The fact that the liposomes were not destabilized by detergent before 
use, could possibly explain the low reconstitution efficiency. DM is known to hardly destabilize 
liposomes and a stepwise addition of DM to preformed liposomes over a long time scale would 
probably achieve a more efficient destabilization of liposomes. Therefore, other detergents like 
octylglucoside were used for destabilization of liposomes in the further experiments. 
Furthermore, the lipid composition was optimized to retain functionality of a mitochondrial protein. 
Cholesterol which was reported to be inhibitory on the transport of mitochondrial membrane 
proteins was exchanged by cardiolipin (Heimpel et al., 2001). In eukaryotes, cardiolipin is a 
characteristic phospholipid of the inner mitochondrial membrane and it was reported to be 
essential for the activity of several mitochondrial proteins (Heimpel et al., 2001; Jiang et al.,    Discussion 
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2000). For the following reconstitution experiments the liposomes were composed of 
phosphatidylcholine, phosphatididylethanolamine and cardiolipin in a ratio of 75:20:5. 
 
To obtain a higher incorporation of Mdl1p into liposomes, solubilized mitochondria were 
directly used and reconstituted into preformed liposomes. Mdl1p was successfully incorporated 
into liposomes as shown by Western blot analysis. Sucrose gradient centrifugation showed that 
proteoliposomes were sealed and floated in the gradient. Azido-ATP-crosslinking experiments 
demonstrated that the ATP binding activity of Mdl1p during the reconstitution procedure was not 
impaired. Proteoliposomes were crosslinked either directly or after solubilization with Triton X-
100. Both signals showed the same intensity, suggesting that the NBDs of reconstituted Mdl1p 
predominantly faced the outside of the vesicles. Although the ATP binding activity was 
demonstrated, no peptide uptake could be observed into the proteoliposomes. It is possible that 
reconstitution of other proteins resulted in release of imported peptides. It was shown that porins 
of the outer membrane were incorporated into the proteoliposomes as well. As porins are water 
filled channels, they might allow the diffusion of molecules up to a molecular mass of 6 kDa 
(Mannella, 1992); (Young et al., 2001). Taking the existence of porins in proteoliposomes into 
account, it cannot be excluded that azido-ATP might have diffused through porins into the 
liposomes as well. 
 
To avoid reconstitution of porins, proteins of solubilized mitoplasts (mitochondria stripped 
of the outer membrane) were reconstituted into liposomes. The proteoliposomes which floated in 
a sucrose gradient contained a high amount of incorporated Mdl1p but were still contaminated 
by porins. No peptide uptake could be observed. In order to trap the imported peptides inside the 
vesicles one could include peptide specific antibodies inside the liposomes. It is very unlikely 
that such immuno-complexes would be released into the medium. Similar strategies were 
applied to measure TAP-mediated peptide import into the ER. Only peptides which were 
glycosylated could accumulate in the ER, non-glycosylated peptides were efficiently exported via 
Sec61 (Koopmann et al., 2000).  
Reconstitution experiments with extracts of solubilized mitochondria had the advantage 
that interaction partners could be co-reconstituted which might be essential for Mdl1p transport 
activity. So far, it is not proven whether Mdl1p is functional in a minimal composition as a 
homodimer. The native molecular mass of the Mdl1p complex was determined to be 200 kDa 
(Young et al., 2001). The accessory proteins of this complex are not defined. 
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6.2.2  Deletion of the mitochondrial targeting sequence 
As it is difficult to study export, we tried to convert Mdl1p into an importer by directing the 
protein to the ER membrane. Mitochondrial targeting is often mediated through N-terminal leader 
sequences usually consisting of 20 to 35 residues highly enriched in basic, hydrophobic and 
hydroxylated amino acids (Neupert, 1997; von Heijne, 1986; Schatz and Dobberstein, 1996). A 
classical leader sequence of 59 amino acids has been predicted for Mdl1p. Mitochondrial 
targeting of ABC-me, a close homolog of Mdl1p, was investigated by deletion of amino acids 2-
69 (Shirihai et al., 2000). The truncated ∆2-69 ABC-me-GFP was distributed in the cytosol, 
indicating that the N-terminus is indeed necessary for mitochondrial localisation. It has to be 
noticed that the truncated protein ABC-me was not incorporated into any membrane. 
A construct of Mdl1p deleted in the amino acids 2-59 was expressed in yeast. To 
investigate if the deletion of the predicted mitochondrial targeting sequence influences the 
localisation of the protein, isolation of mitochondria was performed via sucrose gradients. No 
difference between the distribution of full-length and truncated Mdl1p was observed. This result 
was confirmed by partial digitonin-mediated solubilization of mitochondria followed by proteinase 
K digestion. Both methods showed that N-terminally truncated Mdl1p was still localised in the 
mitochondria and suggested an internal targeting sequence additional to the classical N-terminal 
one. Such internal targeting sequences have been observed in other inner mitochondrial 
membrane proteins e.g. ATP/ADP carrier and oxoglutarate carrier (Luciano et al., 2001; 
Wiedemann et al., 2001; Endres et al., 1999; Kurz et al., 1999; Kubrich et al., 1998; Palmisano 
et al., 1998). The targeting sequence has not been defined, so far. To characterise the 
mitochondrial targeting of Mdl1p in vitro transcription and translation assays would be the 
method of choice. In order to obtain targeting of Mdl1p to the ER, it be might be convenient to 
fuse Mdl1p with a classical ER targeting sequence. 
    Discussion 
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6.3  Identification and characterisation of an intracellular peptide transporter 
of S. cerevisiae 
The transporter associated with antigen processing (TAP) has been for a long time the 
only known intracellular peptide ABC transporter which mediates the import of peptides into the 
lumen of the endoplasmatic reticulum (Lankat-Buttgereit and Tampé, 2002). In experiments 
investigating peptide transport into yeast microsomes, we discovered a new peptide uptake 
activity. This transport is mediated by ORF YLL048 since deletion of YLL048::HIS3 resulted in 
loss of peptide uptake. The transport activity could be fully restored after transformation of the 
deletion mutant by plasmid-encoded YLL048. The ORF encodes a full-length ABC transporter 
which showed overlapping substrate spectrum with TAP and the same subcellular localisation. 
YLL048p is so far the first ABC transporter of S. cerevisiae mainly localised in the ER.  
 
To clarify the subcellular localisation of the transporter several strategies were followed. 
First, we tried to generate a specific antibody against the linker region as well as the C-terminus 
of this ABC transporter. However, no specific antisera were obtained. Secondly, chromosomal 
tagging was tried in order to introduce an antibody-tag or GFP to YLL048. Unfortunately, after 
homologous recombination the ABC transporter was either not expressed or rapidly degraded. 
Lacking tools to identify the localisation of YLL048p, subcellular fractionation experiments in 
sucrose gradients were performed and peptide transport activity of all fractions was measured. 
Fractions corresponding to the ER showed a significantly increased ATP-dependent peptide 
transport activity. Fractions corresponding to vacuoles were identified by using α-mannosidase 
as reporter enzyme and did not show any peptide uptake.  
In order to confirm the ER localisation of the transporter, glycosylation of NXT recognition 
sites of the reporter peptide was investigated. However, the transported peptides were very 
inefficiently glycosylated. One explanation might be that the glycosylation machinery of yeast did 
not accept peptides as substrates, although the reporter peptide R10T was successfully 
glycosylated in human and insect cell microsomes after import by TAP. The functionality of the 
glycosylation machinery of the isolated yeast microsomes was demonstrated using acetylated 
tripeptide (Ac-NYT-NH2) (Wieland et al., 1987; Römisch and Schekman, 1992). 
 
Interestingly, YLL048 was previously described to encode a bile acid transporter (BAT1p) 
localised in vacuoles and secretory vesicles (Ortiz et al., 1997). In line with published data we 
demonstrated an ATP-dependent [
3H]-taurocholate uptake mediated by YLL048 into subcellular 
organelles. The ∆yll048 strain did not exhibit any bile acid transport activity. Furthermore, it was Discussion    
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shown that bile acids competed with peptides for transport. The transporter had a higher affinity 
for peptides than for bile acids. For efficient competition taurocholate had to be used in 
concentration of 1.5 mM, where this reagent based on its amphiphilic character might already 
function as detergent disrupting the integrity of the membrane.  
 
The physiological function of YLL048p is still not well understood. The gene product is 
not essential for cell viability as deletion mutants did not show any phenotype. It is difficult to 
imagine that YLL048p acts as a taurocholate uptake system because yeast cells do not have 
any bile acid metabolism. It was discussed that Bat1p might be responsible for vacuolar 
sequestration of heme-derived catabolites, which could be considered as bile-like molecules in 
yeast (Ortiz et al., 1997). A highly increased toxicity of bile acids was reported towards the PDR1, 
PDR3 double disruptant mutants (Kolaczkowski et al., 2002) suggesting Bat1p as a new 
member of the PDR network. However, we could not observe an influence of the Pdr1p and 
Pdr3p on the transcription level of YLL048.  
 
We have characterised YLL048p as a specific peptide uptake system of yeast ER. The 
physiological relevance of peptide uptake into the ER is not clarified yet. Here, the possibility 
was investigated whether YLL048p might be part of a novel route of peptide trafficking in yeast 
involved in the unfolded protein response (UPR) (Higashio and Kohno, 2002). However, 
upregulation of YLL048 transcription induced by heat shock as well as under stress conditions  
was not observed.    Zusammenfassung 
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7 ZUSAMMENFASSUNG 
Der Transport von Molekülen über Membranen stellt einen vektoriellen Prozess dar, 
der den Stoffaustausch und die Kommunikation der einzelnen Kompartimente untereinander 
sowie mit der extrazellulären Umgebung ermöglicht. ABC (ATP-Binding Cassette) 
Transporter stellen eine der grössten Superfamilie von Membranproteinen dar, die den 
aktiven Transport von unterschiedlichen Substanzen über biologische Membranen 
bewerkstelligen. ABC Transporter sind in allen drei Domänen des Lebens vertreten, wo sie 
eine Vielzahl von zellulären Funktionen ausüben. In Bakterien dienen ABC Transporter 
häufig der Nahrungsaufnahme. Andere bakterielle Transporter sind an der 
Resistenzentwicklung beteiligt, indem sie Antibiotika und Toxine aus dem Cytosol 
exportieren. In Eukaryoten erfüllt diese Proteinfamilie vielfältige Funktionen und neben der 
Transportaktivität können diese Proteine als Ionenkanäle, Regulatoren von Kanälen oder 
Rezeptoren arbeiten. Einige Vertreter weisen eine hohe klinische Relevanz auf. 
Beispielsweise ist die Mutation des ABC Transporters CFTR die molekulare Grundlage für 
die Entstehung der cystischen Fibrose. Andere Vertreter dieser Proteinfamilie sind an der 
Entwicklung der Multidrogenresistenz beteiligt, und ihre Überexpression stellt ein 
ernstzunehmendes Problem bei der Behandlung von Tumoren und AIDS durch 
Chemotherapie dar. Daher sind die Aufklärung des Transportmechanismus sowie die 
potentielle Inhibition des Transporters von zentraler Bedeutung. 
Alle ABC Transporter weisen den gleichen modularen Aufbau aus vier Untereinheiten 
auf.. Zwei Transmembrandomänen (TMD) durchspannen die Membran mehrfach und bilden 
die Translokationspore für das Substrat. Die zwei löslichen Nukleotidbindedomänen (NBD) 
energetisieren den Transportprozess durch ATP Hydrolyse. Die ATP Bindung und 
Hydrolyse findet an stark konservierten Regionen der NBD statt: der Walker A und Walker B 
Sequenz sowie dem C-Loop.  
Kommunikation und Kooperation der einzelnen Untereinheiten sind von zentraler 
Bedeutung, um den Transportprozess effizient zu leisten. Ziel dieser Arbeit war die 
Aufklärung des molekularen Mechanismus, durch den Substrattranslokation an ATP-
Hydrolyse gekoppelt wird. Dabei diente mir der Peptidtransport, der durch ABC Transporter 
in der Hefe ausgeführt wird, als Modellsystem. Die Bäckerhefe stellt aufgrund leichter 
genetischer Manipulierbarkeit und schneller Produktion von Biomasse einen idealen 
Modellorganismus dar. Der ABC Transporter TAP (transporter associated with antigen 
processing) konnte erfolgreich in der Hefe exprimiert werden. Der Transportkomplex ist für Zusammenfassung    
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die Translokation antigener Peptide vom Cytosol ins ER verantwortlich und nimmt eine 
zentrale Funktion bei der Antigenpräsentation ein. Als TAP-homologes Protein wurde Mdl1p 
(multidrug resistance like) im Genom der Hefe S. cerevisiae beschrieben und als 
Peptidtransporter der inneren Mitochondrienmembran identifiziert.  
Ziel dieser Arbeit war die funktionalle Charakterisierung von Mdl1p. Die inneren 
Mitochondrienmembran ist neben der Chloroplastenmembran die einzige zelluläre Membran, 
die nicht mit dem Cytosol in Kontakt tritt und folglich nicht der Qualitätskontrolle durch das 
Ubiquitin/Proteasomsystem unterliegt. Daher verfügen Mitochondrien über eine autonome 
ATP-abhängige Qualitätskontrolle, die durch einen proteolytischen Multienzymkomplex 
vermittelt wird. Die AAA-Proteasen (ATPase associated with a variety of cellular activities) 
sind für den Abbau von missgefalteten Proteinen der inneren Mitochondrienmembran 
verantwortlich. Mdl1p exportiert Peptide, die als Degradationsprodukte von missgefalteten 
Proteinen in der Matrix entstehen, in den Intermembranraum des Mitochondriums. Mdl1p 
bildet einen Homodimer, wobei jede Untereinheit aus einer TMD und einer NBD besteht. 
Der Mechanismus der Peptidtranslokation und deren Energetisierung sind auf molekularer 
Ebene nicht aufgeklärt und wurden im Rahmen dieser Arbeit untersucht. Um die 
Arbeitsweise von Mdl1p zu versehen, wurde Mdl1p in S. cerevisiae und E. coli exprimiert 
und anschliessend partiell reinigt. Es wurde gezeigt, dass Mdl1p funktional hinsichtlich ATP 
Bindung war. Um Peptidtransportaktivitäten in vitro zu messen, wurde aus 
Hefemitochondrien partiell gereinigtes Mdl1p in Proteoliposomen rekonstituiert. Es konnte 
jedoch kein Peptidtransport nachgewiesen werden. Weiterführende Experimente sollen die 
Substratspezifität des Transporters im rekonstituierten System ermitteln. Um die Aktivität 
des Transporters in vivo zu untersuchen, wurde die Strategie verfolgt, durch Deletion der 
klassichen N-terminalen Signalsequenz Mdl1p ins ER zu dirigieren. Durch diese 
Modifikation sollte eine Mdl1p Mutante generiert werden, die als Importer fungiert und so 
eine leichtere Messung der Peptidtransportaktivität ermöglicht. Überraschenderweise wurde 
beobachtet, dass die um 59 Aminosäuren N-terminal verkürzte Variante ebenfalls ins 
Mitochondrium dirigiert wird. Diese Beobachtung lässt die Vermutung zu, dass zusätzlich zu 
der klassischen N-terminalen Präsequenz eine redundante interne Signalsequenz vorliegt, 
wie sie z.B. für die Zielsteuerung des mitochondrialen ADP/ATP carriers beschrieben wurde.  
Aufgrund seines modulartigen Aufbaus konnte der ABC Transporter Mdl1p in seine 
N-terminale TMD und C-terminale NBD unterteilt werden. Die lösliche NBD wurde in E. coli 
überexprimiert und über einen Affinitätstag zur Homogenität gereinigt. Dabei wurde eine    Zusammenfassung 
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Ausbeute von 50 mg Protein pro 1 L Zellkultur erzielt, und das Protein konnte auf 30 mg/ml 
konzentriert werden. Die Aktivität des Proteins wurde bezüglich ATP Bindung und Hydrolyse 
demonstriert. Die ATPase Aktivität folgte einer Michaelis-Menten Kinetik mit einer 
maximalen Wechselzahl von 0.5 ATP/min und einem Km-Wert von 0.2 mM. Hinsichtlich der 
ATPase Aktivität zeigte die isolierte NBD keine Kooperativität, jedoch war die ATPase 
Aktivität nicht linear von der Proteinkonzentrations abhängig. Diese Beobachtung liess auf 
einen nicht monomeren Zwischenzustand im ATPase Zyklus schliessen. Es ist beschrieben, 
dass andere isolierte NBDs wie z.B. HisP und MalK ebenfalls keine Kooperativität in der 
ATPase Aktivität zeigen. Eine kooperative ATPase Aktivität konnte jedoch in den ABC 
Transportkomplex wie HisQMP2 und MalFGK2 nachgewiesen werden. 
Gelfiltrationsexperimente, wie sie an isolierten NBDs wie z.B HisP oder MalK durchgeführt 
wurden, haben keinen Dimer nachweisen können. Zum ersten Mal ist es uns gelungen, 
einen dimeren Zwischenzustand der Wildtyp-NBD unter dem Einfluss von ATPase 
Inhibitoren wie ortho-Vanadat oder Berylliumfluorid in der Gelfiltration zu beobachten. Ortho-
Vanadat und BeFx stellen Analoga des anorganischen Phosphates dar. Sie stabilisieren 
einen Enzymzustand während der ATP Hydrolyse, in dem das ADP Molekül in der 
Bindungstasche erhalten bleibt, während das Phosphat bereits dissoziert ist. Eine 
Stöchiometriebestimmung hat ergeben, dass der Dimer symmetrisch mit zwei Nukleotiden 
beladen war. Beide Nukleotide lagen in hydrolysierter Form vor. 
Mutation des konservierten Glutamats stromabwärts des Walker B Motivs führte zu 
einer ATPase inaktiven NBD (E599). Diese Mutante bildete in Gegenwart von ATP einen 
stabilen Dimer. Die Stöchiometrieuntersuchungen an dem E599Q Dimer haben gezeigt, 
dass zwei Nukleotide inkorporiert waren. Nach einer Inkubation auf Eis in Abwesenheit von 
Mg
2+ blieben zwei ATP Moleküle im Dimer erhalten. Wurde jedoch die NBD in Gegenwart 
von Mg
2+ bei 30°C inkubiert, konnte ein Dimer isoliert werden, in dem ein ATP und ein ADP 
in das Molekül eingebaut waren. Obwohl die Inkubation auf mehrere Stunden verlängert 
wurde, konnte kein Dimer mit zwei ADP Molekülen isoliert wird. Dieses Ergebnis zeigte, 
dass zumindest ein ATP Molekül zur Erhaltung des Dimers erforderlich war. Hydrolyse 
beider Nukleotide führte zu Dissoziation des Komplexes.  
Basierend auf diesen Ergebnissen konnte ein Modell für die ATP-Hydrolyse erstellt 
werden, in dem die Bindung der Nukleotide an die monomeren Untereinheiten eine 
Assoziation der NBD induziert. Zwei ATP Moleküle werden sequentiell hydrolysiert, bevor 
der Dimer mit gebundenen ADP Molekülen dissoziert.  Zusammenfassung    
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  Im zweiten Teilprojekt dieser Arbeit wurde ein intrazellulärer Peptid ABC Transporter 
charakterisiert, der durch den Leserahmen YLL048 im Hefegenom kodiert wird. In Analogie 
zu TAP transportiert YLL048p unter Hydrolyse von ATP Peptide in das Lumen des 
endoplasmatischen Reticulums. Durch den Einsatz von zufallsgerichteten Peptid-
bibliotheken wurde die Substratspezifität des Transporters im Detail untersucht. Dabei 
wurde gezeigt, dass der neu entdeckte Transporter eine Längenspezifität von 6 bis über 56 
Aminosäuren aufweist. Ausserdem konnte gezeigt werden, dass Peptide mit D-Aminosäuren, 
die an unterschiedlichen Positionen eingeführt wurden, als Substrat erkannt werden. Eine 
mögliche physiologische Bedeutung des Peptidtransporters für die Hefezelle konnte nicht 
ermittelt werden. Die Deletion des YLL048 Gens zeigte keinen Phänotyp. Stressfaktoren wie 
erhöhte Osmolarität oder Hitzeschock führten zu keiner erhöhten Transkription des Gens. 
Ferner konnte ausgeschlossen werden, dass die Transkriptionsfaktoren Pdr1p und Pdr3p 
die Expressionsrate von YLL048 beeinflussen. 
 
  Im dritten Teilprojekt wurde ein autokriner Stimulationsassay entworfen, durch den in 
Hefe exprimierte TAP Mutanten auf Funktionalität überprüft werden sollten. Eine 
erfolgreiche Expression des Wildtyp-TAP-Komplexes in dem Hefestamm W303-1A konnte 
bereits etabliert werden. Um eine schnelle und effiziente Selektion von TAP Mutanten zu 
ermöglichen, wurde die Sekretion von Peptidpheromonen unter die Kontrolle der TAP 
Aktivität gestellt. Im Prinzip beruhte der Test auf dem Paarungsverhalten der Hefe, das 
durch die Peptidpheromone a- und α-Faktor vermittelt wird. Hefezellen des Paarungstyps 
MATa sezernieren den a-Faktor über den ABC Transporter Ste6 ins Medium, der die 
Hefezellen des MATα-Paarungstyps zur Konjugation stimuliert. Umgekehrt sezernieren 
Hefezellen des Paarungstyps MATα über den klassischen Sekretionsweg den α-Faktor. Der 
α-Faktor wird natürlicherweise als ein Vorläufermolekül von 120 Aminosäuren exprimiert, 
der über eine klassische Pre-pro-Sequenz verfügt. Nach ihrer Sekretion werden die 
Pheromone von G-Protein gekoppelten Rezeptoren Ste2 oder Ste3 auf der jeweiligen 
Zelloberfläche erkannt. Dadurch wird eine MAPK vermittelte Signaltransduktion in den 
Zellen induziert, die schliesslich zur Verschmelzung der Zellen unterschiedlichen 
Paarungstypes führt.  
  Da gezeigt werden konnte, dass der reife α-Faktor von TAP in vitro transportiert 
wurde, sollte die Sekretion des α-Faktors unter die Kontrolle des TAP-Transportes gestellt    Zusammenfassung 
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werden. Dazu wurde im vorliegenden Versuchsansatz der reife α-Faktor in a-Zellen 
exprimiert. Um seine Sekretion über das ER und Golgi-Kompartiment zu unterbinden, wurde 
die klassische Pre-pro-Sequenz vom α-Faktor deletiert. Der cytoplasmatisch exprimierte α-
Faktor sollte vom TAP-Komplex ins Periplasma gelangen und somit einen autokrinen 
Stimulus an der Zelloberfläche erzeugen. Für diesen Stimulationsassay standen Zellen zur 
Verfügung, deren aktivierte MAPK Kaskade in der Induktion von Genen endete, die das 
Wachstum der Hefezellen von Histidin Auxotrophie auf Prototrophie umstellen. Die 
Funktionalität der autokrinen Signalkaskade wurde durch extern zugeführten α-Faktor 
überprüft. Zugabe des α-Faktors in einer Konzentration von 100 nM führte zum Wachstum 
der Zellen in Abwesenheit von Histidin. Desweiteren konnte die cytoplasmatische 
Expression des α-Faktors gezeigt werden. Jedoch zeigte der TAP transformierte Hefe-
stamm kein Wachstum in Abwesenheit von Histidin. Aus unbekannten Gründen konnte 
keine Expression von TAP in dem verwendeten Stamm gezeigt werden. Anscheinend 
konnte der Hefe intrinsischen YLL048 Peptidtransporter den α-Faktor ebenfalls nicht oder 
nicht effizient ins ER befördern, obwohl in vitro Transportexperimente gezeigt haben, dass 
YLL048p den α-Faktor als Substrat erkennt. Möglicherweise ist die cytoplasmatisch 
exprimierte Konzentration des α-Faktor zu gering, um effizient ins ER zu gelangen. Es ist 
auch vorstellbar, dass Proteasen im Cytosol den α-Faktor degradieren, bevor er ins ER 
gelangen kann.    Summary 
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8 Summary   
The mechanism of peptide transport has been studied on two different ABC transporters 
of S. cerevisiae. Thereby, the aim of this PhD thesis was to characterise the transporter function 
on molecular level and shed light on the physiological role of these transporters. 
 
The ABC gene YLL048 encodes a novel intracellular transporter translocating peptides 
from the cytosol to the lumen of the ER. Deletion of the gene resulted in loss of peptide transport 
activity. The transport activity was fully restored after transformation of the deletion mutant by 
plasmid-encoded YLL048. Studying the substrate specificity using randomized peptide libraries it 
was demonstrated that peptides of the size from 6 to 56 amino acids are recognized. So far, no 
upper limit of the substrate size was obtained. Introduction of D-amino acids in various positions 
of a nonamer peptide did not impair transport activity. The physiological function of YLL048p is 
not well understood. The gene product is not essential for cell viability as the deletion mutant did 
not show any growth phenotype. To examine the possibility that YLL048 encoded protein is part 
of a quality control of yeast cells involved in the unfolded protein response (UPR), upregulation 
of YLL048 transcription by heat shock and stress conditions were investigated. We could not 
observe an influence of stress factors on YLL048 mRNA level. Upregulation of gene expression 
by the transcription factors Pdr1p and Pdr3p was excluded. 
 
The ABC transporter Mdl1p has been identified as peptide transporter of the inner 
mitochondrial membrane. This protein is required for the export of peptides with the size of 6 to 
21 amino acids from the matrix into the intermembrane space. These peptides are generated by 
m-AAA proteases degrading non-assembled or missfolded membrane proteins. In order to 
understand the transport mechanism in detail, Mdl1p was expressed in S. cerevisiae and E. coli. 
Partially enriched protein was reconstituted into liposomes and was active in ATP binding. The 
association of the NBDs has been described as a central step of the ATPase cycle of ABC 
transporters, but it is still controversial how both motor domains cooperate and coordinate ATP 
hydrolysis. To address this question, the Mdl1p-NBD was overexpressed in E. coli and purified 
to homogeneity. The isolated NBD was active in ATP binding and hydrolysis with a turnover of 
0.5 ATP per min and a Km value of 0.2 mM. Isolated NBDs did not show cooperativity in ATPase 
activity. However, the ATPase activity was observed to be non-linearly dependent on protein 
concentration suggesting the active form of this enzyme is not a monomer. Very importantly, for 
the first time an ATP-induced dimer was observed after trapping the NBD by ortho-vanadate or 
BeFx. The nucleotide composition of the trapped intermediate state was determined and two Summary    
116 
ADP molecules were simultaneously bound per dimer. An ATP-induced dimer of the ATPase 
inactive mutant (E559Q) was observed already in the absence of ATPase inhibitor. The E599Q 
dimer contained two ATP molecules in the absence of Mg
2+ at 4°C. Prolonged incubation at 
30°C in the presence of Mg
2+ induced a stable dimer in which one ATP and ADP molecule were 
trapped at the same time. Based on these experiments, a new cycle for ATPase activity of ABC 
transporters was proposed. Binding of ATP to two NBD monomers induces dimerization. Both 
nucleotides are hydrolysed sequentially. During the hydrolysis cycle the nucleotides cannot be 
released from the dimer. After hydrolysis of two ATP molecules the domains dissociate and start 
a new cycle.  
 
    Appendix 
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9 Appendix 
9.1  Thiol-specific labelling of NBDs to assay dimerization by FRET 
Although gelfiltration was a useful method to detect dimer formation, the disadvantage of 
this method is the time required for separation of proteins. This makes it impossible to follow fast 
processes. To determine the association or dissociation kinetics of proteins, it is useful to 
measure the formation of the dimer in real-time e.g. by fluorescent resonance energy transfer 
(FRET). In FRET, nonradiative energy transfer occurs between two fluorophores. The energy 
transfer is based on an overlapping of the emission spectrum of the donor fluorophore with the 
excitation spectrum of the acceptor fluorophore. Because the efficiency of FRET decays with the 
sixth power of the donor-to-acceptor distance, the maximum separation allowing detectable 
FRET is about 100 Å. As energy transfer reports molecular proximity, it is possible to monitor 
dimerization of NBD by labelling each with two different fluorescent dyes.  
The Mdl1p-NBD contains three cysteines, one of them is located three amino acids 
upstream of the Walker A sequence. From three dimensional structural prediction analysis this 
cysteine is highly embedded into the interior of the protein and probably not accessible for 
labelling. The other two cysteines are placed between the Q- and L-loop and should be 
accessible for derivatization by thiol-reactive dyes. One batch of the NBD was coupled to 
maleimide derivatized Oregon Green (OG) which has its excitation maximum at 490 nm and its 
emission maximum at 515 nm. The other batch of NBD was coupled to Texas Red (TR) which 
has its excitation maximum at 580 nm and its emission maximum at 600 nm. The TR-labelled 
NBD functions as acceptor whereas the OG-labelled NBD is the donor in FRET. After excitation 
at 490 nm the formation of the dimer consisting of two different dyes (50 %) is monitored by 
increasing emission at 600 nm of the acceptor or by quenching of donor fluorescence.  
After labelling, the NBD was analysed for dimerization. In gelfiltration experiments 
labelled NBD and unmodified NBD were mixed in an equimolar ratio and trapped by BeFx in the 
presence of MgATP (Fig.45). Only the unmodified NBDs formed a dimer. Obviously, the NBDs 
lost their ability to dimerize after the labelling reaction. To exclude that conditions during the 
labelling reaction had some negative effect, the NBDs was incubated with 0.1% methanol, which 
is the final concentration of methanol in the labelling reaction, mixed with an appropriate amount 
of glutathione and applied to a desalting column. After this procedure the NBDs remained active 
for dimerization (data not shown). As a control, the cysteines of the NBD were derivatized by 
iodacetamide, a thiol-reactive reagent, and again after this modification the NBDs lost their 
ability to dimerize (data not shown). It seems that some of the labelled cysteines or their 
molecular environment is critical for dimerization or ATP binding. Appendix    
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Fig.45 : Analytic gelfiltration of fluorescent labelled wild-type NBD. 
A: Oregon Green-labelled NBD (30µM] was applied to gelfitration (Superdex 75). 
B: After preincubation of a 1:1 mixture of Oregone Green-labelled NBD (15 µM) and non-labelled NBD with 1 mM 
BeFx in the presence of 1 mM MgATP at 37°C, only the non-labelled NBD formed a dimer. The labelled NBD 
remained as a monomer as checked by OD 490 nm. 
C: Incubation of Texas Red-labelled NBD (15 µM) with an equimolar concentration of non-labelled NBD in the 
presence of 1 mM BeFx and 1 mM MgATP at 37°C, showed dimer formation exclusively between non-labelled NBD. 
The labelled NBD remained as a monomer as checked by OD 580 nm. 
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9.2 Heterologous  expression  of transmembrane domain in E.coli 
In bacterial systems the subunits of ABC transporters are mostly encoded as separate 
polypeptides e.g. HisQMP2 or MALFGK2 (Bavoil et al., 1980; Ames and Lever, 1970). After their 
expression the NBD and TMD associate to a functional transport complex. Mdl1p is a half-size 
transporter in which a TMD is fused with a NBD in one polypeptide. However, we established the 
functional expression of the isolated NBD in E. coli. In the next step, we tried to express the 
TMD in E. coli as well. After expression and purification of both subunits we analysed whether 
NBDs and TMDs resemble the transport complex in vitro.  
The TMD without the mitochondrial targeting sequence (59 aa to 422aa) was cloned into 
pET28b under the control of T7 promotor. This construct contains an N-terminal as well as a C-
terminal His6-tag. BL21(DE3) cells transformed with pET28-TMD were induced by IPTG. Inner 
membranes were isolated and solubilized with 30 mM DM, ultracentrifuged and the supernatant 
was applied to a Ni-IDA HiTrap column. After washing with 80 mM and 100 mM imidazole the 
membrane protein was eluted with 250 mM imidazole (Fig.46). The affinity purification of this 
construct was promising as an isolated peak was eluted by high imidazole concentrations. The 
eluted fractions were checked by Western blot using α-Ni-NTA alkine phosphatase conjugate to 
detect His-tagged proteins. A single band of 33 kDa corresponding to the size of TMD was 
demonstrated. As α-Mdl1 is directed against the last C-terminal 15 amino acids of the protein, it 
does not recognize the transmembrane part as an epitope and could not be used. The purified 
fractions were applied to SDS-PAGE and the gel was silver stained revealing a high degree of 
impurities. Therefore, further chromatographies have to follow in order to obtain pure protein. 
The TMD fractions were mixed with purified NBD and analysed for ATPase activity in the 
presence of two different peptides (R9LQK, R10T). No substrate stimulated ATPase could be 
observed (data not shown). This might be due to the inability of the NBD and TMD of Mdl1p to 
reorganize a full-length transporter after separate expression. 
. Appendix    
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Fig.46: Heterologous expression of TMD in E.coli and purification by His-tag. 
A: BL21(DE3) cells transformed with pET28-TMD were induced at OD 0.5 with 0.2 mM IPTG for 3 h at 30°C. After cell 
lysis debris were removed by 20.000 x g for 20 min and the supernatant was centrifuged by 100.000 x g for 1 h. The 
membrane pellet was solubilized with 30 mM DM for 1 h on ice, centrifuged at 20.000 x g for 15 min and the 
supernatant was applied to a Ni-IDA Hitrap column. The column was washed with a step gradient of 80 mM and 100 
mM imidazole buffer containing 3 mM DM.  Protein was eluted with 250 mM imidazole.  
B: The fractions were analysed by SDS-PAGE and immunostaining with Ni-NTA alkine phosphatase conjugate.  
S: solubilized membranes, FT: flow through 
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9.3 Abbreviations 
 
ABC   ATP-binding  cassette 
AHT   anhydrotetracycline 
ADP   adenosine  diphosphate 
ATP   adenosine  triphosphate 
CDP   cytidine  diphosphate 
CTP   cytidine  triphosphate 
DMSO   dimethyl-sulphate 
DTT   1,4-ditho-DL-threitol 
EDTA   ethylenediamine tetraacetic acid 
EGTA   ethylene glycol-bis(2-aminoethylether)-N,N,N´,N´-tetraacetic acid 
ER   endoplasmic  reticulum 
GDP   guanosine  diphosphate 
GTP   guanosine  triphosphate 
HEPES  N-(2-hydroxyethylpiperazine)-N`-2-ethanesulfonic acid 
IDA   iminodiacetic  acid 
IPTG   isopropyl  β-D-thiogalactopyranoside 
LB   Luria  broth 
LEU   leucin 
MHC   major  histocompatibility  complex 
NBD    nucleotide binding domain 
NTA   nitrilotriacetic  acid 
NP40   nonaethylenglycol-p-isooctophenyl ether 
NTA   nitrilotriacetic  acid 
OD600    optical densitiy at 600 nm 
o/n   overnight 
ORF     open reading frame 
PAGE   polyacrylamide gel electrophoreseis 
PBS   phosphate-buffered  saline 
P-gp   P-glycoprotein 
Pi   inorganic  phosphate 
PMSF   phenylmethonylsulfonyl fluoride Appendix    
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RT   room  temperature 
SDS   sodium  dodecyl  sulphate 
TBS   Tris-buffered  saline 
TCA   trichloracetic  acid 
TMD   transmembrane  domain 
Tris   tris-(hydroxymethyl)aminomethane 
UDP   uridine  diphosphate 
UTP   uridine  triphosphate 
YPD   yeast  peptone  dextrose 
wt   wild  type 
MALDI-TOF  matrix-assisted laser desorption ionization - time of flight 
TLC   thin  layer  chromatography 
IMAC    immobilized metal affinity chromatography 
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